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Introduction  
Cigarette smoking  poses a great economic cost on the U.S. health care system by incurring  high 
health care expenditure and health care utilization in the adult population. Although there is a 
sufficient amount of information on the health care cost associated with cigarette smoking  there 
is a gap in how other forms of tobacco use may impact healthcare expenditures  and utilization in 
comparison to cigarette smoking. The main objectives of this study were: 1) to  estimate and 
compare health care expenditure and health care utilization across different tobacco use groups  
(i.e. current exclusive cigarette smokers, current exclusive smokeless tobacco users and never 
tobacco users) using nationally representative data 2) to estimate and compare health care 
utilization across different tobacco use groups. 




Data used in this study was obtained from linking individual-level data from two nationally 
representative data sources, 2009–2016 Medical Expenditure Panel Survey (MEPS) with 2011–
2017 National Health Interview Survey (NHIS). The outcomes of  interest were health care 
expenditure and health care utilization. Sociodemographic, health status, selected comorbidity 
and tobacco use status variables were collected from the NHIS and MEPS data. Tobacco use 
groups were categorized into three groups based on self-reported tobacco use history as 
exclusive current cigarette smoker, exclusive current smokeless tobacco use and never tobacco 
users. Econometric models were used to estimate annual mean total health care expenditures and 
health care utilization by tobacco use status adjusting for several covariates.    
Results   
Current exclusive cigarette smokers tended to be more likely to have one or more ER visits than 
current exclusive smokeless tobacco users (p-value =0.0161) and never tobacco users (p-value 
=0.0009). Modeling results adjusting for sociodemographic and health status variables  indicated 
that current exclusive smokeless tobacco users and current exclusive cigarette smokers were not 
statistically significantly different than never tobacco users  in their utilization of the health care 
services measured (i.e. with at least one ER visit, office-based visit, hospital outpatient visit, 
hospital inpatient visit, home health care visit  and dental visit in the past 12 months). 
Although no statistical association was found between total health care expenditure and tobacco 
use status  at a 5% significant level. The highest annual mean total health care expenditure in US 
2017 dollars was observed in the current exclusive cigarette smoking group $5627.64 (95% CI = 
$4068.50, $7186.78) followed by current exclusive smokeless users $4478.33 (95% CI = 
$3035.05, $5921.62)  and never tobacco users had the lowest annual mean cost  $4426.89 (95% 







Cigarette smoking has a heavy economic burden on the U.S. population.  This study is the first to 
compare medical expenditure and health care utilization associated with current exclusive use of 
different tobacco products of in U.S. adults’ over time.  More data may be needed to obtain more 
conclusive results. This study shows the promise in the potential of  reducing healthcare 
expenditure and utilization by aiding cigarette smokers down the continuum of risk of nicotine 
























































Although adult cigarette smoking prevalence has declined over the past decades, tobacco use 
remains the leading preventable cause of death and disease in the United States.1 The most recent 
Surgeon General’s report on the health consequences of smoking estimated that for the years 
2009–2012, annual smoking-attributable economic costs in the United States were between 
$289–332.5 billion, and $132.5–175.9 billion was spent for direct medical care of adult cigarette 
smokers.2  Indirect cost due to lost productivity was estimated at  approximately $157 billion 
from 2005-2009.2   
Several nationally representative studies found  higher rates of health care utilization (i.e. 
hospitalizations and outpatient visits) in adult cigarette smokers compared to never smokers.3-5 
During the last two decades there has been a vast amount of literature estimating the healthcare 
utilization and/or medical expenditures attributable to cigarette smoking.2,6-12   The current 
literature tends to focus on health care expenditure of cigarette smokers and/or former cigarette 
smokers.12,13 
While there is a sufficient amount of information that indicates a heavy economic impact of adult 
cigarette consumption on the U.S. healthcare system, there is still a gap in how other forms of 
tobacco use may impact healthcare expenditures  and utilization in comparison to cigarette 




of tobacco, like smokeless tobacco products. These are non-combustible tobacco products that 
have high use prevalence and have been available in the U.S. for decades.  
This study fills a gap in the literature by providing  a better understanding of health care 
expenditures and health care utilization in the U.S. population across the spectrum of current 
adult tobacco consumers using nationally representative data. This study would be the first to 
investigate and compare health care expenditures and use between current exclusive use of 
cigarettes and smokeless tobacco products, which have both been on the market for decades. 
This study is based on the payer’s perspective and may aid in both health and insurance policy 
making.  These analyses also have potential societal implications by determining whether the 
economic cost across the spectrum of tobacco products is reflective of the Tobacco Harm 
Reduction Model. 
Background information, theoretical framework, study rationale and specific aims are provided 
in the remainder of  Chapter 1. A systematic review of the literature on health care expense and 
utilization and tobacco usage is provided in Chapter 2. The methods and results for this study are 
presented in Chapters 3 and 4, respectively. The study conclusions, discussion of the study 


















Economic Cost of Cigarette smoking 
 
In the U.S., cigarette smoking  remains the leading cause of preventable diseases, disabilities and 
death and is associated with increased risk of lung cancer, cardiovascular disease, and chronic 
respiratory conditions.2   Even with declines in the prevalence of current cigarette smoking, the 
annual burden of smoking-attributable mortality in the United States has remained above 
400,000 for more than a decade and millions more live with smoking-related diseases.2 
According to the latest Surgeon General report on the health consequences of smoking, cigarette 
smoking causes about one in every five deaths annually and the life expectancy of cigarette 
smokers is about 10 years shorter than non-cigarette smokers in the U.S.2  The Centers for 
Disease Control and Prevention reported that, “smoking is the primary causal factor for at least 
30% of all cancer deaths, for nearly 80% of deaths from chronic obstructive pulmonary 
disease(COPD), and for early cardiovascular disease and deaths.”14 
The dominant cause of COPD in men and women in the United States has been found to be 
associated with cigarette smoking. COPD causes emphysema and damage to the airways.2,15 
Increased risk for pulmonary infections is also associated with cigarette smoking through the 
weakening of the smoker’s immune system.  A causal relationship has also been established 




A vast body of literature reported in the most recent U.S. Surgeon General’s report on the health 
consequences of smoking has shown that cigarette smokers are at a greater risk than non-
cigarette smokers for  cardiovascular diseases (i.e. diseases that affect the heart and blood 
vessels), that lead to coronary heart disease, myocardial infarction (MI) and stroke.2 
The above morbidities associated with cigarette smoking  have a substantial impact on health 
care costs resulting in a high economic burden. Annual smoking-attributable economic costs in 
the United States estimated for the years 2009–2012 were between $289–332.5 billion, including 
$132.5–175.9 billion for direct medical care of adults. Indirect cost due to lost productivity (due 
to premature death and exposure to secondhand smoke) was estimated at  approximately $157 
billion from 2005-2009.2   
 
A causal relationship between cigarette smoking and diminished overall health has been 
established. This reduction in overall health among cigarette smokers is showed through self-
reported poor health, increased absenteeism from work, and increased health care utilization and 
cost.2  Although the prevalence of smoking continues to decline in the U.S., smoking-related 
health care expenditures were found to still account for an estimated 5–14% of the total health 
care expenditures as reported by the Congressional Budget Office (CBO) in 2012 and Levy and 
Newhouse.2,16,17 
The CBO estimated annual per capita health care spending among adults ≥ 18 years of age. They 
found that spending tended to be highest among former smokers, and that current smokers had 
greater expenditures than never smokers. In their report they showed an example of adults 45–64 




current smokers, and $5,040 for never smokers. They also report that never smokers had the 
lowest spending in each age group, except for the oldest age groups (i.e. adults ≥ 75 years of age) 
where spending was $1,060 less for current smokers than for never smokers. As noted in the 
CBO report the above findings suggest that current smokers who survive to older ages may be in 
good health regardless of their cigarette smoking or may have a lower propensity to use health 
care. The CBO report and other studies have indicated that cigarette smoking increases the use 




Smoking cessation has been found to reduce the risk of smoking-related disease, reduce 
mortality, increase lifespan and improve well-being, including higher quality of life and 
improved health status.18 Smoking cessation interventions have also been found to be cost-
effective. Quitting smoking at any age is beneficial. However, it has been found that smokers 
who quit by the time they are 35–44 years of age avoid most of the risk of dying from a 
smoking-related disease.19,20  
The Centers for Disease Control and Prevention (CDC) reported that 80 percent of all people 
who smoke see a physician each year and 70 percent of those smokers report that they want to 
quit. However, only about 32 percent attempted to do so using evidence-based counseling and/or 
medication.21  According to the recent Surgeon General’s report on smoking cessation, the use of 
tobacco cessation resources among persons who use tobacco remains low. Of adults 18 years of 
age and older, only 29.0% used cessation medication, 6.8% used any counseling, and only 4.1% 




and colleagues  also reported that the use of counseling and/or medication was lower among 
young adults (16.6%) than among all adults (31.2%).22 
  
Studies have also found that rather than quitting cigarettes all at once a gradual reduction in the 
number of cigarettes smoked per day leading up to a quit attempt may be a preferred approach to 
quitting by smokers who were unwilling/ unable to quit smoking abruptly.23  An analysis of 
nationally representative data from the 2010–2011 Tobacco Use Supplement to the Current 
Population Survey (TUS-CPS) indicated  that over 40% of adult cigarette smokers in the U.S. 
who had tried to quit smoking in the past year reported gradually cutting down on their cigarette 
use as a cessation strategy.24 
The recent Surgeon General’s report on smoking cessation states that, although evidence-based 
cessation counseling and/or medications have increased among adult cigarette smokers since 
2000,  still over two-thirds of adult cigarette smokers who tried to quit during the past year did 
not use an evidence-based cessation treatment.  This report also found a large proportion of adult 
cigarette smokers reported using non-evidence-based approaches when trying to quit smoking 
like switching to other tobacco products such as e-cigarettes and smokeless tobacco.2 
 
Harm Reduction Strategies  
Given the low usage rate of evidence based cessation treatments and the large proportion of 
cigarette smokers who use other tobacco products as a means to quit smoking, a harm reduction 
model may be another viable option to help reduce the economic cost of adult cigarette 




regulations and actions focused on reducing health risks, usually by providing safer forms of 
hazardous products or encouraging less risky behaviors, rather than simply banning products or 
behaviors.25,26 
The harm reduction model is a public health strategy that was first developed in the 1980s for 
adults with substance abuse disorders for whom abstinence was not feasible. Over time, harm 
reduction strategies have been effective in reducing morbidity and mortality associated with 
risky health behaviors.27  
For example, syringe exchange programs in the U.S. that began in the late 1980s at the state and 
local levels have been shown to be extremely effective in reducing human immunodeficiency 
virus (HIV) transmission among persons who inject drugs. Funding for these programs primarily 
comes from state and local governments and the support of the North American Syringe 
Exchange Network (NASEN).  There are currently approximately 200 programs for syringe 
exchange in the U.S. Additional services are also offered at these sites for drug users, which 
include condom distribution, referrals to substance abuse treatment, HIV, hepatitis C virus 
(HCV) and hepatitis B virus (HBV) counseling and testing, overdose education, and naloxone 
distribution to reverse overdose.  
Harm reduction  programs also have an impact on overall sociomedical health. For example, 
access to and use of methadone maintenance programs have been found to be strongly related to 









The harm reduction model in the tobacco space is referred to as the Tobacco Harm Reduction 
Model, which is a public health strategy to lower the health risks to individuals and the broader 
society by using forms of tobacco products other than combustible tobacco products like 
smoking cigarettes.30  A strong public health consensus has formed that not all tobacco products 
present the same risk. Public health authorities agree that there is a broad continuum of risk 
among tobacco products, with cigarettes at the highest end of that spectrum recognizing that 
most of the harm caused by tobacco results from the burning of tobacco.31-33  Completely 
quitting tobacco use is the best option. Figure 1 below shows the continuum of risk for nicotine 
containing products. The Surgeon General Report on the health consequences of smoking has 
acknowledged that the greatest burden of disease and disability arises from combustible tobacco 
products, especially cigarettes, and that moving adult tobacco consumers away from combustible 
tobacco products is a needed outcome.2  Other tobacco products such as smokeless tobacco 
(particularly, low-nitrosamine Swedish snus) are not safe but are up to 90 percent less harmful 
than cigarettes. 34  The case for lower risk for individual users is well established for smokeless 
tobacco use given that it is non- combustible. Smokeless tobacco has not been found to be 
associated with lung cancer or other respiratory diseases, which account for most cigarette-
caused deaths.35 
My study will evaluate whether the economic cost across the spectrum of tobacco products is 
reflective of the Tobacco Harm Reduction Model. This is a reduction in health care expenditure 
with the usage of tobacco products on the lower continuum of risk compared to those on the 













This proposal hypothesizes that current exclusive cigarette smokers will have the highest mean 
medical expenditure and health care utilization,  followed by current exclusive smokeless 
tobacco users,  and never tobacco users (reference group) will have the lowest mean values after 





Sparse peer-reviewed literature on the economic cost of other forms of tobacco products has 
been published. To date there are only two peer-reviewed articles that estimate the healthcare 




and cigars (2018) respectively.36,37  These two articles focus specifically on smokeless tobacco 
and cigar user populations respectively with the primary objective of estimating health care 
utilization and expenditure attributable to these specific tobacco user populations. In these 
studies, a single point in time  was used to calculate the unit costs for health care expenditure for 
major health care utilization measures. A more accurate methodology would be to link personal-
level data on tobacco usage and health care expenditure and utilization, which allows the 
matching of an individual’s services used to their specific costs rather than an estimated average 
cost. 
 The focus of my study is to investigate the difference in health care expenditure and use across 
current exclusive tobacco users which allows for a more accurate estimation of health care 
expenditures and utilization for current exclusive users of a specific tobacco product. Former 
users of tobacco (i.e. former smokeless users and former smokers) are not included in this study. 
The inclusion of the former tobacco user groups may confound health care estimates because 
when an individual quits tobacco use - particularly cigarettes – this may impact health care costs 
given the residual disease risk that former smokers carry after quitting.   
Given the heavy economic cost of direct medical expenditure for adult cigarette smokers and the 
public health consensus on a Tobacco Harm Reduction model, comparing health care 
expenditure and utilization in the U.S. across the spectrum of current users of tobacco products is 
of great relevance. This comparison  will provide a better understanding of the association 
between tobacco use status and health care expenditure and utilization. Cigarettes and smokeless 
tobacco are the two products  that were used for my research, given they are the most commonly 




tobacco products, such as vaping, have only been on the market a short while and would not 
provide a very large dataset. 
The main purpose of my study was to estimate and compare health care expenditures and health 
care utilization associated with current exclusive cigarette smoking, current exclusive smokeless 
tobacco and never tobacco use. The results of this study can be important in health policy 
decision making. This analysis has potential societal implications by determining whether the 
economic cost across the spectrum of tobacco products is reflective of the Tobacco Harm 
Reduction Model. (i.e. a reduction in health care expenditure with the usage of tobacco products 
on extreme ends of the continuum of risk) and is an important advancement to the literature.   
Specific Aims 
 
This study aims to compare health care expenditures and health care utilization across different 
tobacco use groups  (i.e. current exclusive cigarette smokers, current exclusive smokeless 
tobacco users and never tobacco users) using nationally representative data. Below are the 
specific aims for this study: 
Specific Aim 1:  
• Estimate the prevalence of tobacco use by tobacco use status by year of Medical Expenditure 
Panel Survey collection 
• Estimate the prevalence of tobacco use status by age category  
• Assess the distribution of the study sample of adults by tobacco use status and 




• Assess the distribution of the study sample of adults by tobacco use status and selected 
comorbidities  
• Estimate mean annual medical expenditures by tobacco use status.  
Specifics of Aim 2:  
• Assess the distribution of health care utilization by type of health care service and tobacco 
use status 
• Estimate mean annual health care utilization by tobacco use status 
 






















Chapter 2: Literature Review 
 
 
 Literature Review of Healthcare Expenditure and Utilization and Tobacco use  
 
A comprehensive review of the existing body of literature was conducted using 
PubMed/MEDLINE, Cumulative Index of Nursing and Allied Health Literature (CINAHL) and 
Google Scholar. The search strategy combined multiple search terms and MeSH terms to retrieve 
relevant articles including : “Healthcare Expenditure” or “Medical Expenditures”; “Healthcare 
Utilization” or  “ Health Care Services”; “Tobacco Use” or “Tobacco” or  “Nicotine” or 
“Smoking” or “Tobacco Smoking” or “Smokeless” or “Cigarette” or “Cigar”. The following 
inclusion and exclusion criteria were applied after screening through the titles and abstracts: 
Inclusion Criteria : 
1. Evaluates health care expenditure and /or utilization associated with tobacco product use  
2. Articles between 1980 to date (i.e. 2020) 
3. Published in a peer-review journal and in English language 
 
Exclusion Criteria : 
1. Studies conducted on populations outside of the United States 




The refined search yielded 39 articles. A total of 4 studies were identified for full-text review 
after screening titles and abstracts and applying the inclusion and exclusion criteria, see Figure 2 
below.  To evaluate if any other studies that met the inclusion criteria were missed in the initial 
search the references of the 4 studies were reviewed. Table 1 summarizes the 4 studies. 
 






          
Table 1: Summary of Articles Identified from the Literature review 
Author  Outcome Tobacco product Sample Size  Data Source & Time 
Frame 
Findings  
Xu et al. 
201512 
Annual smoking-
attributable  Healthcare  
Spending 
Cigarette Smokers 
1.Current Smoker  
2. Former Smoker who quit     
    within the last 5 years 
3. Former Smoker who quit  
    greater than 5 years 
4. Never Smoker 
~ 41,000 adults 
(unweighted sample) 
(NHIS & MEPS) 
NHIS (2004 -2009) 
MEPS (2006-2010)  
A total of 8.7% (95%CI(6.8%, 11.2%) of annual 
healthcare spending was attributed to smoking 
between 2006 and 2010. Approximately 60% of 
the attributable spending was paid by public 
programs. 
Swedler et al. 
201913 
Medical Expenditure  
  
Cigarette Smokers  
1. Current Smoker  
2. Former Smoker 
3. Never Smoker 
~ 250 million adults 
(weighted sample) 
(NHIS & MEPS) 
NHIS (2009-2014) 
MEPS (2011-2015)  
Never smokers had statistically significantly 
lower expenditures than current and former 
smokers. 
Former smokers  had the highest expenditure but 
was not significantly different than current 
smokers.  
Wang et al. 
201836 
Health Care Utilization 
Health Care Expenditure  
Smokeless Tobacco users  
 
1. Current Smokeless tobacco 
user  
2. Former Smokeless tobacco 
user 
3. Non- Smokeless tobacco  
users  
4. Never tobacco users 
134,451 adults (NHIS) NHIS (2012-2015) 
MEPS 2014 (to 
calculate unit cost of 
health care services) 
Current smokeless tobacco users significantly 
differed from never tobacco users in ER visits in 
the past 12 months but did not differ in the 
number of hospital nights, doctor visits, and home 
care visits.  
Smokeless tobacco use annual excess 
expenditures were estimated  total 3.4 billion 
across all measured health care services.  
Wang et al. 
201837 
Health Care Utilization 
Health Care Expenditure  
Cigars users 
1. Current sole cigar smokers 
2. Current poly cigar smokers 
3. Former sole cigar smokers  
4. Former poly cigar smokers 
5. Other tobacco users  
6.Never tobacco users 
84,178 adults (NHIS ) NHIS 
(2000,2005,2010 and 
2015) 
MEPS 2014 (to 
calculate unit cost of 
health care services) 
Current and former sole cigar smokers were not 
significantly different from never tobacco users in 
their utilization of  the health care services 
measured. 
Sole cigar smoking attributable annual health care 
expenditures were estimated to be ($625 per sole 






Summary of Literature 
 
Xu et al. (2015)12 
Xu et al. conducted an analysis to estimate nationally representative cigarette smoking– 
attributable and associated healthcare spending for U.S. adults 18 years of age and older. Data 
used in this study was obtained from linking individual-level data from two nationally 
representative data sources, 2006–2010 Medical Expenditure Panel Survey (MEPS) with 2004–
2009 National Health Interview Survey (NHIS). MEPS, a subsample of NHIS, is a survey of 
civilian non-institutionalized families and individuals, their medical providers, and employers, 
that collects information on individual healthcare utilization and medical expenditures and tracks 
respondents for 2 years after their NHIS interview. NHIS is a nationally representative cross-
sectional survey of approximately 35,000 households in the US civilian non-institutionalized 
population which collects information on their health and behaviors; including individuals’ 
sociodemographic, tobacco use information, health conditions, health care utilization, and health 
insurance coverage. 
The study data was grouped into four categories based on self-reported cigarette smoking 
history: (1) current cigarette smokers, (2)  former cigarette smokers who quit smoking within the 
last 5 years, (3) former cigarette smokers who quit smoking > 5 years ago and (4) never cigarette 
smokers (reference).  Current cigarette smokers were those who had smoked 100 cigarettes in 
their lifetime and smoked some days or every day at the time of the interview. 
The main outcome of interest for this study was  annual healthcare spending. Estimates from 
two-part models were combined to predict the share of annual healthcare spending that could be 




Current cigarette smokers made up 21.5% of the final sample of adult respondents , 22.6% were 
former cigarette smokers where 6.0% quit within the last 5 years and 16.6% had quit for longer 
than 5 years, and 56.0% were never cigarette smokers. Current smokers were more likely to be 
younger, male and  non-Hispanic white compared to never smokers. The authors measured other 
markers of risk for their potential association with increased health expenditures. They found that 
current cigarette smokers were more likely to believe in overcoming illness without medicine, 
less likely to have health insurance, more likely to report being an excessive drinker and more 
inclined to take risks compared to never smokers. 
The modeling results indicated that a total of 8.7% (95% CI (6.8%, 11.2%) of annual healthcare 
spending (up to $ 170 billion per year) was attributed to cigarette smoking (i.e. current and 
former smokers) between 2006 and 2010 and approximately 60% of attributable spending was 
paid by public programs (i.e. Medicare, other federal paid programs and Medicaid). 
 
Swedler et al. (2019)13 
Swedler et al.13conducted a retrospective study to assess medical expenditures by smoking status 
among US adults age 18 and older. An objective of this study was to provide the most updated 
information (i.e. 2015) on medical expenditure by cigarette smoking status. Data used in this 
study was obtained from 2011–2015 MEPS linked with 2009–2014 NHIS. Like Xu et al12  
individual level information on medical expenditures was obtained from MEPS and self-reported 
smoking related history was obtained from NHIS.  
The study data was grouped into three categories based on self-reported cigarette smoking 




smokers were those who had smoked 100 cigarettes in their lifetime and did not report that they 
quit smoking. Former smokers were those who had smoked 100 cigarettes in their lifetime and 
reported that they had quit smoking. The authors further categorized former smokers by years 
since quitting (i.e. 1, 2 and 5 years-since-quitting). Never smokers were those who had not 
smoked at least 100 cigarettes in their lifetime. 
The main outcome of interest for this study was medical expenditure. Estimated average 
expenditures per individual and marginal costs for individuals by smoking status were obtained 
using a two-part model adjusting for selected covariates such as sociodemographics, health status 
characteristics and comorbidities.  
Of the approximately 250 million weighted sample of adults in the US from 2011-2015 , 19.7 
million identified themselves as current smokers and 23.9 million as former smokers. Of the 
former smokers, 24.4% quit within the prior 5 years, 8.7% quit within the prior 2 years and only 
4.3% quit within 1 year prior to taking the survey.   
Model results estimated that the average medical expenditures for an adult in the US was $4830 
in 2015 US dollars. Never smokers, $4360 (95% CI 4154.3 to 4566.3), had lower medical 
expenditures than current smokers, $5244 (95% CI 4707.9 to 5580.3) and former smokers, 
$5590 (95% CI 5267.4 to 5913.5) . Former smokers had the highest medical expenditure but 
were not significantly different than current smokers. Years-since-quitting in the former smoker 
group did not impact medical expenditures.  
The definition of the never smoking group in this study allows for the inclusion of users of other 
tobacco products and cigarette smokers that did not meet the lifetime criteria of having smoked 




expenditure, the model results may indicate that cigarette smoking (current and former smoker 
who meet the lifetime criteria of being a smoker)  has a bigger impact on medical expenditure 
than use of other tobacco products.  
 
Wang et al. (2018)35 
Wang et al35 conducted a retrospective study to estimate the health care utilization and 
expenditures attributable to the use of smokeless tobacco among US adults age 18 and older. The 
primary data used in this study was from NHIS.   The final data set comprised pooled 2012–2015 
NHIS data containing 139,451 adults age18 years or older. A single point in time from the MEPS 
database (i.e. 2014 MEPS) was used to calculate the unit costs for health care utilization 
measured from NHIS.  
 
This study focused on smokeless tobacco use. Tobacco use status included four mutually 
exclusive groups based on self-reported tobacco use and were defined as follows : (1) current ST 
users, (2) former ST users, (3) non-ST tobacco users, and (4) never tobacco users (as the 
reference). Current smokeless tobacco users were those who now use smokeless tobacco every 
day or some days. Former smokeless tobacco users were those who have used smokeless tobacco 
products at least once and now do not use smokeless tobacco at all. Non-smokeless tobacco users 
comprised respondents who have smoked 100 cigarettes (including current and former cigarette 
smokers) or have ever smoked cigars (regular cigars, little filtered cigars, or cigarillos) or pipes 
(regular pipes, water pipes, or hookah) at least once in their lifetime but have never used 





The main outcome variables in the study were four types of health care utilization obtained from 
NHIS: Hospital nights: measured by the number of nights spent in a hospital receiving inpatient 
care in the last 12 months, Emergency department (ED) visits: number of visits to the ED for the 
respondents’ own health in the past 12 months.  Doctor visits were determined by the answers to 
the following two NHIS Family Core questions: “During the last 2 weeks, did [person] see a 
doctor or other health care professional at a doctor’s office, a clinic, an emergency room, or 
some other place?” and “How many times did [person] visit a doctor or other health care 
professional during the last 2 weeks? Home care visits were determined as the number of home 
care visits by a health care professional that the respondent had received in the past 2 weeks. The 
health care utilization modeling results were used to estimate what the authors refer to as 
smokeless tobacco-attributable health care utilization and smokeless tobacco-attributable health 
care expenditures adjusting for selected covariates. Smokeless tobacco-attributable health care 
utilization was derived by using an “excess utilization” approach which assessed the difference 
between factual and counterfactual predictions to obtain health care utilization attributable to 
smokeless tobacco use using a zero inflated Poisson regression model (ZIP model).  
Of the 136,035 sampled adults, 51.3% were females between ages 34 and 64, 66.4% were non-
Hispanic white, 53.0% were married, 13.4% had less than a High school education, 36.9%  lived 
in the South and 29.6% reported having low income or being poor.  The majority of the sample 
(60%) were overweight or obese, 23.0% were identified as binge drinkers and 14.1% had no 
health insurance during the past 12 months. The prevalence of adults’ current ST use, former ST 
use, non-ST tobacco use, and never tobacco use through 2012–2015 was 2.1%, 7.9%, 39.8%, and 




Based on the modeling results, current smokeless tobacco users had statistically significantly 
more ER visits in the past 12 months than never tobacco users but did not differ in the number of 
hospital nights, doctor visits, and home care visits. The authors reported that based on the 
estimated excess annual utilization, smokeless tobacco use annual excess expenditures were 3.4 
billion in 2014 dollars across all measured health care services. They conclude that smokeless 
tobacco use is associated with excess health care utilization and expenditures. 
Obtaining linking person-level data from NHIS and MEPS over a four-year period would be a 
more accurate methodology in terms of estimating health care utilization and expenditures. This 
enables a participant’s services used to be matched to their specific costs rather than an average 
cost as used in this study (i.e. a single time point in 2014). Also, other types of health care 
utilization data like dental care visits were not included because they are not collected in NHIS.  
 
Wang et al. (2018)36 
This second article by Wang and colleagues conducted an analysis to estimate the health care 
utilization and expenditures attributable to cigar smoking among US adults age 35 and older. 
Primary data used in this study was from NHIS. The final data set included pooled NHIS data 
from 2000, 2005, 2010 and 2015 and contained 84,178 adults. A single point in time from the 
MEPS database (i.e. 2014 MEPS) was used to calculate unit costs for health care utilization 
measured from NHIS.  
This study focused on cigar use with six defined tobacco use statuses based on self-reported 
tobacco use: (1) current sole cigar smokers (i.e. exclusive cigar use), (2) current poly cigar 




smokers (i.e. former exclusive cigar use), (4)  former poly cigar smokers (i.e. smoked cigars and 
smoked cigarettes or used smokeless tobacco), (5) other tobacco users (ever smoked cigarettes or 
used smokeless tobacco but not cigars), and (6)  never tobacco users (never smoked cigars, 
smoked cigarettes, or used smokeless tobacco: reference). Current sole cigar smokers were those 
who had smoked at least 50 cigars and currently smoked cigars but did not met the lifetime 
criteria for being a cigarette smoker or smokeless tobacco user (i.e.  smoked ≥ 100 cigarettes or 
used smokeless tobacco ≥ 20 times) . Current poly cigar smokers were those who had smoked at 
least 50 cigars and currently smoked cigars and met the lifetime criteria for being a cigarette 
smoker or smokeless tobacco user. Former sole cigar smokers were those who had smoked at 
least 50 cigars and currently did not use cigars at all and did not met the lifetime criteria for 
being a cigarette smoker or smokeless tobacco user. Former poly cigar smokers were those who 
had smoked at least 50 cigars and currently did not use cigars at all and met the lifetime criteria 
for being a cigarette smoker or smokeless tobacco user. Other tobacco users were respondents 
who met the lifetime criteria for being a cigarette smoker or smokeless tobacco user (including 
current and former users) but did not met the classification for the previously defined groups.  
Never tobacco users were defined as those who had never smoked 50 cigars and did not met the 
lifetime criteria for a cigarette smoker or smokeless tobacco user. 
The main outcomes of interest in the study were four types of health care utilization obtained 
from NHIS: hospital nights, emergency department (ED) visits, doctor visits, and home care 
visits.  These were defined in the same way as in the Wang study described earlier.  
The health care utilization models used to estimate cigar smoking-attributable health care 




in the authors’ paper that investigated smokeless tobacco attributable health care utilization and 
expenditure.35  
Of the 84,178 sampled adults, the majority, 75.2%, were between ages 34 and 64, 47.3% were 
male, 73.4% were non-Hispanic white, 64.4% were married, 15.2% had less than a High school 
education and 36.1% lived in the South.  Most respondents  (64.1%) were overweight or obese, 
13.4% were identified as binge drinkers and 32.3% had no health insurance during the past 
12 months. The prevalence of adult current sole cigar smokers, current poly cigar smokers, 
former sole cigar smokers, former poly cigar smokers, other tobacco users and never tobacco 
users were 0.6%, 1.7%, 0.7%, 4.8%, 40.5% and 51.7% respectively. Over 90% of adult 
respondents from the study sample did not use cigars. 
The modeling results indicated that current and former sole cigar smokers were not significantly 
different from never tobacco users in their utilization of  the health care services measured in this 
study. The authors reported that based on the estimated excess annual utilization, sole cigar 
smoking attributable annual health care expenditures were estimated to be $284 million in 2014 
dollars (i.e. $625 per sole cigar smoker) and the inclusion of poly cigar smoking increased the 
attributable annual health care expenditures to $1.75 billion in 2014 dollars. 
A main limitation of this analysis is the low prevalence of current and former cigar usage (i.e.< 
10%) observed from the pooled study sample. Using the recommended methodology of linking 
person-level data from NHIS and MEPS would further reduce the analysis dataset. Also, other 
types of health care services like dental care visits were not included because they are not 





Gap in the literature 
 
A number of studies have examined health care expenditure and smoking status. Few studies 
have examined the impact on healthcare expenditures related to the use of forms of tobacco use 
other than cigarettes. To the best of our knowledge, to date only two studies have assessed 
healthcare utilization and expenditures in relation to other forms of tobacco (i.e. smokeless 
tobacco and cigars). These two studies are identified as the first peer- reviewed articles to 
explore the economic cost of other forms of tobacco usage besides cigarette smoking. None of 
the studies identified compared current exclusive use of more than one type of tobacco product. 
Also, no studies have compared the health care utilization or expenditure across different forms 
of current or exclusive tobacco product usage (i.e.  combustible product compared to non-
combustible ).    
There is a need to better understand health care expenditure across the different types of tobacco 
products, given the hefty economic burden of cigarette smoking on the US health care system. 
The public health strategy of taking cigarette smokers down the continuum of risk of nicotine 


















Chapter 3: Methods 
 
This chapter describes the methods used to address the specific aims of this study and includes  
details on study design, data sources, study sample, variables and statistical analyses. 
Data Sources 
 
The data used for the study was extracted from nationally representative data bases that are 
publicly available: The National Health Interview Survey (NHIS) and Medical Expenditure 
Panel Survey (MEPS). NHIS is an annual, cross-sectional survey designed to monitor health and 
behaviors of non-institutionalized U.S. civilians (e.g.,  individuals not in nursing homes,  prisons, 
or the military) living in the 50 states or the District of Columbia.37  NHIS is sponsored by the 
Centers for Disease Control and Prevention (CDC) and conducted by the National Center for 
Health Statistics (NCHS). The NHIS uses a face-to-face interviewing format and geographically 
clustered sampling techniques to select the sample of dwelling units. NHIS has a continuous data 
collection process, the sample is designed such that each month’s sample is nationally 
representative and collected throughout the year. The NHIS Supplemental Adult Questionnaire 
was used in the study to identify tobacco use status data for adults 18 years and older from 2009-
2016. The NHIS Supplemental Adult Questionnaire captures information on tobacco product use 
and behavioral characteristics of adult tobacco consumers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
MEPS is a complex national probability survey of the U.S. civilian non-institutionalized 
population (i.e. both households and individuals) and is conducted by the Agency for Healthcare 
Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).38  There 




Component (IC). This study utilized data from MEPS-HC which provides data on demographics,  
geographic region, access to health care, charges and sources of payments , priority conditions, 
employment, health status, income, health insurance coverage, health care utilization and 
expenditures from individual households and their members.  The data is also supplemented by a 
survey of medical providers (physicians, hospitals, home health agencies, and pharmacies) who 
provide medical care to respondents of the MEPS-HC. medical providers are contacted by 
telephone if information cannot be accurately provided by the respondents. The MEPS-HC data 
are collected by computer-assisted personal interviews. The MEPS sampling frame is drawn 
from respondents in NHIS. Beginning the year after participants’ NHIS interviews a nationally 
representative subsample of these participants is tracked for 24 months through MEPS. MEPS 
collects five rounds of data per respondent on healthcare visits and expenditures regardless of the 
payment source.  All forms of payment for care are included.  
MEPS provides national estimates of health care use and expenditures and was used to obtain 
data on total health care expenditure and utilization from the individual perspective from 2011- 
2017 in adults 18 years and older. The two data sets were linked via the Agency for Healthcare 
Quality Data Center (AHRQ), providing sample data for individuals with a complete set of 
information from both databases needed to address my specific study aims. This methodology is 
widely used in the literature when analyzing health care expenditure and utilization and tobacco 
use.12,13,39  The final study sample comprised seven years of pooled data. Pooling the data 
increases the sample size, reduces the standard error of the estimates and enhances the ability to 
analyze small subgroups. The information on individuals in the final data sample was obtained 





Linking of NHIS and MEPS Public Use files  
 
As previously mentioned, the two Public Use Files (PUF’s) were linked via the AHRQ Data 
Center.  The MEPS full-year consolidated PUF’s can be linked to the NHIS Core person-level 
PUF by using a MEPS/NHIS link file which is available from 1996-2017. Each MEPS/NHIS 
link file contains a crosswalk that enables  merging of MEPS full-year PUF’s with NHIS person-
level PUF’s that contain data collected for MEPS respondents in the year prior to their initial 
year of MEPS participation. The MEPS/NHIS link file is a restricted file that can only be 
accessed at the AHRQ Data Center.  
The MEPS full-year PUF’s collect data through an overlapping panel design. This design 
collects information from each household through in-person interviews over  two calendar years, 
conducted over five rounds, with Round 3 spanning both calendar years. 
For each panel, Rounds 1, 2, and part of Round 3 typically contain data from calendar year 1; the 
remaining part of Round 3, and Rounds 4 and 5 cover calendar year 2. Therefore, MEPS full 
calendar year PUF’s contain data from the first year of a new panel combined with that of the 
second year of the previous panel.  
Example of 2015 MEPS PUF’s linkage with 2013/2014 PUF’s 
 
Figure 3 illustrates the MEPS/NHIS full calendar year 2015 estimates (i.e. for 2015 MEPS and 
2013/2014 NHIS PUF’s ). Rounds 1, 2, and 3 of Panel 20 (i.e. 2014- 2015 MEPS) uses the 2014 
NHIS as its sampling frame and are combined with Rounds 3, 4, and 5 of Panel 19 (i.e. 2015- 
2016 MEPS) which uses the 2013 NHIS as its sampling frame.  
Table 1Table 2  summarizes the linkages between the two databases. Linkage with the 2013 




for the 2014 NHIS data 17,249 of the 18,849 persons in Panel 20 of 2015 MEPS were linked. 
From the two panels a total of 3,452 persons did not link to either 2013 or 2014 NHIS data. cases 
that were not linked include newborns, newly in-scope persons and a small number of cases 
where the NHIS identified a household as responding but when fielded in MEPS it was 
determined to be a nonresponding household.  
 








2013 NHIS PUF 
(n=104,520) 
Linked to 
2014 NHIS PUF 
(n=104,520) 
Linked to 2013 or 
2014 NHIS PUF 
(n=216,573) 
Not Linked to 
NHIS 
Total 
Panel 19 persons 14,726 0 14,726 1,852 16,578 
Panel 20 persons 0 17,249 17,249 1,600 18,849 








The restricted MEPS and NHIS linkage file for this example, NHMEP15X.DAT, permits the 
data user to merge any of the person-level MEPS 2015 Full Year PUF’s with the 2013 and 2014 
NHIS person-level  PUF’s, specifically the Sample Adult PUF for this study. The linkage file 
(NHMEP15X.DAT ) contains 35,427 person-level records and seven variables listed in Table 3. 
A record exists in the linkage file for each of the 2015 MEPS full-year persons. Each record 
contains the MEPS sample person ID (DUPERSID) and the corresponding NHIS unique sample 
person ID ( Household Serial Number (HHX), Family Sequence Number (FMX), and Person 
Sequence Number (FPX)). A person-level 2015 MEPS Full Year PUF can be linked with the 
linkage file using the variable DUPERSID. Similarly, the NHIS 2013 or 2014 person-level data 
files can be linked with the linkage file by HHX, FMX, FPX, and SRVY_YR. 
HHX is set to 999999, FMX is set to 99, PX is set to 99, FPX is set to 99, SRVY_YR is set to 
9999, and LINKFLAG is set to 0, when a link cannot be established between MEPS sample 









Table 3: Record layout for the person-level MEPS/NHIS Linkage file (NHMEP15X.DAT)40 
Variable Column 
Position 
Type Label and value range 
DUPERSID 1 - 8 Character MEPS encrypted person ID (range=60001101-80571103) 
HHX 9 - 14 Character NHIS household serial number (range=000002 – 065122) 
FMX 15 - 16 Character NHIS family number (range=01-06) 
FPX 17 - 18 Character NHIS person number (range=01-18) 
LINKFLAG 19 - 19 Numeric Linkage status between MEPS and  NHIS (1 or 0) 
PANEL 20 - 21 Numeric MEPS panel number (either 19 or 20) 




Linkage instructions with sample SAS and STATA programs for adding NHIS variables to a 
MEPS dataset can be found on the AHRQ website.42  
For this study the linkage process was repeated 7 times using 2011-2017 MEPS-HC Full Year 
PUF’s and the corresponding 2009-2016 NHIS PUF’s with the associated restricted MEPS/NHIS 
link files (i.e. NHMEP11X.DAT, NHMEP12X.DAT, NHMEP13X.DAT,NHMEP14X.DAT 
,NHMEP15X.DAT,NHMEP16X.DAT and NHMEP17X.DAT).  NHIS PUF’s data for a given 
calendar year was attained from NCHS( NHIS - 1997-2018 (cdc.gov)).43  Yearly MEPS PUF’s 
were obtained from Medical Expenditure Panel Survey Download Data Files (ahrq.gov).42 SAS 
analytical software (SAS Institute, Cary, North Carolina, USA), Version 9.4  was used for data 






Data for this study was obtained from 2011 to 2017. Individuals included in the study had to fall 
into one of three defined tobacco use status categories: current exclusive cigarette smokers, 
current exclusive smokeless tobacco user or never tobacco user as identified from the NHIS 




A retrospective, cross-sectional study design was employed using MEPS/NHIS linked data files 
from 2011-2017.  For Specific Aim 1 : I- II, the prevalence was estimated for tobacco use by 
tobacco use status by year of Medical Expenditure Panel Survey collection  and by age category. 
For Specific Aim 1 : III-IV, the distribution of the study sample of adults by tobacco use status 
and sociodemographic characteristics, health status and selected comorbidities was evaluated. 
Bivariate associations between tobacco use status and sociodemographic characteristics, health 
status and selected comorbidities were also assessed. For Specific Aim 2 : I, the distribution of 
health care utilization by type of health care service and tobacco use status was evaluated. 
Prior to addressing Specific Aim 1: V and Specific Aim 2: II, propensity score matching was 
used to control for observable differences between the tobacco use status groups. The current 
exclusive smokeless tobacco users were considered the “Cases” and current exclusive cigarette 
smokers and never tobacco users were considered the “Controls” respectively (i.e. two separate 
control groups). An econometric approach, described later in this chapter, was then used to 
estimate the mean annual health care expenditure and utilization by tobacco use status for 






The health care expenditure estimation and health care utilization were based on a payer’s 
perspective. The total health care expenditures captured in MEPS are direct payments for care 
provided during a given year based on the sum of  12 sources of payment variables. The study 
data allows the assessment of direct cost component and does not capture indirect cost.  
Variables 
Outcome variables  
 
The primary outcomes of interest were total health care expenditure and health care utilization 
obtained from MEPS. Total expenditure was based on the responses of participants in MEPS-HC 
and was defined as the sum of payments from all sources to hospitals, physicians, other health 
care providers (including dental care), and pharmacies for services. Total expenditure is based on 
expenses on all annual health services including the following: 
• Hospital inpatient care 
• Hospital outpatient care 
• Office-based medical provider services 
• Emergency room services 
• Home health care 





Health care utilization (health care services) measures the number of reported visits for a given 
service within a given year (i.e. the number of visits within the last 12 months). The study 
investigates 6 types of health care services listed below:  
 
• Hospital outpatient visits  
• Hospital inpatient visits 
• Emergency room (ER) visits 
• Office-Based visits 
• Home health care visits  
• Dental visits 
 All positive costs were inflated to 2017 U.S. dollars using the Personal Consumption 
Expenditure Health (PCE-Health) price index as recommended when pooling two or more years 
of MEPS total expenditure data.42,43  The PCE-Health price indexes for 2011-2017 obtained from 
the Bureau of Economic analysis are shown in Table 4. 
 
 
Table 4: Personal Consumption Expenditure (PCE) Price Index 2011-2017 
 Year 2011 2012 2013 2014 2015 2016 2017 







Table 5 displays the ratios used to adjust the raw total expenditure data in the final study sample 
to 2017 U.S. dollars. These ratios were obtained from the series of formulas below: 
             Year 2016 adjustment ratio = (2017 PCE index)/(2016 PCE index) 
             Year 2015 adjustment ratio = (2017 PCE index)/(2015 PCE index) 
             Year 2014 adjustment ratio = (2017 PCE index)/(2014 PCE index) 
                                                               . 
                                                               . 
                                                               . 





 Table 5: Inflation Adjustment Ratios that are multiplied by the Total Expenditure for a        
given Year  
Year 2011 2012 2013 2014 2015 2016 














Tobacco Use Status variable 
 
As previously mentioned, the two tobacco products compared in this study are cigarettes and 
smokeless tobacco because they are the most commonly used in the U.S. and have been on the 
market for decades as compared to the more novel tobacco products such as vaping, and 
therefore they provide the most comprehensive data. The study also assesses current exclusive 
tobacco use status at the time of interviewing, allowing for a more accurate estimation of health 
care expenditures and use for current exclusive users of a specific tobacco product. 
Tobacco use status was categorized into three groups: current exclusive smokeless tobacco users, 
current exclusive cigarette smokers and never tobacco users.  Table 6 provides the NHIS 
questions used to derive the tobacco use status groups. 
• Never tobacco users were defined as those who have never used cigarettes or smokeless 
tobacco in their lifetime (i.e. never smoked 100 cigarettes, and never smoked or used 
smokeless tobacco ) at the time of the interview. 
• Current exclusive cigarette smokers were defined as current cigarette smokers who 
smoked 100 cigarettes in their lifetime and smoked some days or every day at the time of 
the interview. 
• Current exclusive current smokeless tobacco users were defined as current smokeless 
tobacco  users who had used smokeless tobacco  at least 20 times and were currently 
using every day or some days at the time of interview. Smokeless tobacco  use included 






Table 6: Tobacco Use Status Definitions based on NHIS Questionnaires 
 Tobacco Use Status Definitions based on NHIS Sample Adult Questionnaires 
Current exclusive cigarette smokers Responded YES to – “Ever smoked 100 cigarettes”  AND 
Smoking Status -Responded as being “Current every day smoker” or “ Current some day 
smoker” 
Current exclusive current smokeless 
tobacco  users 
Response for NHIS 2010- 
Smoking Status -Responded as being “Never smoker” AND 
Responded YES to “Used snuff at least 20 times” AND  
Responded using Snuff “every day” or “ some day” 
 
Smoking Status -Responded as being “Never smoker”  AND 
Responded YES to “Used chewing tobacco at least 20 times” AND 
Responded using Chewing tobacco “every day” or “ some day” 
Response for NHIS 2012- 
Smoking Status -Responded as being “Never smoker” AND 
Responded YES to – “Ever used smokeless tobacco products” AND 
Responded using smokeless tobacco products “every day” or “ some day” 
Response for NHIS 2016 
Smoking Status -Responded as being “Never smoker” AND 
Responded YES to – “Ever used smokeless tobacco products, even once” AND 
Responded using smokeless tobacco products “every day” or “ some day” 
Never tobacco users Response for NHIS 2010- 
Smoking Status -Responded as being a “Never smoker” AND 
Responded NO to – “Ever smoked 100 cigarettes”  
Responded NO to “Ever used snuff” 
Responded NO to “Ever used chewing tobacco” 
Response for NHIS 2012- 
Smoking Status -Responded as being a “Never smoker”  AND 
Responded NO to – “Ever smoked 100 cigarettes”  








Age was used both as a continuous variable and recoded into a categorical variable. Age was 
categorized as follows: 18-30 years, 31-40 years , 41-50 years, 51-60 years, 61-70 years and 70+ 
years.  The age variable in MEPS is determined by date of birth and age given at the time of 
interview. A participant age is also verified during subsequent MEPS interviews and is top coded 
at 85 years. Only adults 18 years or old were included in the study. Sex was coded as male or 
female in MEPS. Race/ethnicity was coded into 5 categories in MEPS; Hispanic,  non-Hispanic 
White only, non-Hispanic Black only, non-Hispanic Asian only and non-Hispanic Other or 
multiple race only. Region of residency was coded as Northeast, Midwest, South and West. A 
Body Mass Index (BMI) variable is calculated for adults 18 years of age or older.  Adult BMI 
categories are coded as:  underweight = BMI is less than 18.5, normal weight = BMI is between 
18.5 – 24.9 inclusive, overweight = BMI is between 25.0 – 29.9 inclusive, and obesity = BMI 
greater than or equal to 30.0. Poverty status variable in MEPS is constructed using information 
on income, family and poverty categories. Family income is measured as a percent of the poverty 
line. This variable is classified it into one of five poverty categories: negative or poor (less than 
100%), near poor (100% to less than 125%), low income (125% to less than 200%), middle 
income (200% to less than 400%), and high income (greater than or equal to 400%).  Also, 
MEPS codes insurance type as uninsured, public and private. 
Marital status variable was recoded into 4 categories from the original 9 categories in NHIS. 
These categories are married, widow/divorce/separated, living with partner and never married. 
Highest educational level attained was recoded into 4 categories; less than high school, high 
school, some college and college graduate or higher. Self -reported binge drinking status was 




how many days did you have 5 or more drinks of any alcoholic beverage?”.  Binge drinkers were 
considered those who responded that they had 1 or more days of 5 or more drinks.35   
Health Status variables 
 
A Self-Administered Questionnaire is fielded during MEPS interviews and designed to collect 
health status and health care quality measures of adults age 18 and older. The Self-Administered 
Questionnaire contains three measures of health status: Short-Form 12 Version 2,44 the Kessler 
Index of non-specific psychological distress,45 and the Patient Health Questionnaire.46  
Short-Form 12 Version 2 
 
The Short-Form 12 Version 2 (SF-12v2) questions are listed in Table 7.The SF-12v2 
questionnaire comprises two components : Physical Component Summary (PCS) and Mental 
Component Summary (MCS) and is used as a quality of life measure. The standard approach to 
assessing data from the SF-12v2 is to form two summary scores based on responses to the 
questions in Table 7. Summary scores for both the PCS and  MCS are obtained through a scoring 
algorithm which incorporate information from all 12 questions.47  A score ranging from 0 (the 












Table 7: Short-Form 12 Version 2: Questions 
                                                    12  Questions 
General health today 
During a typical day, limitations in moderate activities 
During a typical day, limitations in climbing several flights of stairs 
During past 4 weeks, as result of physical health, accomplished less than would like 
During past 4 weeks, as result of physical health, limited in kind of work or other activities 
During past 4 weeks, pain interfered with normal work outside the home and housework 
During the past 4 weeks, felt calm and peaceful 
During the past 4 weeks, had a lot of energy 
During the past 4 weeks, felt downhearted and depressed 
During past 4 weeks, as result of mental problems, accomplished less than you would like 
During past 4 weeks, as result of mental problems, did work or other activities less carefully than usual 
During the past 4 weeks, physical health or emotional problems interfered with social activities 
 
Non-Specific Psychological Distress 
 
A second measure of health status in the Self-Administered Questionnaire is the Kessler Index of 
non-specific psychological distress. This measure includes six mental health-related questions, 
which assesses the person’s non-specific psychological distress during the past 30 days. The 
questions are listed in Table 8. 
Table 8: Kessler Index: Questions 
                                             6 Questions 
During the past 30 days, felt nervous 
During the past 30 days, felt hopeless 
During the past 30 days, felt restless or fidgety 
During the past 30 days, felt so sad that nothing could cheer the person up 
During the past 30 days, felt that everything was an effort 





The summation of the values of the six questions in Table 8 provides an index to measure non-
specific psychological distress using the following response values:  
0 -None of the Time 
1 -A Little of the Time 
2- Some of the Time 
3 -Most of the Time 
4 - All of the Time 
The Kessler index value ranges from 0 - 24, where the higher the value the greater the person’s 
tendency towards mental disability. 
Patient Health Questionnaire  
 
The final health status measure in the Self-Administered Questionnaire is the Patient Health 
Questionnaire which assesses the frequency of a person’s depressed mood and decreased interest 
in usual activities.  This measure includes two mental health questions listed in the Table 9. This 
index is measured by summing the values of the two questions in Table 9, the score ranges from 
0 - 6. The higher the score the greater a person’s tendency towards depression. A score of 3 is 
suggested to be the optimal cut point for depression screening purposes.46  This index is not 
equivalent to a Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) 
diagnosis of depression and is only intended as a screening measure for depression. 
Table 9:Patient Health Questionnaire 
 2 Questions 
During the past two weeks, bothered by having little interest or pleasure in doing things 






Selected Comorbidities variables 
MEPS captures information on self-reported diagnosis history of various diseases. Table 10, list 
the variables that were included in this study and the associated question asked during the MEPS 
interviews. The response to the questions in Table 10 were “Yes” or “No”. 
Table 10:Self-reported Disease Diagnosis 
Disease  Questions 
Cancer  Have you ever been diagnosed as having cancer or a malignancy of any kind ? 
Lung cancer Have you ever been diagnosed with lung cancer? 
Angina  Have you ever been diagnosed as having angina, or angina pectoris? 
Coronary heart disease  Have you ever been diagnosed as having coronary heart disease? 
Myocardial Infarction Have you ever been diagnosed as having a heart attack, or myocardial infarction? 
Stroke Have you ever been diagnosed as having had a stroke or transient ischemic attack ? 
Emphysema  Have you ever been diagnosed with emphysema? 
Asthma  Have you ever been diagnosed with asthma? 
Arthritis  Have you ever been diagnosed with arthritis? 
Diabetes  Have you ever been diagnosed with diabetes (excluding gestational diabetes)? 
 
 
   
Design variables  
In order to generate national estimates, the complex sampling design of the MEPS dataset was 
taken into account for all study analyses by using person-level weights (PERWT), primary 






Independent  variables  
 
Independent variables were grouped into tobacco use status characteristics, sociodemographic 
characteristics, health status characteristics and comorbidity characteristics. Tobacco use status 
characteristics included: current exclusive smokeless tobacco  users, current exclusive cigarette 
smokers and never tobacco users.  The set of variables under sociodemographic characteristics 
were age, sex, race/ethnicity, marital status, BMI, region of residency, education, poverty status, 
self-reported binge drinking status and insurance type. The variables in the health status 
characteristics group included; Short-form 12 version 2  summary component scores, Kessler 6 
index and  Personal Health index. Comorbidity characteristics contained a self-reported 
diagnosis history for the following diseases; any cancer, lung cancer, angina ,coronary heart 
disease ,myocardial infarction, stroke, emphysema, asthma , arthritis and diabetes. Table 11 
summarizes the predictor variables and their associated coding. 
Sociodemographic characteristics such as age and sex are known to be associated with health 
care expenditure. Healthcare expenditure increases through maturity for both males and females.  
Females on average have higher expenditures during childbearing age.48,49  White , non-
Hispanics have higher healthcare expenditures than all other race/ethnicity groups.48   Those with  
insurance (i.e. private and Medicare) also have been reported to have higher healthcare 
expenditure.48   The health status and selected comorbidity characteristics are variables that have 
been suggested to control for when analyzing administrative medical data.13,50,51,52,53  
Smokeless tobacco use prevalence is about 2% of the U.S. population and is predominately used 











Tobacco Use Status Characteristics 
Tobacco Use status Current exclusive smokeless tobacco  users, Current exclusive cigarette smokers and 
Never tobacco users 
Sociodemographic Characteristics 
Age (years) Continuous:18 through 85 
Categorical :18-30,31-40,41-50,51-60,61-70,70+ 
Sex Male, Female 
Race/ethnicity Hispanic White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Other or 
multiple race, non-Hispanic 
Marital status Married, Living with Partner, Widow/divorce/separated ,Never Married 
Body mass index (BMI) Normal or Under Weight, Overweight ,Obesity 
Education level Less than high school, High school, Some college, College grad or higher 
Region of residency Northeast, Midwest, South, West 
Poverty Status Poor/Negative, Near Poor, Low income, Middle income, High income 
Self-reported binge drinking status No, Yes 
Insurance type Uninsured, Public, Private 
Health Status Characteristics 
Quality of life score (Short-Form 12)  
  Physical Component Summary  Score between 0-100 
  Mental Component Summary Score between 0-100 
Mental Illness score  
  Kessler 6 Index  Score between 0-24 
Depression score  
 Personal Health Index 0,1,2,3,4,5 or 6 
Comorbidity Characteristics 
Cancer  No, Yes 
Lung cancer No, Yes 




Coronary heart disease  No, Yes 
Myocardial Infarction No, Yes 
Stroke No, Yes 
Emphysema  No, Yes 
Asthma  No, Yes 
Arthritis  No, Yes 



























Descriptive and Bivariate analysis 
 
This section describes the statistical approach for Specific Aim 1: I- IV and Specific Aim 2 : I. 
Descriptive statistics were used to describe the sociodemographic, health status, and 
comorbidities characteristics of the overall study population and by tobacco use status. 
Descriptive statistics (frequency, percentage, mean, standard error (SE)) were also calculated to 
describe health care utilization by type of health care service and tobacco use status.  The 
weighted frequency is also calculated in the descriptive statistics which represents the population 
size and is reported as the sum of weights (i.e. weighted total of the sample size). Since the data 
is pooled across several years the sum of weights represents the sum of each year’s population 
for the years pooled. Dividing the weighted frequency by the number of years pooled, allows the 
reporting of the average population size over the years.55   For this study the weighted frequency 
would need to be divided by 7 to obtain the average yearly weighted frequency (i.e. average 
yearly population size). 
Continuous variables were expressed as the weighted mean, SE and the 95% confidence intervals 
(CI) of the mean. Categorical variables were expressed as the weighted frequency and the row 
percent and 95% CI of the row percent. The SURVEYMEANS and  SURVEYFREQ procedures 
were used for continuous and categorical variables respectively.56  These procedures incorporate 
complex survey sample designs where stratification, clustering, and weights can be applied.  
Bivariate associations between tobacco use status groups and the continuous independent 
variables were tested using domain analysis which computes the means and the difference 
among the domain means and assesses the statistical significance based on the t-test. The Wald 




categorical independent variables. Statistical significance level was set at a p-value of 0.05. SAS 
version 9.4 was used for these analyses. 
Propensity Score Matching 
 
Selection bias, which is a result of the lack of randomization, can be a challenge when analyzing 
observational data. The groups of interest may not be comparable and key characteristics like 
age, gender, etc. may differ when groups are not randomized. To control for observable 
differences, the tobacco use status groups were matched using propensity score matching. This 
technique is used to compare groups while adjusting for group differences.57  This matched 
control methodology was used to address potential selection bias and confounding between the 
tobacco use status groups. The study has three tobacco use status groups, therefore propensity 
score matching was performed twice, and the results were merged to obtain the final matched 
dataset. 
Propensity score matching was performed using Greedy nearest neighbor matching which selects 
the control nearest to each case.56 Greedy nearest neighbor matching is done sequentially for 
case units and without replacement. This method allows each case to be matched with the most 
suitable control available for matching at that point in the matching process and then the case and 
control are removed from the matching process. A 1:1 match where each case was matched with 
one control was performed. In this analysis the case and controls are the three-tobacco use status 
groups.  The current exclusive smokeless tobacco group was considered as “group 1” , the 
current exclusive cigarette smoker group was “group 2”  and never tobacco user was “group 3”. 
Specifying the set of confounding variables is a key issue in evaluating  propensity scores. All 




group and one of the other groups were used to fit the logistic regression to estimate the 
propensity scores.  
To maximize the  amount of pairs obtained in the matching procedure the covariates in the 
logistic regression included age (i.e. as a continuous variable), sex (male, female), BMI (normal 
or underweight, overweight and obese), region of residency (northeast, midwest, south, west) , 
poverty status (poor/negative, near poor, low income, middle income, high income) and type of 
insurance (uninsured, public, private). Other variables were explored but due to missing 
responses the match sample sizes were not maximized.  
The current exclusive smokeless tobacco group had a small sample size (1.2% of the final study 
sample) compared to the current exclusive cigarette smokers (19.5%) and never tobacco user 
groups (79.3%), which is reflective of the 2% prevalence of smokeless tobacco use in the U.S. 
population. The descriptive analysis indicated that the current exclusive smokeless tobacco users 
were predominately white non-Hispanic males (i.e. in line with the U.S. population), younger, in 
the middle to high income group, had insurance and resided in the south or midwest.  
The PROC PSMATCH statements in SAS was used to invoke the PSMATCH procedure.55  
Greedy nearest neighbor matching was used to match observations for participants in the current 
exclusive smokeless tobacco group with observations for participants  in the current exclusive 
cigarette smoker group or never smoker group  The PSMODEL statement specifies the logistic 
regression model that creates the propensity score for each observation, which is the probability 
that the participant is a current exclusive smokeless tobacco user. The tobacco use variable was a 
binary treatment indicator variable where current exclusive smokeless tobacco user (group 1) is 
considered the case  since the goal is to obtain matching pairs with current exclusive smokeless 




tobacco user) were consider the control groups. The logits of propensity scores such that only 
observations that have propensity scores in the specified support region are used in matching. 
The logits of the propensity scores were used in computing differences between pairs of 
observations. Exact matches were used for age and sex.  
Propensity score matching diagnostics were assessed using various plots for assessing balance. 
They include the following plots: 
• cloud plots, which are scatter plots in which the points are jittered by adding random 
noise to prevent overplotting  
• box plots for continuous variables 
• bar charts for classification variables 
• a standardized differences plot that summarizes differences between the case and control 
groups.  
The recommended upper limit for standardized mean difference was set to 0.25,58,59  although 
other have used an upper limit of 0.10.60,61,62  The variance ratios between the case and control 
were assessed within the recommended range of 0.5 to 2. 
The absolute standardized difference for continuous variables was computed using the formula 
below:  
 







The absolute standardized difference for categorical variables was computed using the formula,  
 
where  and  denotes the proportions in the groups. 
 
 
The study has three tobacco use status groups, therefore propensity score matching was 
performed twice, and the results were merged to obtain the final matched dataset.  
Multivariate Analysis 
 
Manning and Basu’s63 two-part modeling approach was used to estimate health care services and 
expenditures associated with tobacco usage. These types of models are commonly used in 
modeling health care expenditures, due to their highly skewed distribution (i.e., a large number 
of individuals with zero expenditure and a small number of individuals with substantial 
expenditures).64  The number of participants with zero cost for healthcare expenditure in my 
sample was 21%,  higher than the recommended 10%.65 In two-part models, health care 
expenditures are estimated as a product of probability of any medical expenses and the predicted 
amount of these expenses conditional on the presence of any medical expenses. The two-part 
model consists of:  
(1) A first part which uses a logit or probit regression model to estimate the parameters that 




regression, in the context of my analysis, models whether an individual had any medical 
expenditures or utilization in a given year.  
(2) For the second part, a generalized linear regression with an appropriate link function and 
response distribution was used. The second model estimates the costs for individuals who the 
first model predicted had any medical expenditures or utilization.  
 An upside of generalized linear regressions is that they explicitly model heteroskedasticity. 
Also, with the choice of an appropriate distribution, a generalized linear regression allows the 
variance of the outcome to be a function of its predicted value. 
A generalized linear model (GLM) with a Gamma distribution and a log link function  was the 
best fit for the health expenditure data and was used to estimate the adjusted total healthcare 
expenditure by tobacco use status.  
For count data such as health care utilization (i.e. 6 type of health care services) the Hurdle 
model was employed which is the two-part model used for count data. A logit model was 
assessed for the first model and the best fit for the second model was a truncated Poisson 
regression.   
Both sets of regressions were controlled for appropriate co-variates/ independent variables and 
accounted for the MEPS complex survey sampling design.  
It is important to understand the strengths and limitations of the models being implemented in 
any analysis. Statistical tests and model checks were employed using the Akaike Information 
Criterion (AIC) and Bayesian Information Criterion (BIC)) model fit criteria. Different modeling 




data results were compared with the Zero-Inflated Poisson Regression Models (ZIP) where 
applicable.  
The two-part model was implemented using the “twopm” command or corresponding command 
for count data (i.e. best fit model used “tpoisson”) in Stata which enables the incorporation of the 
survey weights in the model.64,66,67  Access to these survey weights are made available by Agency 
for Healthcare Research and Quality (AHRQ). To generate national estimates, the complex 
sampling design of the MEPS dataset was taken into account by using pooled person-level 
weights (PERWT), primary sampling unit (VARPSU) and variance estimation strata (VARSTR).  
Propensity score matching can significantly reduce the study sample size producing a stratum 
that only has one sample unit. If this occurs then by default Stata’s survey commands will report 
missing standard errors. To resolve this issue variance estimation will be estimated using the 
single unit (center) option in Stata.68  This specifies that strata with one sampling unit are 
centered at the population mean instead of the stratum mean to estimate the variation (i.e. 
standard errors). All modeling analyses was conducted using STATA software version 15 (Stata 
Corp, College Station, Texas, USA)69 and statistically significant levels were set at 5%.  
Sensitivity Analysis 
 
As per best modeling practices, sensitivity analysis was used to determine the extent to which 
some of the assumptions of the study influenced the estimates. The following sensitivity analyses 
were conducted : 
1. It is well known that healthcare expenditure increases with age, therefore the 
older population ( participants older than 65 years) were excluded from the 




2. Excluded female participants from model analysis, since smokeless tobacco 
products are predominately used by males in the U.S. population and participants 
greater than 65 years old. 
3. Models were also conducted with the healthcare expenditure and utilization data 
before  propensity score matching for health care utilization. 
 
 
Human subject protection and data privacy 
 
Based on Virginia Commonwealth University’s guideline for identifying if research is required 
to go through their Institutional Review Board, the proposed research is eligible for exemption 
under 45 CFR 46.101(b)(4) from 45 CFR part 46 requirements because the data is publicly 

















Chapter 4: Results 
 
Descriptive and Bivariate Results of Final Study Sample 
 
This section describes the results for Specific Aim 1: I- IV  
Sample Distribution 
 
The MEPS/NHIS linked 2011-2017 dataset resulted in a total of  207,267 participants.  The final 
pooled study sample, after applying the tobacco use status criteria, included a total of 68,866 
participants  who were eligible for the study. The annual weighted number of participants ranged 
between 89,474,000 and 104,640,000 for the sampled years. Six hundred and thirty-three (633) 
participants (1.2% of the study population) were current exclusive smokeless tobacco users. The 
annual weighted number of current exclusive smokeless tobacco users ranged between 650,000 
and 1,686,000 for the sampled years.  Thirteen thousand four hundred and twenty-three (13,423) 
participants (19.5%) were current exclusive cigarette smokers and the annual weighted number 
of current exclusive cigarette smokers ranged between 16,878,000 and 20,604,000 for the 
sampled years.  Fifty-four thousand eight hundred and ten (54,810) participants (79.3%) were 
never tobacco users. The annual weighted number of never tobacco users ranged between 









 Table 12 shows the distribution of the final study sample size by full MEPS calendar year.  
                        Table 12:Final Study Sample Size by MEPS Calendar Year 



























Note: Percentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for 
survey nonresponse 
Figure 4:Prevalence of Tobacco Use Status by year of MEPS Data collection 
 
Figure 4 depicts tobacco use status by study year. A slight increase was observed in current 
exclusive smokeless tobacco use as a decrease was seen in current exclusive cigarette smoking 
over the 2011 to 2017 timeline.  








Final Study Sample before Matching Tobacco Use Groups 
 
A total of 68,866 participants were eligible for this study. The mean age (SE) of the total 
population was 47.7 (0.18) years and 55.2% were female. Approximately  60% of the study 
population  identified as white, non-Hispanic, 42.7% were married and 77.7%  were in the 
Middle- or High-income bracket in terms of their poverty status. Most of the total population had 
some type of health insurance, 22.2% public insurance (i.e. Medicare) and 67.3% had some type 
of private insurance. 
On average participants in the never tobacco user group were older 50.8 years [95% CI: 50.3 to 
51.2] than those in the current exclusive smokeless user group 46.2 years [95% CI: 44.6 to 47.8]  
and the current exclusive cigarette smoker group 46.5 years [95% CI: 46.1 to 46.9]   by about 4 
years. This difference in mean age was found to be statistically significant between the never 
tobacco user group vs current exclusive smokeless user group (p-value <0.0001) and the never 
tobacco user group vs current exclusive cigarette smoker group (p-value <0.0001). 
As expected, participants in the current exclusive smokeless user group were predominately 
male, 94.6% and white, non-Hispanic (79.5%). The current exclusive cigarette smoker group had 
a higher proportion of male participants (53.1%) compared to females and 62.3% participants 
identified as being white non-Hispanic. The participants in the never tobacco user groups were 
reflective of the total sample population, for example this group had a larger percentage of 
females (58.0%) compared to males.  
Approximately 70 % of participants in the current exclusive smokeless user group reside in the 
South and Midwest and 75%  and  73% of the participants in this group was in the middle- or 




percentages in the other two tobacco user status groups. Also 73% of the current exclusive 
smokeless tobacco user group was overweight or obese compare to 62.1% and 63.9% of current 
exclusive cigarette smokers and never tobacco users respectively.   
A statistically significant association between the tobacco use status groups and the categorical 
sociodemographic characteristic was observed at the 5% statistical significance level, see Table 
13 and  Table 14. A summary of the study participants sociodemographic characteristics by 








  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless 
user 
Current exclusive cigarette 






54,810  (79.3%)ª 
Unweighted  
 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
Age(years), mean (SE)  47.68 (0.18)  50.75 (0.24)*  46.18 (0.98)  46.50 (0.26) <0.0001 
Gender               
  Male 28,909  (44.8%) 21,537  (42.0%) 570  (94.6%) 6,802  (53.1%) 
<0.0001 
  Female 39,957  (55.2%) 33,273  (58.0%) 63  (5.4%) 6,621  (46.9%) 
Race/ethnicity                   
  White, non-Hispanic 29,436  (58.9%) 22,419  (57.8%) 464  (79.5%) 6,553  (62.3%) 
<0.0001 
  Black, non-Hispanic 12,719  (11.3%) 9,983  (11.5%) 62  (4.5%) 2,674  (11.2%) 
  Asian, non-Hispanic 8,797  (13.8%) 7,111  (13.9%) 56  (9.4%) 1,630  (13.9%) 
 Other or multiple race, 
non-Hispanic  
1,589  (2.3%) 1,139   (2.1%) 25  (2.9%) 425  (3.0%) 
  Hispanic 16,325  (13.6%) 14,158  (14.8%) 26  (3.7%) 2,141  (9.5%) 
Marital status                   
 Married 28,105  (42.7%) 23,867  (45.4%) 273  (45.1%) 3,965  (31.5%) 
<0.0001 
 Living with Partner 4,532  (6.0%) 3,126  (5.2%) 41  (6.2%) 1,365  (9.3%) 
Widow/divorce/separated 18,101  (25.7%) 13,859  (24.6%) 150  (21.7%) 4,092  (30.3%) 
 Never Married 18,027  (25.5%) 13,868  (24.6%) 169  (27.0%) 3,990  (28.9%) 
Body mass index (BMI)                 
 Normal or Under Weight 23,504  (36.4%) 18,442  (36.2 %) 160  (26.5 %) 4,902  (37.9 %) 
0.0037  Overweight 22,742  (32.9%) 18,155  (32.9 %) 227  (37.4%) 4,360  (32.8 %) 










  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker   
  





 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
Education level              
 Less than high school 17,882  (24.6%) 14,009  (22.1%) 142  (18.9%) 3,731  (25.6%) 
<0.0001 
 High school 13,430  (20.3%) 10,435  (18.1%) 156  (22.5%) 2,839  (21.1%) 
 Some college 11,007  (17.7%) 8,609  (16.1%) 98  (16.8%) 2,300  (17.8%) 
 College grad or higher 21,306  (37.4%) 17,782  (36.7%) 200  (35.9%) 3,324  (26.5%) 
Region of residency                   
 Northeast 11,263  (17.7%) 9,139  (18.3%) 67  (10.7%) 2,057  (15.8%) 
<0.0001 
 Midwest 14,154  (22.6%) 10,557  (21.4%) 159  (22.9%) 3,438  (27.2%) 
 South 26,189  (37.0%) 20,468  (36.3%) 295  (45.8%) 5,426  (39.3%) 
 West 17,260  (22.7%) 14,646  (23.9%) 112  (20.7%) 2,502  (17.7%) 
Poverty Status                   
 Poor/Negative 14,005  (13.6%) 10,012  (11.5%) 90  (8.8%) 3,903  (22.6%) 
<0.0001 
 Near Poor 4,357  (4.8%) 3,252  (4.4%) 37  (5.0%) 1,068  (6.8%) 
 Low Income 11,207  (13.8%) 8,730  (13.3%) 80  (12.6%) 2,397  (16.3%) 
 Middle Income 19,245  (28.6%) 15,391  (28.3%) 208 (32.6%) 3,646  (29.5%) 







  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker   
  





 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
Self-reported binge drinking statusb
 
              
 No 26,187  (40.8%) 21,292  (42.6%) 148  (25.8%) 4,747  (34.5%) 
<0.0001 
 Yes 14,436  (24.2%) 9,223  (20.0%) 297  (49.5%) 4,916  (39.7%) 
Insurance type                  
 Uninsured 10,158  (10.5%) 7,526  (9.1%) 70  (10.9%) 2,562  (16.5%) 
<0.0001 
 Public 19,045  (22.2%) 14,334  (20.6%) 143 (15.8%) 4,568  (28.9%) 
 Private 39,663  (67.3%) 32,950  (70.3%) 420  (73.3%) 6,293  (54.6%) 
 
ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 
ᵇSelf-reported binge drinking status does not total 100% due to missing response. 
*Statistical significance difference between never tobacco users and current exclusive smokeless user and never tobacco users and  current exclusive cigarette smoker 







The health status measures in the Self-Administered Questionnaire field in MEPS were the 
Short- Form 12 version 2 used to measure the quality of life, the Kessler Index of non-specific 
psychological distress and the Patient Health Index which assesses a person’s tendency towards 
depression. 
 The quality of life scores in both the PCS and MCS tended to be slightly higher in the current 
exclusive smokeless tobacco group indicating slightly better health status compared to the other 
two tobacco status groups and the overall population. Current exclusive cigarette smokers had 
the lowest mean scores. The mean differences in the quality of life scores (i.e. both MCS and 
PCS) were found to be statistically significantly different between current exclusive cigarette 
smokers (MCS: 48.3 [95% CI: 48.0 to 48.7] , PCS: 46.8 [95% CI: 46.5 to 47.3] ) vs current 
exclusive smokeless tobacco users (MCS: 52.6 [95% CI: 51.5 to 53.8 ] , PCS: 50.1 [95% CI: 
48.7 to 51.5]  ) (p-value <0.0001) and current exclusive cigarette smokers vs never tobacco users 
( MCS: 51.9 [95% CI: 51.7 to 52.0 ] , PCS: 49.5 [95% CI: 49.3 to 49.7] ) (p-value <0.0001). 
these differences may or may not be meaningful in terms of an individual’s health status. A 
difference of 3 points has been determined to be a clinically meaningful difference for the PCS 
and MCS on the Short-Form 12.69,70,71,72  A clinically meaningful difference of 4.3 points and 3.3 
points in the MCS and PCS for current exclusive smokeless tobacco users vs current exclusive 
cigarette smokers was observed.  A clinically meaningful difference was only found in the MCS 
for never tobacco users vs current exclusive cigarette smokers at 3.6 points. No statistically 
significant or clinically meaningful difference was observed between participants’ mean scores 
in the never tobacco user group and current exclusive smokeless tobacco user group for both 




Current exclusive cigarette smokers were found to have a greater tendency towards mental 
disability as indicated by their higher Kessler index compared to the never tobacco user group 
and current exclusive smokeless tobacco user group. These differences were statistically 
significantly different between exclusive cigarette smokers ( 4.7 [95% CI: 4.5 to 4.8]) vs current 
exclusive smokeless tobacco users  2.8 [95% CI: 2.4 to 3.3]) (p-value <0.0001) and current 
exclusive cigarette smokers vs never tobacco user ( 2.88 [95% CI: 2.82 to 2.93])  (p-value 
<0.0001). No statistically significant difference was observed between the Kessler index  for 
never tobacco users and current exclusive smokeless tobacco users (p-value=0.8469). 
Findings from the Patient Health index showed that  the majority of participants in all three 
tobacco use groups had little tendency towards depression (i.e. 0 score in 66.1% of never tobacco 
user group, 65.8% of current exclusive smokeless tobacco user group and 52.5% of current 
exclusive cigarette ). Approximately, 15% of current exclusive cigarette smokers had a Patient 
Health score of 3 or greater indicative of a positive screening for depression (i.e. greater 
tendency toward depression in cigarette smokers) compared to 6.2% and 6.1% for never tobacco 
users and current exclusive tobacco users respectively. Table 15 summarizes the study 
participants’ health status characteristics by tobacco use status. 
Of the 10 selected comorbidities identified in MEPS that were explored in this study, only 4  
have positive self-reported disease diagnosis greater than 10% (i.e. arthritis, asthma , diabetes 
and any cancers). Never tobacco users (12.9%) and current exclusive cigarette smokers (10.7%) 
responded to having been diagnosed with any cancer more than current exclusive smokeless 
users (6.5%). Participants in the study had the highest positive diagnosis rates for arthritis, 29.8% 
participants  reported having arthritis in never tobacco user group, 30.6 % in the current 




Current exclusive cigarette smokers  reported the highest positive diagnosis rates for emphysema 
(6.7% ) compared to 2.5% in the current exclusive smokeless user group and 1.5% in the never 
tobacco user group. Similarly, the current exclusive cigarette smokers  reported the highest 
positive diagnosis rates for asthma (11.8% ) compared to 9.8% for current exclusive smokeless 
users and 10.4% in never tobacco users. Although the lung cancer variable had 88% missing data 
for the overall study population, current exclusive cigarette smoker reported the highest positive 
diagnosis rates of 4.0%.  
There was a statistically significant association between tobacco use status and being diagnosed 
with any of the following 7 comorbidities (i.e. any cancer, coronary heart disease, myocardial 
infarction, stroke, emphysema, diabetes and asthma). No association was found between tobacco 
use status and arthritis and tobacco use status and angina. A statistical significance level was 
assessed at 5%. 
Table 16 summarizes the study participants self-reported selected comorbidity characteristics ( 








  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless 
user 







 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
Quality of life score (Short-Form 12) Mean (SE)  Mean (SE)  Mean (SE)  Mean (SE) 
  Physical Component Summary (0-100) 49.31 (0.08) 49.53 (0.11) 50.09 (0.70) 46.89 (0.21)*  
  Mental Component Summary (0-100) 51.48 (0.06) 51.85 (0.07) 52.65 (0.59) 48.34 (0.17)* 
Mental illness score Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
  Kessler 6  Index 3.10 (0.03) 2.88 (0.03) 2.83 (0.24) 4.66 (0.07)* 
Depression score n (%) 
  Patient health Index             
0 42,728  (70.0%) 35,358  (66.1%) 406                (65.8%) 6,964               (52.5%) 
1 6,222   (10.1%) 4,841  (9.0%) 49  (8.0%) 1,332   (10.0%) 
2 7,348  (11.3%) 5,368  (9.3%) 54   (7.3%) 1,926   (14.6%) 
3 1,982  (2.8%) 1,395  (2.2%) -˟   (1.9%) 570    (4.0%) 
4 2,093  (3.0%) 1,329  (2.1%) 23   (2.6%) 741   (5.3%) 
5 740  (1.0%) 481  (0.7%) -˟   (0.3%) 254    (1.8%) 
6 1,270  (1.8%) 773  (1.2%) -˟   (1.3%) 489   (3.4%) 
ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 
*Statistical significance difference between current exclusive cigarette smoker status and current exclusive smokeless user status and exclusive current cigarette smoker status and never tobacco user 
˟Sample size for this cell is < 20 and cannot be disclose based on Agency for Healthcare Research and Quality (AHRQ) guidelines  





                           





  Total Sample 
  
Never tobacco user 
  










 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
 Any Cancer Diagnosis               
  Yes 7,239   (12.4%) 5,902   (12.9%) 46   (6.5%) 1,291   (10.7%) <0.0001 
  No 61,516   (87.6%) 48,824   (86.9%) 586   (93.4%) 12,106   (89.1%) 
Cardiovascular Disease Diagnosis   
Angina                
  Yes 1,811   (2.7%) 1,426   (2.7%) -˟    (1.6%) 372   (2.8%) 0.1650 
  No 66,951   (97.3%) 53,306   (97.1%) 619   (98.3%) 13,026   (97.0%) 
Coronary heart disease                    
  Yes 4,030   (6.0%) 3,223   (6.1%) 27    (3.3%) 780    (5.8%) 0.0076 
  No 64,726   (94.0%) 51,506   (93.8%) 605   (96.6%) 12,615   (94.1%) 
Myocardial Infarction                   
  Yes 2,831   (4.2%) 2,118   (4.0%) 25   (3.0%) 688   (5.2%) 0.0010 
  No 65,933   (95.8%) 52,613   (95.9%) 607   (96.9%) 12,713   (94.6%) 
Stroke                   
  Yes 3,299   (4.7%) 2,525   (4.6%) 21   (2.4%) 753    (5.2%) 0.0124 
  No 65,468   (95.3%) 52,209   (95.2%) 611    (97.4%) 12,648   (94.7%) 
Emphysema Diagnosis                   
  Yes 1,588        (2.5%) 772   (1.5%) -˟    (2.5%) 800    (6.7%) <0.0001 








  Total Sample 
  
Never tobacco user 
  










 633 (1.2%)ª 
Unweighted  
13,423 (19.5%)ª 
Asthma Diagnosis                   
  Yes 7,248   (10.6%) 5,505   (10.4%) 64   (9.8%) 1,679   (11.8%) 0.0210 
  No 61,526   (89.4%) 49,237   (89.5%) 568   (90.0%) 11,721   (88.1%) 
Arthritis Diagnosis                   
  Yes 19,934   (30.0%) 15,623   (29.8%) 109    (26.5%) 4,121   (30.6%) 0.2246 
  No 48,821   (70.0%) 39,109   (70.1%) 442   (73.4%) 9,270   (69.2%) 
Diabetes Diagnosis                   
  Yes 8,216   (10.7%) 6,708   (10.9%) 81    (12.0%) 1,427   (9.4%) 0.0018 
  No 60,555   (89.3%) 44,030   (88.9%) 551 7   (87.8%) 11,974   (90.5%)  
Lung cancer  n=83,948,815  n=69,329,221    n= 537,005   n=14,082,588  
  Yes 204   (2.2%) 142   (1.9%) -˟   (0.0%) 62    (4.0%) 
  No 7,035   (97.8%) 5,760   (98.1%) 46   (100.0%) 1,229   (96.0%) 
 ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 









 Propensity Score Matching of Tobacco Use Groups 
 
The study population before propensity score matching consisted of current exclusive smokeless  
tobacco users (N=633 unweighted) , current exclusive cigarette smokers (N=13,423 unweighted)  
and never tobacco users (N=54,810 unweighted). For this analysis current exclusive smokeless 
tobacco users were considered as the “group 1-case”, current exclusive cigarette smokers “group 
2-control”,  and never tobacco users “group 3-control ”. Two sets of propensity score matching 
analyses were conducted and the matched datasets were pooled to obtain the final dataset used 
for the main analysis of the study.  
The  relatively small sample observed in the group 1 differed in their sociodemographic 
characteristic - age, sex, race/ethnicity, region of residency, poverty status, insurance type and 
BMI - compared to the groups 2 and 3. Individuals in group 1 were younger, predominately male 
white non-Hispanic, largely resided in the South or Midwest, were in a middle to high income 
bracket, possessed some type of health insurance and were in the overweight or obese BMI 
category. Propensity scores for the case (i.e. group 1) and controls (i.e. group 2 and group 3) 
were computed using logistic regression adjusting for age, gender, region of residency, poverty 
status, BMI category and insurance type. Other variables like binge drinking status, health status 
and comorbidities were not included in the matching analysis given their high nonresponse rate 
or not being diagnosed with a particular comorbidity quite a few of the potential match pairs 
would be lost . Since matching was with grp1 (current exclusive smokeless tobacco users, 
N=633) a significant portion of the already small matching sample would be lost. All 




Similar matching analysis was conducted including only participants who were 65 years of age 
or less. This set of matched data was used in a sensitivity analysis to assess health care 
expenditure without the inclusion of potentially high values based on the increase of healthcare 
cost with aging.49 
 
 
Propensity score matching diagnostics 
 
 Group 1 matching on Group 2  
Of the 13,423 observations in Group 2, 12,846 fell within the support region in which matching 
was assessed. The mean difference between the propensity scores was 0.0001 for the matched 
observations (N=633). The standardized mean differences were significantly reduced in the 
matched observations, and the largest of these differences was  0.05118 , which was less than the 
recommended upper limits of 0.25 or 0.1.61,62  The group 1-to- group 2 variance ratios were 
1.2434 and 1.0012 in the matched observations, which are within the recommended range of 0.5 
to 2.  
Group 1 matching on Group 3  
Of the 54,810 observations in Group 3, 53,845 fell within the support region in which matching 
was assessed. The mean difference between the propensity scores was 0.00001 for the matched 
observations (N=633). The standardized mean differences were significantly reduced in the 
matched observations, and the largest of these differences was  0.02150 in absolute  value , 
which was less than the recommended upper limit of 0.25 or 0.1.61,62  The group 1-to-group 3 
variance ratios were 0.9648 and 1.0000 in the matched observations, which are within the 




Figure 5 and Figure 6 illustrate the distribution of the propensity scores after matching between 
the case and two controls.  Both show overlapping distributions indicating that the common 
support assumption holds true. 
Figure 7 is a plot of the standardized mean differences in gender, age and the logit of the 
propensity score for all observations and matched observations.  Figure 8 displays box plots that 
compare the distributions of the logit propensity score for units in the case and control groups, 
based on all observations, on observations in the support region, and on matched observations. 
the 4 figures below show the distributions are well balanced for the matched observations, 































































Study Sample After Matching Tobacco Use Groups 
 
After matching, the sample size reduced significantly as expected given that current exclusive 
smokeless tobacco users, the smallest tobacco use status group, was used as the case group. The 
total sample size after matching was N=1899 participants . After matching the three groups had 
equal number of participants (N=633).   
The descriptive and bivariate results showed no statistically significant difference or association 
between the three tobacco use status groups and most of the sociodemographic characteristics 
including all the  covariates used in the matching analysis. An association between the three 
tobacco groups with education level, self-reported binge drinking status and race was still 
observed (see Table 18 and Table 17).  
The health status characteristic after matching produced similar trends as observed before 
matching.  The quality of life scores in both the PCS and MCS after matching tended to be 
slightly higher  in never tobacco users indicating slightly better health status compared to the 
other two tobacco status group and the overall population. Before matching current exclusive 
smokeless user had slightly higher quality of life scores.  
The mean quality of life scores increased for both current exclusive cigarette smokers and never 
tobacco users, current exclusive cigarette smokers still had the lowest mean scores. The mean 
differences in the quality of life scores were still found to be statistically significantly different 
but not clinically meaningful (PCS= 2.1 points and MCS= 1.7 points difference) between current 
exclusive cigarette smokers and current exclusive smokeless tobacco users ((PCS: 48.0 [95% CI: 
46.9 to 49.1] vs PCS: 50.1 [95% CI: 48.7 to 51.5] ) (p-value =0.0183)), ((MCS: 50.9 [95% CI: 




statistically significantly different between the mean scores of current exclusive cigarette 
smokers and never tobacco users ((PCS: 48.0 [95% CI: 46.9 to 49.1] vs PCS: 50.50 [95% CI: 
49.2 to 51.8]) (p-value=0.0044)), ((MCS: 50.9 [95% CI: 49.8 to 51.9] vs MCS: 52.8 [95% CI: 
51.8 to 53.7 ]) (p-value =0.0050)) but no clinically meaningful difference (PCS= 2.5 points and 
MCS= 1.9 points). No statistically significant  or clinically meaningful difference was observed 
between participants’ mean scores in the never tobacco user group and current exclusive 
smokeless tobacco user group for either quality of life score (MCS: p-value=0.8709 , PCS: p-
value=0.6866).  
After matching, current exclusive cigarette smokers still had a greater tendency towards mental 
disability as indicted by their higher Kessler index compared to never tobacco users and current 
exclusive smokeless tobacco users. These differences were statistically significantly different 
between current exclusive cigarette smokers ( 3.8 [95% CI: 3.4 to 4.2]) vs current exclusive 
smokeless tobacco users  2.8 [95% CI: 2.4 to 3.3]) (p-value =0.0021) and current exclusive 
cigarette smokers vs never tobacco user ( 2.7 [95% CI: 2.82 to 2.93])  (p-value <0.0001). No 
statistically significant difference was observed between the Kessler index for participants in the 
never tobacco user group and current exclusive smokeless tobacco user group (p=0.5233). 
After matching, the Patient Health index showed that the majority of participants in all three 
tobacco use groups had little tendency towards depression (i.e. 0 score in 71.3% of never tobacco 
user group, 65.8% of current exclusive smokeless tobacco user group and 58% of current 
exclusive cigarette smokers). Current exclusive cigarette smokers (8%) still had greater tendency 
toward depression (i.e. those who had a patient health score of 3 or greater) compared to 4.2% 




summarizes the study participants health status characteristics by tobacco use status after 
matching. 
The sample size for the selected comorbidities was also  reduced after matching as expected. 
Only 2 of the 10 have positive self-reported disease diagnosis greater than 10% (i.e. arthritis and  
diabetes) compared to the 4 observed before matching. Participants in the study still had the 
highest positive diagnosis rates for arthritis, 20.7% participants  reported having arthritis in never 
tobacco user group, 28.8 % in the current exclusive cigarette smoker group and 26.5% in the 
current exclusive smokeless user group. 
Current exclusive cigarette smokers  also still reported the highest positive diagnosis rates for 
emphysema (6.9%) compared to 2.5% in the current exclusive smokeless user group and 0.9% in 
the never tobacco user group. Similarly, the current exclusive cigarette smokers  reported the 
highest positive diagnosis rates for coronary heart disease (7.4% ) compared to 3.3 % for current 
exclusive smokeless users and 4.3% in never tobacco users.  
After matching, a statistically significant association was found between tobacco use status and 
having reported being diagnosed with emphysema,  coronary heart disease or arthritis at a 5% 
statistical significance level. No association was found between tobacco use status and with 
having reported being diagnosed with the other 7 selected comorbidities examined in this study.  
Table 20 summarizes the study participants self-reported selected comorbidity characteristics ( 









  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker   
  





 633 (%)ª 
Unweighted  
633 (%)ª 
Age(years), mean (SE)  46.69 (0.47)  46.65 (0.80)  46.18 (0.98)  47.33 (0.69)  0.5164 
Gender               
  Male 1710   (93.7%) 570    (94.0%) 570    (94.6%) 570    (92.3%) 0.4063 
  Female 189    (6.3%) 63    (6.0%) 63   (5.4%) 63    (7.7%) 
Race/ethnicity                   
  White, non-Hispanic 1048    (67.0%) 262    (59.0%) 464    (79.5%) 322    (60.4%) <0.0001 
  Black, non-Hispanic 311    (8.8%) 143    (13.1%) 62    (4.5%) 106    (9.8%) 
  Asian, non-Hispanic 234    (13.8%) 79   (12.7%) 56    (9.4%) 99     (17.4%) 
 Other or multiple race,    
non-Hispanic  
60    (3.1%) -˟   (3.0%) 25    (2.9%) 22    (3.5%) 
  Hispanic 264    (8.1%)  136   (12.2%) 26    (3.7%) 84    (9.3%) 
Marital status                   
 Married 789   (43.1%) 296    (47.1%) 273    (45.1%) 229    (37.0%) 0.1016 
 Living with Partner 138    (6.7%) 37    (5.6%) 41    (6.2%) 60    (8.3%) 
Widow/divorce/separated 444    (22.5%) 133    (21.0%) 150    (21.7%) 161    (25.1%) 
 Never Married 519    (27.6%) 167   (26.3%) 169    (27.0%) 183    (29.6%) 
Body mass index (BMI)               
 Normal or Under Weight 491    (25.3%) 155    (24.3%) 160   (26.5 %) 176    (31.5%) 0.8805 
 Overweight 685    (37.0%) 231    (35.9%) 227   (37.4%) 227    (32.5%) 
 Obesity 723    (37.6%) 247   (39.7%) 246   (36.0%) 230    (31.9%) 
 ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse ,  ˟Sample size for this cell is < 20 and cannot be disclose based on Agency for Healthcare Research and Quality (AHRQ) guidelines 








  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker   
  
P-value 
Unweighted   
1,899  (100%)ª 
Unweighted   
633  (%)ª 
Unweighted   
 633   (%)ª 
Unweighted   
633   (%)ª 
Education level             
0.0078 
 Less than high school 467    (23.1%) 142    (19.5%) 142    (18.9%) 183    (26.4%) 
 High school 431    (23.4%) 133    (19.4%) 156   (22.5%) 142    (23.1%) 
 Some college 282    (17.2%) 104    (18.6%) 98    (16.8%) 80    (12.4%) 
 College grad or higher 573    (36.4%) 203    (35.6%) 200    (35.9%) 170    (29.7%) 
Region of residency                   
 Northeast 191   (10.5%) 70    (10.2%) 67    (10.7%) 54    (10.4%) 
0.5230 
 Midwest 472     (25.5%) 158   (28.4%) 159    (22.9%) 155    (25.8%) 
 South 902     (46.5%) 295    (45.1%) 295    (45.8%) 312    (48.6%) 
 West 334     (17.6%) 110    (16.3%) 112    (20.7%) 112   (15.1%) 
Poverty Status                   
 Poor/Negative 278     (9.6%) 93    (9.0%) 90    (8.8%) 95    (11.1%) 
0.2468 
 Near Poor 94     (4.0%) 24  (2.8%) 37    (5.0%) 33   (4.2%) 
 Low Income 251    (11.3%) 84   (10.1%) 80   (12.6%) 87    (11.0%) 
 Middle Income 627    (31.6%) 210    (31.2%) 208    (32.6%) 209    (30.7%) 
 High Income 649    (43.5%) 220    (46.9%) 218    (41.1%) 211    (43.0%) 
Self-reported binge drinking statusᵇ                  







  Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker   
  
P-value 
Unweighted   
1,899  (100%)ª 
Unweighted   
633  (%)ª 
Unweighted   
 633   (%)ª 
Unweighted   
633   (%)ª 
 Yes 
753    (57.9%) 153    (27.2%) 297   (49.5%) 303   (49.8%) 
Insurance type                   
 Uninsured 195    (8.6%) 63    (6.8%) 70   (10.9%)  62   (7.5%) 
0.2840  Public 396   (15.3%) 128    (13.6%) 143    (15.8%) 125    (16.3%) 
 Private 1308   (76.1%) 442    (79.5%) 420    (73.3%) 446    (76.1%) 
ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 














Table 19:Descriptive Statistics of Study Sample, Among US Adults (≥ 18 years) by Health Status and Tobacco Use Status after propensity score matching, 2011–2017 
  
  
Characteristics   Total Sample 
  
Never tobacco user 
  
 Current exclusive smokeless user Current exclusive cigarette smoker 
Unweighted   
1,899  (100%)ª 
Unweighted   
633  (%)ª 
Unweighted   
 633   (%)ª 
Unweighted   
633   (%)ª 
Quality of life score (Short-Form 12) Mean (SE) Mean (SE) Mean (SE) Mean (SE)* 
  Physical Component Summary (0-100) 49.52 (0.35) 50.50 (0.66) 50.09 (0.70)  48.02 (0.54)* 
  Mental Component Summary (0-100) 52.08 (0.32) 52.77 (0.47) 52.65 (0.59)  50.86 (0.53)* 
Mental illness score Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
 Kessler 6 Index 3.10 (0.13) 2.65 (0.16) 2.83 (0.24)  3.82 (0.22) 
Depression score  n (%)ª 
 Patient health Index             
0 1215             (71.8%) 438   (71.3%) 406    (65.8%) 371    (58%) 
1 162    (10.3%) 52    (8.6%) 49   (8.0%) 61    (11.5%) 
2 184    (9.7%) 55   (6.6%) 54   (7.3%) 75    (12.6%) 
3 53   (2.4%) -˟    (2.0%) -˟   (1.9%) 22    (2.5%) 
4 61   (3.0%) -˟    (1.8%) 23   (2.6%) 27    (3.7%) 
5 -˟    (0.8%) -˟    (0.4%) -˟   (0.3%) -˟    (1.3%) 
6 38    (2.1%) -˟    (2.1%) -˟   (1.3%) -˟    (2.5%) 
ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 
*Statistical significance difference between current exclusive cigarette smoker status and current exclusive smokeless user status and exclusive current cigarette smoker status and never tobacco user 
˟Sample size for this cell is < 20 and cannot be disclose based on Agency for Healthcare Research and Quality (AHRQ) guidelines  












  Total Sample 
  
Never tobacco user 
  






1,899  (100%)ª 
Unweighted 
633  (%)ª 
Unweighted 
633   (%)ª 
Unweighted 
633   (%)ª 
 Any Cancer Diagnosis               
  Yes 159   (8.4%) 56   (8.5%) 46   (6.5%) 57   (10.4.%) 0.1424 
  No 1,737   (91.6%) 576   (91.5%) 586   (93.4%) 12,106   (89.6%) 
Cardiovascular Disease Diagnosis   
Angina                
  Yes 53   (2.6%) -×   (3.3%) -×    (1.6%) 22   (3.2%) 0.0947 
  No 1,843    (97.4%) 614   (96.7%) 619   (98.3%) 610   (96.8%) 
Coronary heart disease                    
  Yes 99   (4.9%) 31   (4.3%) 27    (3.3%) 41   (7.4%) 0.0238 
  No 1797   (95.1%) 601   (95.7%) 605   (96.6%) 591   (92.6%) 
Myocardial Infarction                   








  Total Sample 
  
Never tobacco user 
  






1,899  (100%)ª 
Unweighted 
633  (%)ª 
Unweighted 
633   (%)ª 
Unweighted 
633   (%)ª 
  No 1813   (95.8%) 609   (96.7%) 607   (96.9%) 632   (94.6%) 
Stroke                   
  Yes 74   (3.4 %) 26   (3.9%) 21   (2.4%) 27    (4.1%) 0.2718 
  No 1822   (96.6%) 606   (96.1%) 611    (97.4%) 605   (95.9%) 
Emphysema Diagnosis                   
  Yes 65        (3.4%) -×  (0.9%) -×    (2.5%) 41    (6.9%) <0.0001 
  No 1831       (96.6%) 624   (99.1%) 616   (97.4%) 591   (93.1%) 
Asthma Diagnosis                   
  Yes 171   (8.8%) 54   (8.0%) 64   (9.8%) 53   (8.3%) 0.6850 
  No 1726   (91.2%) 578   (92.0%) 568   (90.0%) 579   (91.7%) 
Arthritis Diagnosis                   
  Yes 482   (25.4%) 129   (20.7%) 109    (26.5%) 163   (28.8%) 0.0363 








  Total Sample 
  
Never tobacco user 
  






1,899  (100%)ª 
Unweighted 
633  (%)ª 
Unweighted 
633   (%)ª 
Unweighted 
633   (%)ª 
Diabetes Diagnosis                  
  Yes 230   (11.3%) 91   (12.2%) 81    (12.0%) 58   (9.5%) 0.4287 
  No 1666   (88.7%) 541   (87.8%) 551    (87.8%) 574   (90.5%)  
Lung cancer 
 n=1,852,835  n=577,983  n= 537,005   n=737,847  
  
  Yes -×    (2.7%) -×    (1.7 %) -× 0  (0.0%) -×   (5.5%)   - 
  No 155   (97.3%) 55   (98.3%) 46   (100.0%) 54   (94.5%) 
ªPercentages were developed using survey weights to account for selection probabilities from the complex sampling design and to adjust for survey nonresponse 






The next sections of this chapter will describe the results of Specific Aim 2: I-II and Specific 
Aim 1: V. 
Health Care Utilization Results 
 
Description of Health Care Utilization 
 
Before Propensity Score matching 
Table 21 shows the utilization rates and mean health care utilization for the 6 types of health care 
services by tobacco use status group examined in this study before matching.  The utilization 
rates  are presented as  the  percentages of participants that had at least 1 visit in the last 12 
months for a given health care service. Mean health care utilization is based on individuals who 
have at least 1 visit in the last 12 months.   
Current exclusive cigarette smokers had the highest ER utilization rate (21.8%) compared to 14.4 
% and 13.3 % for never tobacco users and current exclusive smokeless tobacco users 
respectively. Of those who had an ER visit, never tobacco users had a mean of 1.44 ER visits, 
current exclusive smokeless users had a mean of 1.33 ER visits and current exclusive cigarette 
smokers had the highest mean value at 1.60 ER visits. This difference in mean ER visits was 
found to be statistically significant between current exclusive cigarette smokers vs never tobacco 
users (p-value <0.0001) and current exclusive cigarette smokers vs current exclusive  smokeless 
users (p-value =0.0005). No significant difference was found between never tobacco users and 
current exclusive  smokeless users. 
Current exclusive smokeless users had the lowest office-based utilization rate (66.7%) compared 
to 79.6 % and 71.7 % for never tobacco users and current exclusive cigarette smokers 




number of office-based visits at  9.32, smokeless users had a mean of 6.08 office -based visits 
and current exclusive cigarette smokers had a mean of 8.25 office- based visits. This difference 
in mean office-based visits was found to be statistically significant between current exclusive 
cigarette smokers vs never tobacco users (p-value <0.0001), current exclusive cigarette smokers 
vs current exclusive  smokeless users (p-value =0.0044) and never tobacco users vs current 
exclusive  smokeless users (p-value <0.0001). 
Hospital outpatient utilization rates were lowest in current exclusive smokeless users (11.1%) 
and comparable for never tobacco users (20.9%) and current exclusive cigarette smokers 
(19.0%). In the past 12 months, current exclusive smokeless users had a mean of 2.41 hospital 
outpatient visits and never tobacco users and current exclusive cigarette smokers  had a  mean of 
3.24 and 3.22 hospital outpatient visits respectively.  There were statistically significant 
differences in mean hospital outpatient visits between current exclusive cigarette smokers vs 
current exclusive  smokeless users (p-value =0.0237) and never tobacco users vs current 
exclusive  smokeless users (p-value =0.0190). 
Hospital inpatient utilization rates were lowest in current exclusive smokeless users (5.5%) and 
comparable for never tobacco users (8.6%)and current exclusive smokers (8.9%). In the past 
12 months, current exclusive smokeless users had a mean of 5.42 hospital inpatient visits and 
never tobacco users and current exclusive cigarette smokers  had a  mean of 6.48 and 8.69 
hospital inpatient visits respectively.  There were statistically significant differences in mean 
hospital inpatient visits between current exclusive cigarette smokers vs current exclusive  
smokeless users (p-value =0.0315) and current exclusive cigarette smokers vs never tobacco 





Dental utilization rates were highest in never tobacco users (46.2%) and comparable for current 
exclusive cigarette smokers (29.5%)and current exclusive smokeless tobacco users (30.6%). In 
the past 12 months, the mean dental visits for  never tobacco users, current exclusive cigarette 
smokers and current exclusive smokeless users were 2.28, 2.32 and 1.86 respectively. There 
were statistically significant differences in mean dental visits between current exclusive cigarette 
smokers vs current exclusive  smokeless users (p-value <0.0001) and never tobacco users vs 























Table 21:Health Care Utilization before Propensity Score Matching by Types of Health Care Service and 
Tobacco Use Status  among US Adults, 2011–2017 
  
Health Care Service 
Total Sample Never Tobacco 
User  
Current exclusive  
smokeless user 
Current exclusive  
   cigarette smoker  
N=68,866 N= 54,810 N= 633 N= 13,423 
Hospital Outpatient visits (in the past 12 months) 
% with ≥ 1 visit 20.4 20.9 11.1ᶳ 19.0ᶲ 
Mean number of visits (se) 3.13 (0.06) 3.24(0.08) 2.41 (0.33) 3.22 (0.15) 
Hospital Inpatient visits (in the past 12 months) 
% with ≥ 1 visit 8.9 8.6 5.5 10.1ᶲᶱ 
Mean number of visits (se) 6.80 (0.15) 6.48 (0.19) 5.42 (1.38) 8.69 (0.55) 
Emergency room (ER) visits (in the past 12 months) 
% with ≥ 1 visit 15.8 14.4 13.3ᶳ 21.8ᶲ 
Mean number of visits (se) 1.45 (0.01) 1.44 (0.01) 1.33 (0.07) 1.60 (0.03) 
Office Based visits (in the past 12 months) 
% with ≥ 1 visit 77.9 79.6 66.7ᶳ 71.7* 
Mean number of visits (se) 8.48 (0.08) 9.32 (0.11) 6.08 (0.73) 8.25(0.21) 
Home Health care visits (in the past 12 months) 
% with ≥ 1 visit 4.2 4.3 2.4 3.8 
Mean number of visits (se) 70.38 (2.57) 73.02 (3.34) 58.68 (12.33) 73.12 (6.45) 
Dental visits (in the past 12 months) 
% with ≥ 1 visit 42.8 46.2 30.6ᶳ 29.5ᶲ 
Mean number of visits (se) 2.21 (0.01) 2.28 (0.02) 1.86 (0.08) 2.32 (0.05) 
*Statistical significance difference between current exclusive cigarette smoker status and current exclusive smokeless user status and exclusive current cigarette smoker status and never tobacco 
user 
ᶳ Statistical significance difference between never tobacco user and current exclusive smokeless user status   ᶱ Statistical significance difference between never tobacco user and current exclusive 




After Propensity Score matching 
 
Table 22 shows the utilization rates and mean health care utilization by health care services by 
tobacco use status after the tobacco status groups were balanced.   
After matching, current exclusive cigarette smokers still had the highest ER utilization rate 
(16.4%) compared to 12.0 % and 13.3 % for never tobacco users and current exclusive 
smokeless tobacco users respectively. Of those who had an ER visit, never tobacco users had a 
mean of 1.25 ER visits, current exclusive smokeless users had a mean of 1.33 ER visits and 
current exclusive cigarette smokers had the highest mean value at 1.50 ER visits. A statistically 
significant  difference was still found between current exclusive cigarette smokers vs never 
tobacco users (p-value =0.0009) and current exclusive cigarette smokers vs current exclusive  
smokeless users (p-value =0.0161), with no significant difference found between never tobacco 
users and current exclusive  smokeless users. 
Hospital outpatient utilization rates were still lowest in current exclusive smokeless users 
(11.1%) and comparable for never tobacco users (17.9%) and current exclusive cigarette smokers 
(14.1%) after matching. In the past 12 months, current exclusive smokeless users had a mean of 
2.41 hospital outpatient visits and never tobacco users and current exclusive cigarette smokers  
had a  mean of 3.29 and 3.32 hospital outpatient visits respectively.  A statistically significant 
difference in mean hospital outpatient visits between current exclusive cigarette smokers vs 
current exclusive  smokeless users (p-value =0.0051) was still observed.  Never tobacco users vs 




Hospital inpatient utilization rates were still lowest in current exclusive smokeless users (5.5%) 
and comparable for never tobacco users (6.9%)and current exclusive smokers (8.6%). In the past 
12 months, current exclusive smokeless users had a mean of 5.42 hospital inpatient visits and 
never tobacco users and current exclusive cigarette smokers  had a  mean of 6.48 and 8.69 
hospital inpatient visits respectively.  A statistically significant differences in mean hospital 
inpatient visits between current exclusive cigarette smokers vs current exclusive  smokeless users 
(p-value =0.0114) and current exclusive cigarette smokers vs never tobacco users (p-value 
=0.0085) was also still observed after matching. 
After matching, dental utilization rates were still highest in never tobacco users (42.2%) and 28.2 
% and  30.6% for current exclusive cigarette smokers and current exclusive smokeless tobacco 
users respectively.  In the past 12 months, mean dental visits for  never tobacco users, current 
exclusive cigarette smokers and current exclusive smokeless users were 2.11, 2.19 and 1.86 
respectively. A statistically significant difference in mean dental visits was still found between 
current exclusive cigarette smokers vs current exclusive  smokeless users (p-value =0.0365). 
After matching, no statistically significant differences in mean office-based visit was found 
between current exclusive cigarette smokers vs never tobacco users, current exclusive cigarette 
smokers vs current exclusive  smokeless users or  never tobacco users vs current exclusive  
smokeless users. The results of home health care visit remained the same as before matching, 
were no statistically significant differences in mean home health care visit between tobacco use 







Table 22:Health Care Utilization after Propensity Score Matching by Types of Health Care Service and 
Tobacco Use Status  among US Adults, 2011–2017 
  
Health Care Service 





cigarette smoker  
N=1899          N= 633           N= 633         N= 633  
 Hospital Outpatient visits (in the past 12 months) 
% with ≥ 1 visit 14.2 17.9 11.1 14.1ᶲ 
Mean number of visits (se) 3.05 (0.21) 3.29 (0.47) 2.41 (0.21) 3.32 (0.18) 
Hospital Inpatient visits (in the past 12 months)  
% with ≥ 1 visit 6.9 6.9 5.5 8.6ᶲᶱ 
Mean number of visits (se) 6.11 (0.29) 5.34 (0.47) 5.42 (0.51) 7.22 (0.42) 
Emergency room (ER) visits (in the past 12 months) 
% with ≥ 1 visit 13.9 12.0 13.3 16.4* 
Mean number of visits (se) 1.37 (0.03) 1.25 (0.01) 1.33 (0.07) 1.50 (0.03) 
Office Based visits (in the past 12 months) 
% with ≥ 1 visit 70.8 73.8 66.7 72.5 
Mean number of visits (se) 6.40 (0.37) 6.93 (0.65) 6.08 (0.73) 6.23 (0.53) 
Home Health Care visits (in the past 12 months) 
% with ≥ 1 visit 2.3 2.2 2.4 2.1 
Mean number of visits (se) 61.94 (6.07) 55.69 (10.78) 58.68 (6.14) 72.32 (10.61) 
Dental visits (in the past 12 months) 
% with ≥ 1 visit 33.4 42.2 30.6ᶲ 28.2 
Mean number of visits (se) 2.05 (0.08) 2.11 (0.16) 1.86 (0.07) 2.19 (0.13) 
*Statistical significance difference between current exclusive cigarette smoker status and current exclusive smokeless user status and exclusive current cigarette smoker status and never tobacco 
user 
ᶳ Statistical significance difference between never tobacco user and current exclusive smokeless user status  ᶱ Statistical significance difference between never tobacco user and current exclusive 




Estimation of Annual Health Care Utilization by Tobacco Use Status 
 
The final models were executed using the matched data set. Count-data models were fit and 
compared using a likelihood-based model-selection approach (i.e. identifying  the model with the 
smallest AIC and BIC values) applying the full set of  covariates (i.e. both sociodemographic and 
health status variables). The Hurdle count model, using a logit and a truncated Poisson regression 
was found to have the best fit for health care utilization data in this study.  
Emergency room (ER) Visits 
Table 23 shows the estimated results of the Hurdle model for ER visits including covariates;  
tobacco use status, age, gender, education, race/ethnicity, region, marital status, BMI, poverty 
status, binge drinking status, insurance type, physical component summary, mental component 
summary, Kessler index and Patient health index. 
The logit indicated that there was no difference in the current exclusive smokeless tobacco user 
group or current exclusive cigarette smoker group compared to the never tobacco user group in 
their probability of having at least one ER visit (i.e. p-value =0.285 and  p-value =0.092 
respectively). 
The Poisson model indicated for those who had at least one ER visit there was no statistically 
significant difference between current exclusive smokeless tobacco users or current exclusive 
cigarette smokers compared to never tobacco users at the 5% level (i.e. p-value =0.659 and  p-
value =0.268 respectively). Although not statistically significantly different, estimates for 
marginal effects on the conditional mean for the entire sample were calculated.  Conditional on 




never tobacco users and current exclusive smokeless tobacco users on average have 0.07 more 
visits than never tobacco users.  
However, no significant association between tobacco use status and ER visits was observed. 
Statistically significant associations were found for BMI ((p-value = 0.010, odds ratio 
(OR)=0.432), (p-value=0.074, OR= 0.587) for overweight and obesity respectively), self-
reported binge status  (p-value = 0.019, OR =0.378)  and insurance type (p-value = 0.022, OR 
=3.130)  for those who had at least one ER visit.  
Table 23: Results for the Hurdle model for number of Emergency room visits, 2011-2017 
Covariates 
Emergency room visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  0.367 0.092 0.428 0.268 
Current exclusive smokeless tobacco  user 0.251 0.285 0.209 0.659 
Never Tobacco User Reference Reference 
Age -0.014 0.074 0.007 0.515 
Gender 
 Male Reference Reference 
 Female 0.308 0.259 0.578 0.121 
Education 
 College or Higher 0.096 0.679 -0.136 0.694 





Emergency room visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
 High School -0.044 0.856 0.216 0.452 
 Less than High School Reference Reference 
Race/ethnicity 
  White, non-Hispanic Reference Reference 
  Black, non-Hispanic 0.065 0.790 -0.146 0.722 
  Asian, non-Hispanic 0.262 0.288 -0.390 0.339 
 Other or multiple race, non-Hispanic  0.180 0.698 -0.538 0.355 
 Hispanic -0.104 0.744 -0.126 0.875 
Region of residency 
 Northeast 0.436 0.137 -0.228 0.605 
 Midwest 0.490 0.027 0.375 0.192 
  West -0.179 0.520 -0.669 0.344 
  South Reference Reference 
Marital Status 
 Married -0.089 0.707 0.102 0.794 
 Living with Partner 0.325 0.287 -0.354 0.447 
 Widow/divorce/separated 0.125 0.636 -0.700 0.074 
  Never Married Reference Reference 





Emergency room visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Normal or Under Weight Reference Reference 
  Overweight -0.245 0.272 -0.839 0.010 
  Obesity -0.110 0.597 -0.532 0.074 
Poverty Status 
  Poor/Negative 0.148 0.626 0.426 0.474 
  Near Poor -0.210 0.638 -0.471 0.680 
  Low Income -0.216 0.509 0.547 0.231 
  Middle Income 0.291 0.196 0.510 0.231 
  High Income Reference Reference 
Self-reported binge drinking status 
  No Reference Reference 
  Yes -0.208 0.319 -0.974 0.019 
Insurance type 
   Uninsured Reference Reference 
   Public 1.342 0.001 1.141 0.022 
   Private 0.519 0.138 0.737 0.197 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.016 0.068 0.011 0.488 





Emergency room visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Mental illness score (Kessler 6 Index)  0.068 0.081 0.081 0.102 
Depression score  (Patient Health Index) 
0 Reference Reference 
1 0.287 0.330 -0.755 0.260 
2 -0.262 0.490 -0.160 0.775 
3 -0.024 0.960 -0.540 0.398 
4 -0.003 0.996 -0.310 0.585 
5 -1.517 0.165 -13.811 0.0001 
6 -0.235 0.745 -0.708 0.416 


















Table 24 shows the estimated results of the Hurdle model for office-based visits including all 
covariates used in the ER model above.  
The logit indicated that there was no difference in the current exclusive smokeless tobacco user 
group or current exclusive cigarette smoker group compared to the never tobacco user group in 
their probability of having at least one office- based visit (i.e. p-value =0.056 and  p-value 
=0.074 respectively). 
The Poisson model indicated for those who had at least one office-based visit there was no 
statistically significant difference between current exclusive smokeless tobacco users or current 
exclusive cigarette smokers  compared to never tobacco users at the 5% level (i.e. p-value =0.310 
and  p-value =0.389 respectively). Although not statistically significantly different, estimates for 
marginal effects on the conditional mean for the entire sample were calculated.  Current 
exclusive cigarette smokers averaged 0.63 visits less than never tobacco users and current 
exclusive smokeless tobacco users on average have 0.70 less visits than never tobacco users.  
No significant association between tobacco use status and office-based visits was observed. 
However, statistically significant associations were found for self- reported binge status (p-value 
= 0.034, OR =0.785) , insurance type ((p-value =0.005 , OR = 2.243), (p-value = 0.007, OR = 
2.10) public and private insurance respectively) for those who had at least one office-based visit. 
A participant is more likely to have at least one office-based visit with an unit increase in age (p-
value = 0.008, OR =1.01)  and less likely to have at least one office-based visit with an increase 
in  health status-physical component score (p-value = 0.0001, OR =0.977) 




Table 24: Results for the Hurdle model for number of Office-based visits, 2011-2017 
Covariates 
 
Office-based visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  -0.295 0.074 -0.114 0.389 
Current exclusive smokeless tobacco  user -0.350 0.056 -0.128 0.310 
Never Tobacco User Reference Reference 
Age 0.17 0.005 0.011 0.008 
Gender 
 Male Reference Reference 
 Female 1.047 0.001 -0.138 0.415 
Education 
 College or Higher 0.264 0.153 0.199 0.120 
Some College 0.100 0.647 0.145 0.341 
 High School 0.053 0.783 -0.040 0.780 
 Less than High School Reference Reference 
Race/ethnicity 
  White, non-Hispanic Reference Reference 
  Black, non-Hispanic -0.129 0.545 -0.144 0.387 
  Asian, non-Hispanic -0.355 0.069 0.001 0.994 






Office-based visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
 Hispanic -0.314 0.160 -0.082 0.553 
Region of residency 
 Northeast 0.389 0.121 0.117 0.461 
 Midwest 0.397 0.024 0.152 0.226 
  West 0.074 0.704 0.094 0.471 
  South Reference Reference 
Marital Status 
 Married -0.210 0.242 0.056 0.631 
 Living with Partner -0.038 0.895 -0.215 0.429 
 Widow/divorce/separated -0.124 0.583 0.069 0.680 
  Never Married Reference Reference 
Body mass index (BMI) 
  Normal or Under Weight Reference Reference 
  Overweight 0.325 0.061 0.037 0.821 
  Obesity 0.130 0.464 0.198 0.220 
Poverty Status 
  Poor/Negative -0.590 0.040 0.067 0.679 
  Near Poor -0.004 0.991 -0.021 0.905 






Office-based visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Middle Income -0.321 0.052 0.063 0.608 
  High Income Reference Reference 
Self-reported binge drinking status 
  No Reference Reference 
  Yes -0.197 0.186 -0.242 0.034 
Insurance type 
   Uninsured Reference Reference 
   Public 1.899 0.0001 0.808 0.005 
   Private 1.776 0.0001 0.745 0.007 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.070 0.0001 -0.023 0.0001 
  Mental Component Summary (0-100) -0.029 0.027 -0.015 0.094 
  Mental illness score (Kessler 6 Index)  -0.003 0.925 -0.010 0.665 
Depression score  (Patient Health Index) 
0 Reference Reference 
1 0.067 0.784 0.067 0.676 
2 -0.123 0.680 -0.032 0.843 
3 0.933 0.147 -0.136 0.505 






Office-based visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
6 0.159 0.841 -0.114 0.700 
Statistical significance is at the 5% level 
 
 
Hospital Outpatient Visits 
Table 25 shows the estimated results of the Hurdle model for hospital outpatient visits including 
all covariates previously mentioned for the other health care services. The logit indicated that 
there was no difference in current exclusive smokeless tobacco users or current exclusive 
cigarette smokers compared to never tobacco users in their probability of having at least one 
hospital outpatient visit (i.e. p-value =0.109 and  p-value =0.832 respectively). 
The Poisson model indicated for those who had at least one hospital outpatient visit there was no 
statistically significant difference between current exclusive smokeless tobacco users or current 
exclusive cigarette smokers compared to never tobacco users at the 5% level (i.e. p-value =0.130 
and  p-value =0.879 respectively). Although, not statistically significantly different, estimates for 
marginal effects on the conditional mean for the entire sample were calculated.  Conditional on 
having at least one hospital outpatient visit, current exclusive cigarette smokers averaged 0.06 
visits more than never tobacco users and current exclusive smokeless tobacco users on average 





No significant association between tobacco use status and hospital outpatient visits was 
observed.  A statistically significant association was found between insurance type ((p-value 
=0.035 , OR = 0.390), (p-value = 0.033, OR = 0.365) public and private insurance respectively) 
and hospital outpatient visits.  
 
Table 25:Results for the Hurdle model for number of Hospital Outpatient visits, 2011-2017 
Covariates 
Hospital Outpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  -0.048 0.832 0.033 0.879 
Current exclusive smokeless tobacco  user -0.426 0.109 -0.629 0.130 
Never Tobacco User Reference Reference 
Age 0.018 0.033 0.021 0.079 
Gender 
 Male Reference Reference 
 Female 0.395 0.215 0.435 0.173 
Education 
 College or Higher 0.984 0.001 0.703 0.023 
Some College 1.06 0.001 -0.287 0.415 
 High School 0.890 0.003 0.116 0.731 





Hospital Outpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Race/ethnicity 
  White, non-Hispanic Reference Reference 
  Black, non-Hispanic -0.409 0.169 0.003 0.997 
  Asian, non-Hispanic 0.068 0.809 0.309 0.423 
 Other or multiple race, non-Hispanic  -0.181 0.762 -1.019 0.365 
 Hispanic -0.086 0.803 -0.178 0.680 
Region of residency 
 Northeast 0.630 0.049 0.530 0.246 
 Midwest 0.383 0.093 0.073 0.803 
  West -0.504 0.134 0.848 0.044 
  South Reference Reference 
Marital Status 
 Married 0.203 0.445 0.469 0.203 
 Living with Partner 0.562 0.148 0.787 0.064 
 Widow/divorce/separated 0.371 0.213 0.006 0.986 
  Never Married Reference Reference 
Body mass index (BMI) 
  Normal or Under Weight Reference Reference 





Hospital Outpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Obesity 0.188 0.444 0.101 0.758 
Poverty Status   
  Poor/Negative -0.495 0.187 -1.329 0.045 
  Near Poor 0.141 0.755 0.015 0.972 
  Low Income -0.146 0.667 0.376 0.211 
  Middle Income -0.166 0.488 -0.481 0.104 
  High Income Reference Reference 
Self-reported binge drinking status 
  No Reference Reference 
  Yes -0.312 0.183 0.179 0.595 
Insurance type 
   Uninsured Reference Reference 
   Public 0.853 0.079 -0.942 0.035 
   Private 1.030 0.019 -1.007 0.033 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.048 0.0001 -0.017 0.214 
  Mental Component Summary (0-100) -0.002 0.878 0.010 0.625 
  Mental illness score (Kessler 6 Index)  0.052 0.209 0.044 0.311 





Hospital Outpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
0 Reference Reference 
1 0.325 0.291 0.894 0.028 
2 -0.070 0.854 0.790 0.083 
3 -0.431 0.409 0.678 0.253 
4 -0.651 0.229 0.099 0.860 
5 -1.145 0.370 0.608 0.448 
6 -0.468 0.552 -0.717 0.448 
Statistical significance is at the 5% level 
 
 
Hospital Inpatient Visits 
Table 26 shows the estimated results of the Hurdle model for hospital inpatient visits including 
all covariates previously mentioned for the other health care services. The logit indicated that 
there was no difference in current exclusive smokeless tobacco users or current exclusive 
cigarette smokers compared to never tobacco users in their probability of having at least one 
hospital inpatient visit (i.e. p-value =0.250 and  p-value =0.304 respectively). 
The Poisson model indicated for those who had at least one hospital inpatient visit there was no 
statistically significant difference between current exclusive smokeless tobacco users or current 




=0.932and  p-value =0.090 respectively). Although, not statistically significantly different, 
estimates for marginal effects on the conditional mean for the entire sample were calculated.  
Conditional on having at least one hospital inpatient visit, current exclusive cigarette smokers 
averaged 4.23 visits more than never tobacco users and current exclusive smokeless tobacco 
users on average have 0.11 less visits than never tobacco users.  
No significant association between tobacco use status and hospital inpatient visits was observed. 
A statistically significant association was found between the Short -Form 12-mental component 
score (p-value = 0.0001, OR =0.941), were a participant is less likely to have at least one hospital 
inpatient visits  with an increased score.  Also, participants were less likely to have at least one 
hospital inpatient visit  as the Kessler 6 index (mental illness score) decreases (p-value = 0.027, 
OR =0.924).  
Table 26:Results for the Hurdle model for number of Inpatient visits, 2011-2017 
Covariates 
Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  0.353 0.250 0.643 0.090 
Current exclusive smokeless tobacco user -0.380 0.304 -0.026 0.934 
Never Tobacco User Ref Ref 
Age 0.016 0.133 0.018 0.062 
Gender 
 Male Ref Ref 
 Female -0.125 0.761 0.384 0.118 
Education 





Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Some College 0.107 0.767 0.060 0.824 
 High School -0.123 0.708 1.13 0.001 
 Less than High School Ref Ref 
Race/ethnicity 
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic 0.036 0.920 0.773 0.011 
  Asian, non-Hispanic 0.207 0.581 -0.706 0.052 
 Other or multiple race, non-Hispanic  0.267 0.628 -0.769 0.069 
 Hispanic 0.048 0.926 1.18 0.016 
Region of residency 
 Northeast -0.260 0.565 0.300 0.519 
 Midwest -0.221 0.507 -0.616 0.065 
  West -0.881 0.060 0.008 0.983 
  South Ref Ref 
Marital Status 
 Married 0.177 0.649 -0.387 0.253 
 Living with Partner 0.395 0.476 0.862 0.121 
 Widow/divorce/separated 0.283 0.507 -0.508 0.174 
  Never Married Ref Ref 
Body mass index (BMI) 
  Normal or Under Weight Ref Ref 
  Overweight 0.507 0.199 0.402 0.191 
  Obesity 0.380 0.296 0.504 0.087 





Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Poor/Negative -0.187 0.669 0.678 0.043 
  Near Poor -0.265 0.663 -0.008 0.986 
  Low Income -0.438 0.351 -0.763 0.125 
  Middle Income -0.481 0.211 0.571 0.049 
  High Income Ref Ref 
Self-reported binge drinking status 
  No Ref Ref 
  Yes -0.105 0.747 -0.336 0.371 
Insurance type 
   Uninsured Ref Ref 
   Public 0.790 0.221 -0.368 0.466 
   Private 0.676 0.290 -0.568 0.325 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.050 0.0001 -0.006 0.646 
  Mental Component Summary (0-100) -0.005 0.791 -0.061 0.0001 
  Mental illness score (Kessler 6 Index)  0.055 0.307 -0.079 0.027 
Depression score  (Patient Health Index) 
0 Ref Ref 
1 -0.021 0.965 0.018 0.961 
2 -0.844 0.181 0.766 0.045 
3 -0.737 0.329 -0.510 0.393 
4 0.171 0.796 0.003 0.995 
5 -0.769 0.539 -2.160 0.005 








Table 27 shows the estimated results of the Hurdle model for dental visits including all covariates 
previously mentioned for the other health care services. The logit indicated that both current 
exclusive smokeless tobacco users and current exclusive cigarette smokers have lower 
probability of having at least one dental visit compared to never tobacco users (i.e. p-value 
=0.004 and  p-value =0.001 respectively).  
The Poisson model indicated for those who had at least one dental visit there was no statistically 
significant difference between current exclusive smokeless tobacco users or current exclusive 
cigarette smokers compared to the never tobacco users at the 5% level (i.e. p-value =0.163 and  
p-value =0.940 respectively). Although, not statistically significantly different, estimates for 
marginal effects on the conditional mean for the entire sample were calculated.  Conditional on 
having at least one dental visit, current exclusive cigarette smokers averaged 0.01 visits less than 
never tobacco users and current exclusive smokeless tobacco users on average have 0.23 less 
visits than never tobacco users.  
No significant association between tobacco use status and dental visits was observed. A 
statistically significant association was found between BMI ((p-value =0.002 , OR = 1.657), (p-







Table 27:Results for the Hurdle model for number of Dental visits, 2011-2017 
Covariates 
Dental visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  -0.531 0.001 -0.010 0.940 
Current exclusive smokeless tobacco  user -0.499 0.004 -0.217 0.163 
Never Tobacco User Reference  
Age -0.010 0.092 0.003 0.525 
Gender 
 Male Reference  Reference 
 Female -0.040 0.885 -0.491 0.075 
Education 
 College or Higher 0.472 0.007 -0.077 0.654 
Some College   0.257 0.230 -0.262 0.186 
 High School 0.147 0.449 -0.086 0.612 
 Less than High School Reference Reference 
Race/ethnicity 
  White, non-Hispanic Reference Reference 
  Black, non-Hispanic -0.229 0.282 -0.162 0.458 





Dental visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
 Other or multiple race, non-Hispanic  -0.585 0.203 -0.490 0.356 
 Hispanic -0.097 0.666 -0.014 0.948 
Region of residency 
 Northeast 0.502 0.030 0.050 0.816 
 Midwest 0.432 0.010 0.041 0.812 
  West 0.662 0.0001 0.243 0.164 
  South Reference Reference 
Marital Status 
 Married 0.376 0.032 -0.105 0.549 
 Living with Partner -0.070 0.803 -0.202 0.429 
 Widow/divorce/separated 0.213 0.321 0.005 0.976 
  Never Married Reference Reference 
Body mass index (BMI) 
  Normal or Under Weight Reference Reference 
  Overweight 0.062 0.714 0.505 0.002 
  Obesity -0.041 0.813 0.324 0.038 
Poverty Status 
  Poor/Negative -0.919 0.001 -0.276 0.327 





Dental visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Low Income -1.077 0.0001 -0.081 0.776 
  Middle Income -0.666 0.0001 0.027 0.853 
  High Income Reference Reference 
Self-reported binge drinking status 
  No Reference Reference 
  Yes -0.111 0.465 -0.027 0.827 
Insurance type 
   Uninsured Reference Reference 
   Public 1.314 0.0001 0.850 0.104 
   Private 1.086 0.001 0.395 0.426 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.002 0.802 -0.010 0.229 
  Mental Component Summary (0-100) 0.005 0.638 -0.009 0.522 
  Mental illness score (Kessler 6 Index)  0.019 0.544 -0.010 0.803 
Depression score  (Patient Health Index) 
0 Reference Reference 
1 0.105 0.670 -0.049 0.805 
2 0.284 0.297 -0.084 0.703 





Dental visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
4 0.291 0.511 -0.433 0.262 
5 -1.047 0.413 -11.797 0.0001 
6 -0.868 0.184 -0.564 0.564 
Statistical significance is at the 5% level 
 
Home Health Care Visits 
 Table 28 shows the estimated results of the Hurdle model for home health care visits including 
tobacco use status and the sociodemographic variables: age, gender, Education, Race/ethnicity, 
region, marital status, BMI, poverty status, binge drinking status and insurance type. The logit 
indicated that there was no difference in current exclusive smokeless tobacco users or current 
exclusive cigarette smokers compared to never tobacco users in their probability of having at 
least one home health care visit (i.e. p-value =0.922 and  p-value =0.286 respectively). 
The Poisson model indicated for those who had at least one home health care visit there was no 
statistically significant difference between current exclusive smokeless tobacco users or current 
exclusive cigarette smokers compared to the never tobacco users at the 5% level (i.e. p-value 
=0.546 and  p-value =0.127 respectively).  
No significant association between tobacco use status and home health care visits was observed.  
Statistically significant associations were found for gender (p-value = 0.003, OR = 3.219)  and 
education ((p-value =0.002 , OR = 0.291), (p-value = 0.0001, OR = 0.293) some college and 





Table 28:Results of the Hurdle model for number of Home Health Care visits, 2011-2017 
Covariates 
Home Health Care visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  -0.412 0.286 -0.931 0.127 
Current exclusive smokeless tobacco  user -0.033 0.922 -0.207 0.546 
Never Tobacco User Reference Reference 
Age 0.039 0.002 -0.016 0.366 
Gender 
 Male Reference Reference 
 Female -0.184 0.622 1.169 0.003 
Education 
 College or Higher -0.497 0.212 -1.236 0.114 
Some College -0.168 0.827 -1.233 0.002 
 High School 0.082 0.720 -1.211 0.0001 
 Less than High School Reference Reference 
Race/ethnicity 
  White, non-Hispanic Reference Reference 
  Black, non-Hispanic 0.059 0.880 -0.250 0.418 





Home Health Care visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
 Other or multiple race, non-Hispanic  0.483 0.416 -1.322 0.268 
 Hispanic -0.310 0.628 0.567 0.254 
Region of residency 
 Northeast 0.216 0.652 -0.319 0.709 
 Midwest -0.015 0.971 0.885 0.082 
  West -1.934 0.069 2.082 0.007 
  South Reference Reference 
Marital Status 
 Married -0.556 0.250 -0.139 0.776 
 Living with Partner -1.605 0.119 1.772 0.166 
 Widow/divorce/separated -0.222 0.621 0.310 0.638 
  Never Married Reference Reference 
Body mass index (BMI) 
  Normal or Under Weight Reference Reference 
  Overweight 0.389 0.313 0.526 0.212 
  Obesity 0.137 0.717 -0.118 0.827 
Poverty Status 
  Poor/Negative 1.201 0.032 0.657 0.541 





Home Health Care visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Low Income 0.143 0.831 0.106 0.917 
  Middle Income 1.065 0.033 -0.349 0.716 
  High Income Reference Reference 
Self-reported binge drinking status 
  No Reference Reference 
  Yes -0.436 0.311 -0.436 0.500 
Insurance type 
   Uninsured Reference Reference 
   Public 2.190 0.035 0.869 0.107 
   Private 1.090 0.310 0.889 0.080 
Statistical significance is at the 5% level 
 
 
In summary, no statistically significant association was found between tobacco use status and the 
6 health care services examined in this study using a Hurdle count model. Sociodemographic 
variables like age and insurance type were found to be associated with the health care services 
studied. Stata output for the final models for health care utilization for the 6 health care services 





Sensitivity Analysis for Health Care Utilization 
 
Sensitivity analysis was conducted using the original data set before propensity score matching. 
Hurdle count models were run for ER visits, office-based visits, hospital outpatient visits, dental 
visits and home health care visits adjusting for tobacco use status, sociodemographic and health 
status variables. 
The Hurdle model results indicated that there was no statistically significant association between 
tobacco use status and ER visits or home health care visits. Statistically significant associations 
between tobacco use status and office-based visits, hospital outpatient visits, and dental visits 
(only for current smokeless tobacco users vs never tobacco users) were observed (see Table 29).  
The Poisson model indicated for those who had at least one office-based visit there was a 
statistically significant difference between current exclusive smokeless tobacco users and current 
exclusive cigarette smokers compared to the never tobacco user group at the 5% level (i.e. p-
value =0.039 and  p-value =0.0001 respectively). Marginal effects on the conditional mean for 
the entire sample indicated that conditional on having at least one office-based visit, current 
exclusive cigarette smokers averaged 1.3 visits less than never tobacco users and current 
exclusive smokeless tobacco users on average have 1.6 less visits than never tobacco users.  
For those who had at least one hospital outpatient visit there was a statistically significant 
difference between current exclusive smokeless tobacco users and current exclusive cigarette 
smokers compared to the never tobacco user group at the 5% level (i.e. p-value =0.003 and  p-
value =0.046 respectively). The marginal effects indicated that conditional on having at least one 
hospital outpatient visit, current exclusive cigarette smokers and current exclusive smokeless 




A statistically significant difference between current exclusive smokeless tobacco users and the 
never tobacco users at the 5% level for those having at least one dental visit , with marginal 
effects indicating that current exclusive smokeless users on average have 0.34 less visits than 
never tobacco users. The full results of the fitted models for this analysis are in Appendix A. 
Table 29:Results for the Hurdle model for each of health service by tobacco use status 
Covariate 
Emergency room visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  0.265 0.0001 0.057 0.396 
Current exclusive smokeless tobacco  user -0.043 0.836 -0.807 0.096 
Never Tobacco User Reference Reference 
 
Office based visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Current exclusive cigarette smoker  -0.407 0.0001 -0.180 0.0001 
Current exclusive smokeless tobacco  user -0.375 0.005 -0.238 0.039 
Never Tobacco User Reference Reference 
 
Outpatient visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Current exclusive cigarette smoker  -0.184 0.0001 -0.229 0.046 
Current exclusive smokeless tobacco  user -0.617 0.006 -1.161 0.003 
Never Tobacco User Reference Reference 
 
Inpatient visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Current exclusive cigarette smoker  0.005 0.938 0.121 0.046 




Never Tobacco User Reference Reference 
 
Dental visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Current exclusive cigarette smoker  -0.478 0.0001 0.032 0.318 
Current exclusive smokeless tobacco  user -0.741 0.0001 -0.296 0.036 
Never Tobacco User Reference Reference 
 
Home Health care visits (in the past 12 months)ª 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Current exclusive cigarette smoker  -0.017 0.862 -0.193 0.124 
Current exclusive smokeless tobacco  user 0.254 0.648 0.443 0.269 
Never Tobacco User Reference Reference 
ªAll models control for tobacco use status, age, gender, education, race/ethnicity, region, marital status, BMI, poverty status, binge drinking 
status, insurance type,   physical component summary, mental component summary, Kessler index and Patient health index. 
 
Estimation of Annual Total Health Care Expenditure by Tobacco Use Status 
 
The final models were executed using the matched data set. Two-part models were fit using 
different distribution and link functions (e.g. gaussian distribution  with a log link) and compared 
using a likelihood-based model-selection approach (i.e. identifying  the model with the smallest 
AIC and BIC values) applying the full set of  covariates (i.e. both sociodemographic and health 
status variables). A generalized linear regression (GLM) with a Gamma distribution and a log 
link function was the best fit for the health expenditure data in this study.  
Final Total Health Care Expenditure Model 
 
Table 30 shows the estimated coefficients and linearized standard errors and associated p-values 





The logit indicated that there was no statistically significant difference in current exclusive 
smokeless tobacco users or current exclusive cigarette smokers compared to the never tobacco 
users in their probability of having at least some spending (i.e. p-value =0.439 and  p-value 
=0.159 respectively). Among those who spend something, the GLM model indicates that there 
was no statistically significant difference between current exclusive smokeless tobacco users or 
current exclusive cigarette smokers compared to the never tobacco users at the 5% level (i.e. p-
value =0.874 , OR= 1.029 and  p-value =0.115, OR=1.306 respectively). Although not 
statistically significantly different, the marginal (or incremental) effects for the combined logit 
and GLM of the two-part model were estimated. The marginal effects for tobacco use status 
indicated that current exclusive cigarette smokers spend more than never tobacco users by about 
$1200 (standard error (se)=$902)and current exclusive smokeless tobacco user spend about $50 
(se=$796)more than never tobacco users. The overall mean annual health care expenditure for 
US adults was $4868 (se=$436). Table 31 shows the estimated annual mean total health care 
expenditure by tobacco use status. Although no statistical association was found between total 
health care expenditure and tobacco use status, never tobacco user had the lowest annual mean 
total health care expenditure ($4426.89) followed by current exclusive smokeless users 
($4478.33) and current exclusive cigarette smokers have the highest annual mean cost 
($5627.64).   
Covariates that were found to be statistically significantly associated with total health care 
expenditure, shown in Table 30, were age, insurance type and the quality of life scores (physical 
and mental health component scores). 
The estimated coefficients for age were positive in both the logit and GLM and statistically 




probability of spending and the amount of spending conditional on any spending increased with 
age. The marginal effect of age averages $68.23 per year of age. 
The estimated coefficients for insurance type were also statistically significant at the 5% level 
and positive in both the logit (p-value= 0.0001 and p-value=0.001 for public and private 
insurance respectively) and GLM((p-value =0.0001 , OR = 3.095), (p-value = 0.0001, OR = 
3.669) for public and private insurance respectively). Those who have any type of health 
insurance ( i.e. public or  any private ) are more likely than the uninsured to spend at least $1, 
and, conditional on spending any amount, they are more likely to spend more than the uninsured. 
The marginal effect of those with public or any private insurance spend more than the uninsured 
by about $4451.19 and $3608.88 respectively.  
The two-part model results for physical and mental health component scores show adults who 
are in better health are both less likely to spend and to spend less when they do spend GLM((p-
value =0.0001 , OR = 0.956), (p-value = 0.010, OR = 0.969) for PCS and MCS respectively).The 
physical and mental health component scores indicate that adults who are in better health spend 
significantly less than those in poorer health( i.e. about $250.97 and $154.71 less than those in 
poorer health). The model predicted that the overall total spending was about $4868 per person 
per year. 
Given the statistically significant increase in spending with age, predicted values for age 
categories (i.e. decade of life) by tobacco use status were examined.  Figure 9 shows that the 
predicted total health expenditures rise for all the tobacco use  status groups with age. The 
predicted total health expenditures are highest for current exclusive cigarette smokers followed 
by current exclusive smokeless users and never tobacco users adults. The separation in spending 




the average marginal effect may mask the fact that the observed marginal effects may vary with 
age. 
Based on the fact that the significant variables, like insurance type, in the model have a larger 
effect size as estimated by the odds ratio compared to the estimates of the non-significant 
tobacco use status variable with a small effect size, therefore the study should have enough 
power to detect a statistical significant difference. 
The final model was also run with just the set of sociodemographic variables as a sensitivity 
analysis. Similar results for tobacco use status were observed. The logit indicated that there was 
no statistically significant difference in current exclusive smokeless tobacco users or current 
exclusive cigarette smokers compared to the never tobacco users in their probability of having at 
least some spending (i.e. p-value =0.615 and  p-value =0.396 respectively). Among those who 
spend something, the GLM model indicates that there was no statistically significant difference 
between current exclusive smokeless tobacco users or current exclusive cigarette smokers 
compared to the never tobacco users at the 5% level (i.e. p-value =0.842 , OR= 1.036 and  p-
value =0.061, OR=1.363 respectively). 
 
Table 30:Results of the Two-part model  for Total Health Care Expenditure (2017 US $) per year, 2011-2017 
Covariates 
Total Health Care Expenditure 













Total Health Care Expenditure 








Current exclusive cigarette smoker  -0.352 (0.248) 0.159 0.267 (0.169) 0.115 
Current exclusive smokeless tobacco  user -0.229 (0.295) 0.439 0.029 (0.179) 0.874 
Never Tobacco User Ref Ref 
Age 0.019 (0.010) 0.069 0.013 (0.005) 0.035 
Insurance type   
   Public 1.63 (0.326) 0.0001 1.13 (0.284) 0.0001 
   Private 1.50 (0.452) 0.001 1.30 (0.317) 0.0001 
   Uninsured Ref Ref 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.086 (0.015) 0.0001 -0.045 (0.007) 0.0001 














     Table 31:Adjusted estimated mean Total Health Care Expenditure by Tobacco use status 
Tobacco Use Status Mean health careª 
cost (US$,2017) 
95%  CI 
Current exclusive cigarette smoker $5627.64 ($4068.50, $7186.78) 
Current exclusive smokeless tobacco  user $4478.33 ($3035.05, $5921.62) 
Never Tobacco User  $4426.89 ($3514.19, $5339.59) 




NT= never tobacco users  ST= current exclusive smokeless user,  CIG=  current exclusive cigarette smoker 
 95% Confidence Interval 
 








Sensitivity Analysis-Age (≤ 65 years) 
 
The analysis described above was rerun with restricting the data to adults between 18 and 65 
years.  Given that healthcare expenditure increases with adulthood, excluding older adults from 
the modeling analysis allows the assessment of total healthcare expenditure by tobacco use status 
in the general working population and removes older adults who may be sicker and have higher 
total healthcare spending than the average adult. 
Table 32 show the estimated coefficients and linearized standard errors and associated p-values 
for tobacco use status and key variables that were found to be significant from the two-part 
model.  
As previously found, the logit indicated that there was no statistically significant difference in 
current exclusive smokeless tobacco users or current exclusive cigarette smokers compared to 
never tobacco users in their probability of having at least some spending (i.e. p-value =0.358 and  
p-value =0.359 respectively). Among those who spend something, the GLM model indicates that 
there was no statistically significant difference between current exclusive smokeless tobacco 
users or current exclusive cigarette smokers compared to never tobacco users at the 5% level (i.e. 
p-value =0.100 and  p-value =0.073respectively).  At the 10% level a statistically significant 
difference would be observed between current exclusive cigarette smokers and never tobacco 
users.  The marginal effects for the combined logit and GLM of the two-part model for tobacco 
use status indicated that current exclusive cigarette smokers spend more than never tobacco users 
by about $1130 (se=$717) and current exclusive smokeless tobacco users spend about $ 893 




($50). The overall mean annual health care expenditure for US adults between 18 and 65 was 
$3903 (se=$419). Table 33 shows the estimated annual mean total health care expenditure by 
tobacco use status. Although no statistically significant association was found between total 
health care expenditure and tobacco use status, never tobacco users had an annual mean total 
health care expenditure of $3196.20 followed by current exclusive smokeless users ($4089.01) 
and current exclusive cigarette smokers had annual mean cost ($4326.73).   
Covariates that were found to be statistically significantly associated with total health care 
expenditure, shown in Table 32 included insurance type and quality of life scores (physical and 
mental health component scores). With the restriction of older adults, age no longer was a 
statistically significant covariate in the model. 
The estimated coefficients for insurance type were also statistically significant at the 5% level 
and positive in both the logit (p-value= 0.002 and p-value=0.0001 for public and private 
insurance respectively) and GLM((p-value =0.0001 , OR = 6.959), (p-value = 0.0001, OR = 
4.055) for  public and private insurance respectively). Those who have any type of health 
insurance ( i.e. public or  any private ) are more likely than the uninsured to spend at least $1, 
and, conditional on spending any amount, they are more likely to spend more than the uninsured. 
Those with public or any private insurance spend more than the uninsured by about $5519.58 
and $3021.13 respectively.  
The two-part model results for physical and mental health component scores show adults who 
are in better health are both less likely to spend and to spend less when they do spend  GLM((p-
value =0.0001 , OR = 0.939), (p-value = 0.004 OR = 0.960) for PCS and MCS respectively).  
The physical and mental health component scores indicate that adults who are in better health 




those in poorer health). The model predicted that overall total spending was about $3902.96 per 
person per year which was $965.50 less than the results of the final model, indicating the impact 
of total health care spending in the older population. 
Predicted values for age categories (i.e. 30 to 65 by 5 years) by tobacco use status were also 
examined.  Figure 10 shows that the predicted total health expenditures rise for all tobacco use  
status groups with age. Predicted total health expenditures are highest for current exclusive 
cigarette smokers followed by current exclusive smokeless users and never tobacco users. A 
clear separation can be observed between the three groups and this difference is consistent 
overtime, which shows a different pattern than seen in the final model. 
 
Table 32: Results of the Two-part model  for Total Health Care Expenditure (2017 US $) per year (Age ≤65 
years), 2011-2017 
Covariates 
Total Health Care Expenditure 
Logit GLM  
Coefficient  
(Linearized std. error) 
P-value Coefficient  
(Linearized std. error) 
P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  -0.219 (0.238) 0.359 0.323 (0.180) 0.073 
Current exclusive smokeless tobacco  user -0.243 (0.264) 0.358 0.270 (0.163) 0.100 
Never Tobacco User Ref Ref 
Insurance type   
   Public 1.32 (0.427) 0.002 1.94 (0.266) 0.0001 





Total Health Care Expenditure 
Logit GLM  
Coefficient  
(Linearized std. error) 
P-value Coefficient  
(Linearized std. error) 
P-value 
   Uninsured Ref Ref 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.086 (0.015) 0.0001 -0.063 (0.008) 0.0001 
  Mental Component Summary (0-100) -0.010 (0.019) 0.179 -0.041 (0.014) 0.004 
 
 
Table 33: Adjusted Estimated mean Total Health Care Expenditure by Tobacco Use Status for Age (≤ 65 
years), 2011-2017 
 




95%  CI 
Current exclusive cigarette smoker $4326.73 ($2965.46, $5687.99) 
Current exclusive smokeless tobacco  user $4089.01 ($2759.49, $5418.54) 
Never Tobacco User  $3196.20 ($2476.35, $3916.04) 







NT= never tobacco users  ST= current exclusive smokeless user,  CIG=  current exclusive cigarette smoker 
 95% Confidence Interval 
 
Figure 10: Conditional Marginal Effects of Age by Tobacco Use Status for Total Health Care Expenditure for 




Sensitivity Analysis-Age (≤ 65 years) and males only 
 
This analysis restricts the data to adults equal to or less than 65 years and males only. Since 
smokeless tobacco products are predominately used by males in the U.S. population, females 
were removed to assess the impact on total health care  expenditure. Both age and gender were 
evaluated in this sensitivity analysis.  
The results of this model were similar to those in the previous sensitivity analysis. There was no 
statistically significant difference in current exclusive smokeless tobacco users or current 




least some spending (i.e. p-value =0.455 and  p-value =0.366 respectively). Among those who 
spent something, there was no statistically significant difference between current exclusive 
smokeless tobacco users or current exclusive cigarette smokers compared to the never tobacco 
user group at the 5% level (i.e. p-value =0.162 and  p-value =0.099 respectively). At the 10% 
level a statistically significant difference would be observed between current exclusive cigarette 
smokers and never tobacco users.  The marginal effects for tobacco use status indicated that 
current exclusive cigarette smokers spend more than never tobacco users by about $1055 
(se=$722) and current exclusive smokeless tobacco users spend about $796 (se=$655)more than 
never tobacco users which is not that different than the previous sensitivity analysis ($1130 and 
$892). The overall mean annual health care expenditure for US adults was $3668 (se=$417). 
Table 34 shows the estimated annual mean total health care expenditure by tobacco use status. 
Although no statistically significant association was found between total health care expenditure 
and tobacco use status, never tobacco users have the lowest annual mean total health care 
expenditures ($3053.73) followed by current exclusive smokeless users ($3796.06) and current 
exclusive cigarette smokers ($4073.95).   
Two covariates were found to be statistically significantly associated with total health care 
expenditure  - insurance type and the quality of life scores (physical and mental health 
component scores). The estimated coefficients for insurance type were statistically significant at 
the 5% level and positive in both the logit (p-value= 0.0001 and p-value=0.001 for public and 
private insurance respectively) and GLM((p-value =0.0001 , OR = 6.410), (p-value = 0.0001, OR 
= 3.559) for  public and private insurance respectively). Those who had any type of health 
insurance (i.e. public or  any private ) were more likely than the uninsured to spend at least $1, 




uninsured. Those with public or any private insurance spend more than the uninsured by about 
$7391.55 and $5240.10 respectively.  
The results for physical and mental health component scores also showed that adults who were in 
better health were both less likely to spend and to spend less when they do spend GLM((p-value 
=0.0001 , OR = 0.939), (p-value = 0.004 OR = 0.959) for PCS and MCS respectively).   The 
physical and mental health component scores indicate that adults who were in better health spend 
significantly less than those in poorer health (i.e. about $256.20 and $160.86 less than those in 
poorer health). The model predicted that overall total spending was about $3667.98 per person 
per year which was close to the previous sensitivity analysis $3902.96.  






Table 34: Adjusted estimated mean Total Health Care Expenditure by Tobacco use status for Age ( ≤ 65 
years) and Males only 
Tobacco Use Status Mean health care 
cost (US$,2017) 
95%  CI 
Current exclusive cigarette smoker $4073.95 ($2719.24, $5428.66) 
Current exclusive smokeless tobacco  
user 
$3796.06 ($2496.46, $5095.67) 
Never Tobacco User  $3053.73 ($2334.92, $3772.54) 






Chapter 5: Discussion 
This final chapter discusses the results of the study, the study strengths and limitations, 
implications and ends with the study conclusion and future research.  
Discussion 
The study sample used in this analysis was U.S. adults age 18 years and older from the 2011-
2017 linked MEPS/NHIS national surveys who were identified as current exclusive cigarette 
smokers, current exclusive smokeless tobacco users or never tobacco users. Approximately 35% 
of the individuals obtained from the MEPS/NHIS linked files met study eligibility. A slight 
increase in the prevalence of  current exclusive smokeless tobacco use by year of MEPS data 
collection was observed across the seven years (2011 through 2017).  A decrease was seen in 
current exclusive cigarette smoking over the same timeframe.  This decrease is similar to what 
has been observed in the adult U.S. population over the same period of time.2 
The average adult was 48 years  of age for this study population. The majority of the population 
was female (55.2 %), non-Hispanic white (58.9%),  reported being in middle- or high-income 
bracket (67.7%)  and reported having some type of health care insurance (89.5%) . Similar socio-
demographic trends were observed in Wang et al1  whose study population data was obtained 
from NHIS  2012 through 2015. Majority of adults in the study population were never tobacco 
users (79.3%) followed by current exclusive cigarette smokers (19.5%) while current exclusive 
smokeless tobacco users had the smallest prevalence (1.2%).  
The quality of life scores in both the PCS and MCS were slightly higher in never tobacco users 
indicating slightly better health status compared to the other two tobacco status groups in the 
study population. These mean differences in the quality of life scores were found to be 
statistically significant between current exclusive cigarette smokers vs current exclusive 




observed between participants’ mean scores in the never tobacco user group and current 
exclusive smokeless tobacco user group for either quality of life score. 
Current exclusive cigarette smokers had a greater tendency towards mental disability as indicted 
by their higher Kessler index compared to never tobacco users and current exclusive smokeless 
tobacco users. These differences were found to be statistically significant between current 
exclusive cigarette smokers vs current exclusive smokeless tobacco and never tobacco user. No 
significant difference was observed between the Kessler index for never tobacco users and 
current exclusive smokeless tobacco users. 
Of the ten selected comorbidities examined in this study, a statistically significant association 
was found between tobacco use status and having reported being diagnosed with emphysema,  
coronary heart disease and arthritis, with current exclusive cigarette smokers  reporting the 
highest positive self-reported diagnosis rates. These findings are inline with the literature where 
cigarette usage has been found to be associated with increased emphysema and coronary heart 
disease due to the combustion produced during cigarette smoking.2   
Health care utilization 
Current exclusive cigarette smokers tended to be more likely to have one or more ER  visits than 
current exclusive smokeless tobacco users and never tobacco users. Based on univariate analysis 
current exclusive cigarette smokers had a statistically significant higher mean number of ER and 
home health care visits than current exclusive smokeless tobacco users and never tobacco users. 
The modeling results adjusting for sociodemographic and health status variables (multivariate 
analysis) indicated that current exclusive smokeless tobacco users and current exclusive cigarette 
smokers were not statistically significantly different than never tobacco users  in their utilization 




outpatient visit, hospital inpatient visit, home health care visit  and dental visit in the past 12 
months). Wang et al1 found current smokeless tobacco users (i.e. an adult 18 years or older who 
now uses smokeless tobacco every day or some days) significantly differed from never tobacco 
users in ER visits in the past 12 months (p-value =0.043) but did not differ in the number of 
hospital nights (in the past 12 month), doctor visits (in the past 2 weeks) , and home care visits 
(in the past 2 weeks) using NHIS data from 2012-2015 and a Zero-Inflated  Poisson regression 
model. This significant difference observed by Wang for ER visits could be due to the definition 
of current smokeless tobacco user which included current use of other tobacco products at the 
same time and former use of cigarettes. 
Health Care Expenditure 
The two-part model results indicated that no significant statistical association was found between 
total health care expenditure and tobacco use status. The marginal effects for tobacco use status 
indicated that current exclusive cigarette smokers spend more than never tobacco users by about 
$1200 and current exclusive smokeless tobacco users spend about $50 more than never tobacco 
users. The highest annual mean total health care expenditure in US 2017 dollars was observed in 
the current exclusive cigarette smoking group $5627.64 (95% CI = $4068.50, $7186.78) 
followed by current exclusive smokeless users $4478.33 (95% CI = $3035.05, $5921.62)  and 
never tobacco users had the lowest annual mean cost  $4426.89 (95% CI = $3514.19, $5339.59). 
A statistical association of age with total health care expenditure was also examined and showed 
that the predicted total health expenditures increased for all the tobacco use status groups with 
age. Swedler et al13 examined the association between current smokers, former smokers and 
never smokers and medical expenditures. They found that current smokers had higher medical 




smokers - $4360, (95%CI = $4154.3, $4566.3) - using 2011-2015 MEPS/NHIS linked data and 
former smokers had the highest medical expenditure ,$5590, (95%CI = $5267.4, $5913.5).  
Swedler et al2 estimates for annual medical expenditures for all civilian non-institutionalized 
adults in the U.S. was $4830 in 2015 US dollars. The overall estimate for annual health care 
expenditure for U.S. adults in this study was $4869 in 2017 US dollars. The estimates for overall 
annual health care expenditure were close to estimates by Swedler et al and Mitchell and 
Machlin13,73 estimate of  $4978 for average total medical expenditures in 2015 using MEPS data. 
Health care expenditure increases with aging, therefore a sensitivity analysis restricting the data 
to adults ≤ 65 years was run to remove the older adult population who may have higher total 
healthcare spending than the average adult. Although no statistical association was found 
between total health care expenditure and tobacco use status ( at a 5% significant level), similar 
to the previous findings, at a 10% significance level a statistical difference was observed 
between current exclusive cigarette smokers and never tobacco users (p-value=0.073).  The 
estimated annual mean total health care expenditure was highest in current exclusive cigarette 
smokers $4326.73 (95% CI = ($2965.46, $5687.99) followed by current exclusive smokeless 
users $4089.01 (95% CI = $2759.49, $5418.54)  and never tobacco user has the lowest annual 
mean total health care expenditure $3196.20 (95% CI = $2476.35, $3916.04). Removing the 
older population which was about ~ 17% of the data. As expected, a decrease in total health care 
expenditure across all tobacco status groups was observed since the older population on average 
has higher health care expenditure compared to the younger population.  
Another sensitivity analysis was conducted to evaluate the impact of total health care  
expenditure restricting  the analysis to adults ≤ 65 years and males only, since smokeless tobacco 




Similar to the previous sensitivity analysis findings, no statistical association was found between 
total health care expenditure and tobacco use status ( at a 5% significant level), but at a 10% 
significance level a statistical difference was observed between current exclusive cigarette 
smokers and never tobacco users (p-value=0.099).  Never tobacco users still had the lowest 
annual mean total health care expenditures ($3053.73) followed by current exclusive smokeless 
users ($3796.06) and current exclusive cigarette smokers ($4073.95) which had the highest 
annual mean total health care expenditure.  Excluding the small  percentage of female 
participants (~5%) further reduced the annual mean total expenditures for all three groups which 
is expected given that females particularly in their childbearing age tend to have higher 
expenditure than males.48,49  
Although the findings from the study showed no statistical association between total health care 
expenditure and tobacco use status, the highest annual mean expenditure was observed in current 
exclusive cigarette smokers. High medical expenditure estimates due to smoking are in line with 
other peer-reviewed work.2,12,13,39  Unlike the study findings, a statistical significance difference 
was found between smokers and never/non smokers in terms of their total healthcare/ medical 
expenditure.13,16  This difference in observing a statistical association between total health care 
expenditure and tobacco use status could be due to the definitions and classification of tobacco 
user groups and /or the study design and associated sample size.  
Studies from the peer-viewed literature investigated only cigarette smoking status, where the 
smoking groups were defined as current smoker, former smoker and never/non smoker2,12,13 or 
smoker (current and former combined) and non-smoker.39  In studies where current smokers, 
former smokers and never/non-smokers  were defined, former smokers tended to have the 




findings  likely reflect quitting following the onset of an illness due to cigarette smoking. 2,4,5  In 
contrast this study’s objective was to compare  health care expenditures and health care 
utilization across different current exclusive tobacco product usage, therefore tobacco use status 
definitions were extended  across two different tobacco products  (cigarettes and smokeless 
tobacco use) and never/non users of these tobacco products and are further restricted to current 
exclusive use of the tobacco products at time of interview excluding former tobacco product 
users.  
Secondly, this study is the first to my knowledge that uses propensity score matching to control 
for observable differences between the tobacco use status groups. This reduced the original 
sample size (i.e. 68,866 to 1,899) and therefore potentially increased the variability in the sample 
distribution. The current exclusive smokeless tobacco group (group1-‘case’) (N=633)was used to 
match observations in the other tobacco status groups ( i.e. group 2; current cigarette smokers, 
group 3; never tobacco users-‘controls’). The final matched analysis dataset on average had 
younger participants than observed in the original data set (also in both smokers  and never 
smokers groups), ~83% of the sample was ≤ 65 years old and was predominately male (94% ) 
since smokeless tobacco is mainly used by male in the U.S.54  In comparison the peer-reviewed 
studies had larger sample sizes with less variability in their sample distributions and on average 
tended to have approximately similar ratio of males to females. 
The sensitivity analysis excluding participants ≥ 65 years from the analysis resulted in a 
statistically significant difference between current exclusive cigarette user and never tobacco 
users at a 10% significance level. 
Comparing estimates for annual expenditures from this study and other studies that used MEPS 




database, the study estimates are lower than similar estimates using NHEA data.74,75  This is not 
unexpected given the fact that NHEA is more comprehensive than MEPS in capturing Medicaid 
costs covering institutionalized adults including those in nursing homes, active-duty military and 
foreign visitors to the USA.75,76 
 
Strengths and Limitation 
 
This is the first study to my knowledge that estimates and compares health care expenditures and 
utilization associated with current exclusive cigarette smoking, current exclusive smokeless 
tobacco use and never tobacco use, among U.S. adults aged 18 years and older. The rationale for 
selecting the two tobacco products (i.e. cigarettes and smokeless tobacco use) is because they are 
the most commonly used tobacco products in the U.S. and have been on the market for decades 
as compared to the more novel tobacco products, therefore providing the most comprehensive 
data. Also, these two products are on opposite ends of the continuum of risk for nicotine 
containing products; cigarettes on the highest level and smokeless tobacco on the lower end. 
The analyses compared healthcare expenditure and use estimates across current exclusive use of 
tobacco products within the U.S.  we are not aware of any other studies that have systematically 
quantified and compared the direct economic costs of adults who are current exclusive users of 
cigarettes, smokeless tobacco users or never users of tobacco products. 
 A common challenge in observational data analysis is addressing selection bias or confounding 
resulting from a lack of randomization. When the groups of interest are not randomized, there is 
the likelihood for the groups to differ in key variables  (e.g. sociodemographics like age and 
gender) and not be comparable. To reduce the potential for bias, propensity score matching was 




through propensity score matching were controlled for in the models used in the multivariate 
analyses. As with most self-reported data, health care use may be subject to recall bias or 
underreporting. In the case of this study data, MEPS addresses nonresponse bias by imputing 
missing expenditure data instead of excluding these cases from the analysis dataset.77  Also 
MEPS provides valuable data on characteristics of MEPS non respondents that reduces MEPS 
nonresponse bias through various checks and balances during the  five rounds of MEPS data 
collects (e.g. variables like age are checked across a selected number of rounds for age 
verification).78 
The model estimates from the study should be considered in the context of some limitations. 
Although two-part models are considered the best modeling approach for health expenditure 
data, the robustness of the estimates depends on the extent to which all the factors of healthcare 
spending are identified and considered.13,68  As indicated in Swedler et al, while these types of 
models allocate costs to a specified risk factor or medical condition based on statistical 
estimations, the underlying cause of a person’s medical event or cost is not known. Individuals 
who are more conscious of their health and seek out care may have more medical spending (e.g. 
more preventive care visits) than those who are involved in risky behavior.13 
Findings from the study are only relevant to the non-institutionalized population. Due to this, 
NHIS and MEPS survey design may underestimate total health care expenditure given that cost 
information on institutionalized adults are excluded from this analysis.  Another limitation is that 
there is a time lag of approximately a year that occurs between when individual characteristics 
are measured in the NHIS and when healthcare expenditures measured in the MEPS, so that the 




Smoking at least 100 cigarettes in one's lifetime (and smoked some days or every day at the time 
of the interview) was used to categorize smoking status to comply with the CDC's health 
surveillance definition and to be able to make comparisons with other studies. This definition is 
age dependent. Results from subgroup analysis by age group indicate that older adults with 
potentially longer smoking histories have substantially higher healthcare expenditure compared 
with their younger counterparts. 
Conclusion and Future Research 
In conclusion, cigarette smoking remains the leading preventable cause of death and disease in 
the U.S. and poses a major health hazard and public health issue, even though the results of this 
study found no statistical differences in health care expenditures and utilization among current 
exclusive cigarette smoking, current exclusive smokeless tobacco use and never tobacco use. 
This study is the first to compare medical expenditure and health care utilization associated with 
current exclusive cigarette smoking, current exclusive smokeless tobacco use and never tobacco 
use, in U.S. adults’ over time. More data may be needed to capture a larger balanced dataset 
across current exclusive cigarette smoking, current exclusive smokeless tobacco use and never 
tobacco use. Given the relatively low prevalence of smokeless tobacco use compared to cigarette 
smoking and the stringent definitions used to define current exclusive tobacco product usage a 
large percentage of the data was not included in the study analysis. 
Although not statistically significant, the mean annual healthcare expenditure for current 
exclusive cigarette smokers tended to be higher compared to the mean values for current 
smokeless tobacco users and never tobacco users. Study findings show the economic cost of 
tobacco products directionally reflects the continuum of risk in the Tobacco Harm Reduction 
Model, with cigarettes on one end and smokeless tobacco users on the other end. Indicating a 




risk of nicotine containing products to non-combustible tobacco products with less associated 
risk.  
Future research should focus on examining other databases that capture both the institutionalized 
and non-institutionalized U.S. population using the same study design (e.g. use data from 
NHEA). Given the continuous changes to the tobacco use landscape, future studies where there 
is enough data should use a longitudinal design to estimate heath care expenditure of cigarette 
smokers who switched to a lower risk tobacco product (i.e. based on the Tobacco Harm 
Reduction model) and have a significant history of usage of the product to assess the potential 
reduction in healthcare expenditure.  Results from the quality of life and depression analyses 
support this possibility, because in this study we observed both quality of life and tendencies 
towards mental disability were worst for current cigarette smokers compared to smokeless 
tobacco users. 
Future research should also compare health care expenditure and use in the older adult U.S. 
population (i.e. age 65 and older), given that most of the tobacco related disease that lead to 
higher medical expenditures in tobacco users are typically observed at later stages in life. My 
current analysis dataset did not have sufficient sample size to explore this subset of the 
population.  A better understanding of the comparison of healthcare expenditure and use across 
tobacco use status within the older population can help identify other underlying variables that 
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Section 1 : Sensitivity Analysis- Healthcare Utilization Models before Propensity Score 
Matching 
 
Table 35: Results of the Two-part model  for Total Health Care Expenditure (2017 US $) per year, 2011-2017 
before Propensity Score Matching 
Covariates 
Total Health Care Expenditure 








Tobacco Use Status   
Current exclusive cigarette smoker  -0.441 (0.058) 0.0001 -0.018 (0.049) 0.720 
Current exclusive ST user -0.616 (0.217) 0.005 -0.389 (0.234) 0.099 
Never Tobacco User Ref Ref 
Age 0.032 (0.002) 0.0001 0.015 (0.001) 0.0001 
Gender     
 Female 1.046 (0.055) 0.0001 0.147 (0.041) 0.0001 
Male Ref Ref 
Poverty Status   
  Poor/Negative -0.601 (0.085) 0.0001 -0.268 (0.064) 0.0001 
  Near Poor -0.516 (0.113) 0.0001 -0.230 (0.090) 0.012 





Total Health Care Expenditure 








  Middle Income -0.417 (0.062) 0.0001 -0.160 (0.048) 0.001 
  High Income Ref Ref 
Insurance type   
   Public 1.47 (0.062) 0.0001 1.13 (0.284) 0.0001 
   Private 1.19 (0.084) 0.0001 1.30 (0.317) 0.0001 
   Uninsured Ref Ref 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.056 (0.004) 0.0001 -0.045 (0.007) 0.0001 





Table 36:Results of the Two-part model  for Total Health Care Expenditure (2017 US $) per year (Age ≥ 65 
years), 2011-2017 
Covariates 
Total Health Care Expenditure 








Tobacco Use Status   
Current exclusive cigarette smoker  -0.405 (0.058) 0.0001 -0.033 (0.056) 0.559 
Current exclusive ST user -0.593 (0.215) 0.006 -0.340 (0.249) 0.173 
Never Tobacco User Ref Ref 
Age 0.027 (0.003) 0.0001 0.015 (0.002) 0.0001 





Total Health Care Expenditure 








 Female 1.056 (0.056) 0.0001 0.198 (0.045) 0.0001 
Male Ref Ref 
Poverty Status   
  Poor/Negative -0.571 (0.089) 0.0001 -0.305 (0.071) 0.0001 
  Near Poor -0.532 (0.116) 0.0001 -0.233 (0.106) 0.029 
  Low Income -0.579 (0.079) 0.0001 -0.297 (0.067) 0.0001 
  Middle Income -0.409 (0.066) 0.0001 -0.160 (0.053) 0.004 
  High Income Ref Ref 
Insurance type   
   Public 1.46 (0.064) 0.0001 0.609 (0.109) 0.0001 
   Private 1.13 (0.084) 0.0001 0.685 (0.112) 0.0001 
   Uninsured Ref Ref 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.055 (0.004) 0.0001 -0.045 (0.007) 0.0001 









Section 2 : Sensitivity Analysis- Healthcare Expenditure Models before Propensity Score 
Matching  
 






Emergency room visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  0.265 0.0001 0.057 0.396 
Current exclusive ST user -0.043 0.836 -0.807 0.096 
Never Tobacco User Ref Ref 
Age -0.007 0.0001 -0.006 0.008 
Gender   
 Male Ref Ref 
 Female 0.278 0.0001 0.072 0.244 
Education   
 College or Higher 0.041 0.309 0.065 0.393 
 Some College 0.089 0.098 0.248 0.003 
 High School 0.084 0.102 0.124 0.144 
 Less than High School Ref Ref 
Race/ethnicity   
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic 0.239 0.0001 -0.029 0.743 
  Asian, non-Hispanic -0.221 0.0001 -0.157 0.111 
 Other or multiple race, non-Hispanic  0.178 0.111 -0.184 0.344 
 Hispanic -0.078 0.138 -0.179 0.032 
Region of residency   
 Northeast 0.116 0.028 0.131 0.123 
 Midwest 0.073 0.123 -0.074 0.358 
  West -0.131 0.007 -0.224 0.009 




Marital Status     
Married Ref Ref 
 Living with Partner 0.162 0.019 0.186 0.101 
 Widow/divorce/separated 0.164 0.001 0.061 0.472 
Never Married 0.128 0.007 0.127 0.160 
Body mass index (BMI)   
  Normal or Under Weight Ref Ref 
  Overweight 0.018 0.698 -0.101 0.198 
  Obesity 0.126 0.005 -0.042 0.572 
Poverty Status   
  Poor/Negative 0.265 0.0001 0.228 0.043 
  Near Poor 0.233 0.005 0.152 0.237 
  Low Income 0.143 0.017 0.128 0.233 
  Middle Income 0.062 0.203 0.067 0.494 
  High Income Ref Ref 
Self-reported binge drinking status   
  No Ref Ref 
  Yes -0.006 0.886 -0.020 0.759 
Insurance type   
   Uninsured Ref Ref 
   Public 0.544 0.0001 0.314 0.001 
   Private 0.232 0.0001 0.178 0.092 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.041 0.0001 -0.026 0.0001 
  Mental Component Summary (0-100) -0.014 0.0001 -0.006 0.124 
  Mental illness score (Kessler 6 Index)  0.012 0.117 0.023 0.018 




0 Ref Ref 
1 -0.022 0.724 0.054 0.602 
2 0.057 0.393 -0.041 0.712 
3 0.144 0.185 -0.041 0.795 
4 0.098 0.390 -0.014 0.934 
5 -0.261 0.135 -0.096 0.671 





Table 38: Results for Hurdle model for number of Office-based visits, 2011-2017 before Propensity Score 
Matching 
Covariates 
Office based visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  -0.407 0.0001 -0.180 0.0001 
Current exclusive ST user -0.375 0.005 -0.238 0.039 
Never Tobacco User Ref Ref 
Age 0.313 0.0001 0.008 0.0001 
Gender   
 Male Ref Ref 
 Female 0.954 0.0001 0.240 0.0001 
Education   
 College or Higher 0.228 0.0001 0.169 0.0001 
 Some College 0.150 0.001 0.121 0.0001 
 High School -0.038 0.391 0.051 0.120 




Race/ethnicity   
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic -0.380 0.0001 -0.211 0.0001 
  Asian, non-Hispanic -0.141 0.003 -0.215 0.0001 
 Other or multiple race, non-Hispanic  -0.014 0.892 -0.067 0.286 
 Hispanic -0.402 0.0001 -0.207 0.0001 
Region of residency   
 Northeast 0.113 0.017 0.079 0.0001 
 Midwest 0.209 0.0001 0.228 0.005 
  West -0.304 0.451 0.157 0.0001 
  South Ref Ref 
Marital Status     
 Married Ref Ref 
 Living with Partner -0.400 0.493 0.050 0.188 
 Widow/divorce/separated 0.032 0.472 0.059 0.022 
  Never Married 0.116 0.004 0.107 0.0001 
Body mass index (BMI)   
  Normal or Under Weight Ref Ref 
  Overweight -0.061 0.103 -0.051 0.052 
  Obesity -0.014 0.724 -0.041 0.137 
Poverty Status   
  Poor/Negative -0.543 0.0001 -0.214 0.0001 
  Near Poor -0.500 0.0001 -0.195 0.002 
  Low Income -0.443 0.0001 -0.283 0.0001 
  Middle Income -0.346 0.0001 -0.219 0.0001 
  High Income Ref Ref 




  No Ref Ref 
  Yes 0.085 0.011 -0.032 0.196 
Insurance type   
   Uninsured Ref Ref 
   Public 1.242 0.0001 0.532 0.0001 
   Private 1.312 0.0001 0.522 0.0001 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.048 0.0001 -0.029 0.0001 
  Mental Component Summary (0-100) -0.027 0.0001 -0.015 0.0001 
  Mental illness score (Kessler 6 Index)  0.021 0.008 0.004 0.329 
Depression score  (Personal health Index)   
0 Ref Ref 
1 0.125 0.030 -0.005 0.882 
2 -0.026 0.684 -0.037 0.393 
3 -0.140 0.249 0.025 0.726 
4 -0.237 0.059 -0.062 0.397 
5 -0.339 0.119 -0.156 0.150 






Table 39: Results for Hurdle model for number of Hospital Outpatient visits, 2011-2017 before Propensity 
Score Matching 
Covariates 
Hospital Outpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   




Current exclusive ST user -0.617 0.006 -1.161 0.003 
Never Tobacco User Ref Ref 
Age 0.023 0.0001 0.004 0.091 
Gender   
 Male Ref Ref 
 Female 0.524 0.0001 -0.212 0.008 
Education   
 College or Higher 0.129 0.004 0.001 0.995 
 Some College 0.107 0.046 -0.077 0.547 
 High School 0.093 0.086 -0.019 0.885 
 Less than High School Ref Ref 
Race/ethnicity   
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic -0.244 0.0001 0.394 0.001 
  Asian, non-Hispanic -0.265 0.0001 0.082 0.414 
 Other or multiple race, non-Hispanic  0.0005 0.997 0.467 0.108 
 Hispanic -0.427 0.0001 0.040 0.743 
Region of residency   
 Northeast 0.565 0.0001 0.171 0.124 
 Midwest 0.562 0.0001 0.119 0.274 
  West -0.170 0.001 0.286 0.025 
  South Ref Ref 
Marital Status   
 Married Ref Ref 
 Living with Partner -0.101 0.164 0.001 0.990 
 Widow/divorce/separated -0.026 0.549 0.001 0.966 




Body mass index (BMI)   
  Normal or Under Weight Ref Ref 
  Overweight -0.011 0.797 0.067 0.475 
  Obesity 0.135 0.002 0.082 0.341 
Poverty Status   
  Poor/Negative -0.168 0.009 -0.008 0.957 
  Near Poor -0.285 0.002 0.399 0.106 
  Low Income -0.227 0.0001 -0.153 0.166 
  Middle Income -0.188 0.0001 -0.068 0.400 
  High Income Ref Ref 
Self-reported binge drinking status   
  No Ref Ref 
  Yes 0.039 0.327 0.053 0.636 
Insurance type   
   Uninsured Ref Ref 
   Public 0.834 0.0001 0.506 0.026 
   Private 0.924 0.0001 0.337 0.003 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.038 0.0001 -0.027 0.0001 
  Mental Component Summary (0-100) -0.011 0.0001 -0.016 0.003 
  Mental illness score (Kessler 6 Index)  0.006 0.411 -0.003 0.852 
Depression score  (Personal health Index)   
0 Ref Ref 
1 0.112 0.056 0.013 0.939 
2 0.040 0.556 -0.215 0.101 
3 0.177 0.125 -0.270 0.154 




5 0.086 0.630 -0.494 0.094 







Table 40:Results for Hurdle model for number of Dental visits, 2011-2017 before Propensity Score Matching 
Covariates 
Dental visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  -0.478 0.0001 0.032 0.318 
Current exclusive ST user -0.741 0.0001 -0.296 0.036 
Never Tobacco User Ref Ref 
Age 0.4119 0.0001 0.010 0.0001 
Gender   
 Male Ref Ref 
 Female 0.412 0.0001 0.034 0.139 
Education   
 College or Higher 0.263 0.0001 0.038 0.198 
 Some College -0.033 0.429 0.003 0.935 
 High School -0.038 0.340 0.061 0.082 
 Less than High School Ref Ref 
Race/ethnicity   
  White, non-Hispanic Ref Ref 




  Asian, non-Hispanic -0.030 0.444 -0.016 0.589 
 Other or multiple race, non-Hispanic  -0.279 0.002 0.131 0.071 
 Hispanic -0.412 0.0001 -0.014 0.697 
Region of residency   
 Northeast 0.274 0.0001 0.126 0.0001 
 Midwest 0.400 0.0001 0.094 0.001 
  West 0.275 0.0001 0.138 0.0001 
  South Ref Ref 
Marital Status   
 Married Ref Ref 
 Living with Partner -0.136 0.013 0.001 0.990 
 Widow/divorce/separated -0.108 0.002 0.001 0.966 
  Never Married 0.063 0.076 0.127 0.0001 
Body mass index (BMI)   
  Normal or Under Weight Ref Ref 
  Overweight -0.108 0.001 -0.048 0.060 
  Obesity -0.203 0.0001 0.009 0.738 
Poverty Status   
  Poor/Negative -0.753 0.0001 -0.041 0.427 
  Near Poor -0.772 0.0001 -0.169 0.019 
  Low Income -0.883 0.0001 -0.113 0.008 
  Middle Income -0.479 0.0001 -0.091 0.0001 
  High Income Ref Ref 
Self-reported binge drinking status   
  No Ref Ref 
  Yes -0.018 0.554 -0.059 0.024 




   Uninsured Ref Ref 
   Public 0.661 0.0001 0.107 0.097 
   Private 1.078 0.0001 0.154 0.008 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) 0.005 0.007 -0.005 0.0001 
  Mental Component Summary (0-100) -0.001 0.551 -0.006 0.005 
  Mental illness score (Kessler 6 Index)  0.018 0.005 -0.008 0.174 
Depression score  (Personal health Index)   
0 Ref Ref 
1 0.095 0.045 -0.021 0.584 
2 -0.042 0.436 0.005 0.917 
3 -0.126 0.211 -0.025 0.827 
4 -0.229 0.030 -0.030 0.747 
5 -0.395 0.020 0.222 0.119 








Table 41: Results for Hurdle model for number of Home Health care visits, 2011-2017 before Propensity 
Matching 
Covariates 
Home Health care visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status   
Current exclusive cigarette smoker  -0.017 0.862 -0.193 0.124 
Current exclusive ST user 0.254 0.648 0.443 0.269 




Age 0.046 0.0001 0.012 0.006 
Gender   
 Male Ref Ref 
 Female 0.124 0.164 -0.269 0.017 
Education   
 College or Higher 0.157 0.140 0.102 0.445 
 Some College 0.041 0.743 -0.109 0.439 
 High School 0.062 0.603 -0.350 0.015 
 Less than High School Ref Ref 
Race/ethnicity   
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic 0.349 0.002 0.116 0.404 
  Asian, non-Hispanic -0.190 0.178 0.186 0.298 
 Other or multiple race, non-Hispanic  0.474 0.041 0.019 0.940 
 Hispanic -0.124 0.351 0.268 0.084 
Region of residency   
 Northeast 0.369 0.001 -0.092 0.599 
 Midwest 0.156 0.172 -0.135 0.388 
  West 0.187 0.097 0.190 0.147 
  South Ref Ref 
Marital Status   
 Married Ref Ref 
 Living with Partner 0.060 0.793 0.228 0.380 
 Widow/divorce/separated 0.452 0.0001 0.455 0.002 
  Never Married 0.651 0.0001 0.662 0.0001 
Body mass index (BMI)   




  Overweight -0.215 0.048 -0.307 0.027 
  Obesity -0.028 0.792 -0.254 0.072 
Poverty Status   
  Poor/Negative 0.375 0.008 0.592 0.004 
  Near Poor 0.010 0.959 0.348 0.146 
  Low Income 0.073 0.607 0.445 0.030 
  Middle Income -0.024 0.841 0.020 0.927 
  High Income Ref Ref 
Self-reported binge drinking status   
  No Ref Ref 
  Yes -0.131 0.229 -0.162 0.216 
Insurance type   
   Uninsured Ref Ref 
   Public 1.352 0.0001 1.039 0.013 
   Private 1.085 0.0001 0.843 0.046 
 Quality of life score (Short-Form 12)   
  Physical Component Summary (0-100) -0.081 0.0001 -0.016 0.001 
  Mental Component Summary (0-100) -0.031 0.0001 -0.004 0.631 
  Mental illness score (Kessler 6 Index)  0.021 0.204 0.030 0.125 
Depression score  (Personal health Index)   
0 Ref Ref 
1 -0.010 0.944 -0.074 0.641 
2 -0.237 0.098 -0.132 0.479 
3 -0.183 0.384 0.197 0.441 
4 -0.269 0.231 -0.269 0.318 
5 -0.522 0.099 -0.161 0.652 











Table 42: Results for Hurdle model for number of Hospital Inpatient visits, 2011-2017 before Propensity 
Matching 
Covariates 
Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
Tobacco Use Status 
Current exclusive cigarette smoker  0.005 0.938 0.121 0.195 
Current exclusive smokeless tobacco user -1.110 0.009 -0.412 0.526 
Never Tobacco User Ref Ref 
Age 0.002 0.287 0.002 0.562 
Gender 
 Male Ref Ref 
 Female 0.395 0.0001 -0.298 0.001 
Education 
 College or Higher 0.084 0.192 -0.150 0.099 
Some College 0.132 0.076 0.187 0.101 
 High School 0.058 0.423 0.290 0.022 
 Less than High School Ref Ref 
Race/ethnicity 
  White, non-Hispanic Ref Ref 
  Black, non-Hispanic 0.026 0.712 0.133 0.193 





Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
 Other or multiple race, non-Hispanic  0.157 0.311 0.208 0.340 
 Hispanic -0.031 0.666 -0.194 0.072 
Region of residency 
 Northeast -0.024 0.743 -0.030 0.788 
 Midwest 0.050 0.441 -0.203 0.030 
  West -0.163 0.015 -0.147 0.253 
  South Ref Ref 
Marital Status 
 Married Ref Ref 
 Living with Partner 0.083 0.391 0.026 0.847 
 Widow/divorce/separated -0.120 0.056 0.173 0.116 
  Never Married -0.204 0.003 0.079 0.469 
Body mass index (BMI) 
  Normal or Under Weight Ref Ref 
  Overweight -0.205 0.001 -0.056 0.416 
  Obesity -0.077 0.206 -0.078 0.619 
Poverty Status   
  Poor/Negative 0.370 0.0001 -0.004 0.979 
  Near Poor 0.253 0.027 0.165 0.318 
  Low Income 0.067 0.431 0.162 0.232 
  Middle Income 0.059 0.371 -0.012 0.901 
  High Income Ref Ref 
Self-reported binge drinking status 





Hospital Inpatient visits (in the past 12 months) 
Logit Truncated Poisson  
Coefficient  P-value Coefficient  P-value 
  Yes 0.032 0.580 0.050 0.541 
Insurance type 
   Uninsured Ref Ref 
   Public 1.129 0.0001 0.251 0.154 
   Private 0.899 0.0001 0.061 0.718 
 Quality of life score (Short-Form 12) 
  Physical Component Summary (0-100) -0.059 0.0001 -0.025 0.0001 
  Mental Component Summary (0-100) -0.017 0.0001 -0.019 0.002 
  Mental illness score (Kessler 6 Index)  -0.002 0.882 -0.016 0.236 
Depression score  (Patient Health Index) 
0 Ref Ref 
1 0.010 0.903 -0.035 0.810 
2 -0.134 0.142 -0.122 0.517 
3 -0.100 0.494 -0.116 0.601 
4 0.028 0.851 -0.073 0.759 
5 -0.119 0.607 -0.005 0.988 






























Outputs for Healthcare Expenditure and Healthcare Utilization Models 
 
Healthcare Expenditure Models 
Full Expenditure  Model 
* Two-part model, with logit first part and GLM second part all variables (i.e 
sociodemographic and comorbidities) 
svy:twopm totexpi c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242  , 
firstpart(logit) secondpart(glm, family(gamma) link(log)) 
(running twopm on estimation sample) 
 
Survey data analysis 
 
Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 
                                               Design df         =         135 
                                               F(  34,    102)   =        6.66 
                                               Prob > F          =      0.0000 
--------------------------------------------------------------------------------------- 
                      |             Linearized 
              totexpi |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
logit                 | 
              agelast |   .0185455   .0101043     1.84   0.069    -.0014376    .0385287 
                tobs2 | 
                   1  |   -.351833   .2483546    -1.42   0.159    -.8430021     .139336 
                   2  |   -.229222   .2953677    -0.78   0.439    -.8133684    .3549245 
                      | 
                2.sex |   .8284252   .4388348     1.89   0.061    -.0394549    1.696305 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.1590572   .2743212    -0.58   0.563      -.70158    .3834657 
                  HS  |  -.0906717   .2749685    -0.33   0.742    -.6344749    .4531314 
        SOME COLLEGE  |  -.0778594    .335173    -0.23   0.817    -.7407285    .5850098 
              marcat2 | 
                   1  |   -.423125   .2783135    -1.52   0.131    -.9735435    .1272936 
                   2  |  -.1540523   .3726572    -0.41   0.680    -.8910535     .582949 
                   4  |   .0719318   .4346279     0.17   0.869    -.7876286    .9314921 
              bmicat2 | 
                   2  |   .0576359   .2466911     0.23   0.816    -.4302431     .545515 




              racethx | 
                   1  |  -.4531627   .3224679    -1.41   0.162    -1.090905    .1845795 
                   3  |   .0270999   .3087996     0.09   0.930    -.5836107    .6378104 
                   4  |  -.2905011   .2493947    -1.16   0.246    -.7837271    .2027249 
                   5  |  -.3448759   .6868663    -0.50   0.616    -1.703286    1.013534 
              regcat2 | 
                   1  |   .4420181   .3618344     1.22   0.224     -.273579    1.157615 
                   2  |   .5771603   .2449452     2.36   0.020      .092734    1.061587 
                   4  |   .4965339   .3367915     1.47   0.143    -.1695362    1.162604 
             1.binge2 |  -.4568187   .2639217    -1.73   0.086    -.9787745    .0651371 
               povcat | 
                   1  |  -.9555049   .4380112    -2.18   0.031    -1.821756   -.0892536 
                   2  |  -.2478917   .5249494    -0.47   0.638     -1.28608    .7902967 
                   3  |  -.9535605   .4322168    -2.21   0.029    -1.808352   -.0987687 
                   4  |  -.8089066   .2314143    -3.50   0.001    -1.266573   -.3512404 
               inscov | 
                   1  |   1.630839   .3263201     5.00   0.000     .9854779    2.276199 
                   2  |   1.500713   .4523487     3.32   0.001     .6061066     2.39532 
                pcs42 |   -.085994   .0150781    -5.70   0.000    -.1158139   -.0561741 
                mcs42 |  -.0098869   .0185662    -0.53   0.595    -.0466051    .0268313 
              k6sum42 |   .0647854   .0512515     1.26   0.208    -.0365743    .1661452 
               phq242 | 
                   1  |   .1059072   .3142879     0.34   0.737    -.5156576     .727472 
                   2  |   .2047224    .450697     0.45   0.650    -.6866175    1.096062 
                   3  |   1.212215   .8330678     1.46   0.148    -.4353362    2.859767 
                   4  |   .0925209    .712875     0.13   0.897    -1.317326    1.502368 
                   5  |          0  (empty) 
                   6  |  -.0389743   1.327388    -0.03   0.977     -2.66414    2.586191 
                      | 
                _cons |   5.105925   1.752638     2.91   0.004     1.639747    8.572104 
----------------------+---------------------------------------------------------------- 
glm                   | 
              agelast |   .0125686   .0058949     2.13   0.035     .0009102    .0242269 
                tobs2 | 
                   1  |   .2671609   .1685367     1.59   0.115    -.0661528    .6004747 
                   2  |   .0285081   .1787777     0.16   0.874    -.3250591    .3820754 
                2.sex |  -.1815554   .2220142    -0.82   0.415    -.6206312    .2575204 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .2363892   .1719946     1.37   0.172    -.1037632    .5765417 
                  HS  |   .0569295    .189573     0.30   0.764    -.3179876    .4318466 
        SOME COLLEGE  |   .0817419   .2368567     0.35   0.731    -.3866878    .5501715 
              marcat2 | 
                   1  |   .1089897   .1717587     0.63   0.527    -.2306962    .4486756 
                   2  |   .0700352   .1980271     0.35   0.724    -.3216014    .4616719 
                   4  |   .0278552   .3016614     0.09   0.927    -.5687381    .6244486 
              bmicat2 | 
                   2  |  -.0686064   .1534513    -0.45   0.656    -.3720859    .2348732 
                   3  |     .06135   .1668256     0.37   0.714    -.2685798    .3912797 
              racethx | 
                   1  |  -.0907519   .2457461    -0.37   0.712    -.5767621    .3952583 
                   3  |   .1496835   .1946592     0.77   0.443    -.2352925    .5346595 
                   4  |   .0384385    .160984     0.24   0.812    -.2799384    .3568154 
                   5  |  -.4601158    .228316    -2.02   0.046    -.9116546    -.008577 
              regcat2 | 
                   1  |   .1782905   .2442561     0.73   0.467    -.3047729    .6613539 
                   2  |  -.0170598   .1654098    -0.10   0.918    -.3441895      .31007 
                   4  |    .137903   .2588982     0.53   0.595     -.374118     .649924 
             1.binge2 |  -.4771534   .1379921    -3.46   0.001    -.7500593   -.2042475 
               povcat | 
                   1  |  -.0072448   .2064153    -0.04   0.972    -.4154708    .4009811 




                   3  |  -.3963214   .1910549    -2.07   0.040    -.7741691   -.0184736 
                   4  |   .1602088   .1758436     0.91   0.364    -.1875557    .5079734 
               inscov | 
                   1  |   1.134259   .2838527     4.00   0.000     .5728853    1.695632 
                   2  |   1.304568   .3170781     4.11   0.000      .677485    1.931651 
                pcs42 |  -.0446406   .0067848    -6.58   0.000    -.0580588   -.0312225 
                mcs42 |  -.0310079    .011916    -2.60   0.010     -.054574   -.0074417 
              k6sum42 |  -.0217276   .0221661    -0.98   0.329    -.0655654    .0221102 
               phq242 | 
                   1  |    -.09249    .199679    -0.46   0.644    -.4873936    .3024136 
                   2  |  -.1284248   .2948409    -0.44   0.664    -.7115293    .4546797 
                   3  |  -.2207303   .3444264    -0.64   0.523    -.9018998    .4604391 
                   4  |  -.2283418   .3151703    -0.72   0.470    -.8516517     .394968 
                   5  |  -1.232874   .3842957    -3.21   0.002    -1.992893   -.4728554 
                   6  |  -.2327141   .4774268    -0.49   0.627    -1.176917    .7114891 
                _cons |   10.41554   .9596208    10.85   0.000     8.517709    12.31338 
--------------------------------------------------------------------------------------- 
Note: Strata with single sampling unit centered at overall mean. 




Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 
Model VCE    : Linearized                      Design df         =         135 
 
Expression   : twopm combined expected values, predict() 
 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       _cons |   4868.459   436.0241    11.17   0.000     4006.137    5730.781 
------------------------------------------------------------------------------ 
 
 * Conditional mean by Tobacco Status 
margins tobs2 /* change in Tob_stat2*/ 
Predictive margins 
Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 
Model VCE    : Linearized                      Design df         =         135 
 
Expression   : twopm combined expected values, predict() 
 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       tobs2 | 
          1  |   5627.641    788.362     7.14   0.000     4068.503    7186.778 
          2  |   4478.333   729.7839     6.14   0.000     3035.045    5921.621 
          3  |   4426.889   461.4979     9.59   0.000     3514.189     5339.59 
------------------------------------------------------------------------------ 
 
* Marginal effects, averaged over the sample 
margins, dydx(*) 
Average marginal effects 
Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 





Expression   : twopm combined expected values, predict() 
dy/dx w.r.t. : agelast 1.tobs2 2.tobs2 2.sex 1.educat3 2.educat3 4.educat3 1.marcat2 2.marcat2 
4.marcat2 2.bmicat2 3.bmicat2 1.racethx 3.racethx 4.racethx 5.racethx 1.regcat2 2.regcat2 
4.regcat2 1.binge2 1.povcat 2.povcat3.povcat 4.povcat 1.inscov 2.inscov pcs42 mcs42 k6sum42 
1.phq242 2.phq242 3.phq242 4.phq242 5.phq242 6.phq242 
 
--------------------------------------------------------------------------------------- 
                      |            Delta-method 
                      |      dy/dx   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |    68.2292   28.13612     2.42   0.017      12.5846    123.8738 
                tobs2 | 
                   1  |   1200.751   902.1839     1.33   0.185    -583.4911    2984.993 
                   2  |   51.44363   795.7262     0.06   0.949    -1522.258    1625.145 
                2.sex |  -612.1792    1027.63    -0.60   0.552    -2644.515    1420.156 
              educat3 | 
COLLEGE GRAD OR HIGH  |   1107.783   852.9509     1.30   0.196    -579.0916    2794.657 
                  HS  |   226.6126   860.8732     0.26   0.793     -1475.93    1929.155 
        SOME COLLEGE  |   347.7521   1104.229     0.31   0.753    -1836.073    2531.577 
              marcat2 | 
                   1  |   365.2657   832.3003     0.44   0.661    -1280.768      2011.3 
                   2  |   280.9105   942.2005     0.30   0.766    -1582.472    2144.293 
                   4  |   152.2877   1442.717     0.11   0.916    -2700.963    3005.539 
              bmicat2 | 
                   2  |  -299.4418     748.79    -0.40   0.690    -1780.318    1181.434 
                   3  |   284.8546    840.115     0.34   0.735    -1376.634    1946.344 
              racethx | 
                   1  |  -595.5511   1065.522    -0.56   0.577    -2702.827    1511.724 
                   3  |   801.0806   1091.076     0.73   0.464    -1356.733    2958.894 
                   4  |   72.64053   803.8245     0.09   0.928    -1517.077    1662.358 
                   5  |  -1891.176   757.6234    -2.50   0.014    -3389.522   -392.8305 
              regcat2 | 
                   1  |   1103.589    1336.25     0.83   0.410    -1539.102    3746.279 
                   2  |   127.8672   782.4741     0.16   0.870    -1419.626     1675.36 
                   4  |   896.8828    1427.97     0.63   0.531    -1927.203    3720.969 
             1.binge2 |  -2264.394   654.7739    -3.46   0.001    -3559.336   -969.4531 
               povcat | 
                   1  |   -399.185   1033.218    -0.39   0.700    -2442.572    1644.202 
                   2  |  -513.5474   1659.374    -0.31   0.757    -3795.279    2768.184 
                   3  |  -1900.979   777.7645    -2.44   0.016    -3439.158   -362.7999 
                   4  |   532.6112   951.6994     0.56   0.577    -1349.557     2414.78 
               inscov | 
                   1  |   3608.875   562.8657     6.41   0.000       2495.7    4722.051 
                   2  |   4451.189   1015.397     4.38   0.000     2443.046    6459.332 
                pcs42 |  -249.9732   48.10175    -5.20   0.000    -345.1036   -154.8427 
                mcs42 |  -154.7134   63.87207    -2.42   0.017    -281.0327   -28.39411 
              k6sum42 |  -81.18823   109.0209    -0.74   0.458     -296.798    134.4216 
               phq242 | 
                   1  |  -422.3858   1012.692    -0.42   0.677     -2425.18    1580.408 
                   2  |  -559.4209   1420.242    -0.39   0.694    -3368.222     2249.38 
                   3  |  -762.9956   1563.337    -0.49   0.626    -3854.795    2328.804 
                   4  |  -1034.501   1429.481    -0.72   0.471    -3861.574    1792.572 
                   5  |          .  (not estimable) 
                   6  |  -1094.172   2028.011    -0.54   0.590    -5104.952    2916.609 
--------------------------------------------------------------------------------------- 
Note: dy/dx for factor levels is the discrete change from the base level. 
 





svy: twopm totexpi c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , 
firstpart(logit) secondpart(glm, family(gamma) link(log)) 
(running twopm on estimation sample) 
 
Survey data analysis 
Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 
                                               Design df         =         135 
                                               F(  34,    102)   =        6.66 
                                               Prob > F          =      0.0000 
--------------------------------------------------------------------------------------- 
                      |             Linearized 
              totexpi |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
logit                 | 
              agelast |   .0185455   .0101043     1.84   0.069    -.0014376    .0385287 
                tobs2 | 
                   1  |   -.351833   .2483546    -1.42   0.159    -.8430021     .139336 
                   2  |   -.229222   .2953677    -0.78   0.439    -.8133684    .3549245 
                2.sex |   .8284252   .4388348     1.89   0.061    -.0394549    1.696305 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.1590572   .2743212    -0.58   0.563      -.70158    .3834657 
                  HS  |  -.0906717   .2749685    -0.33   0.742    -.6344749    .4531314 
        SOME COLLEGE  |  -.0778594    .335173    -0.23   0.817    -.7407285    .5850098 
              marcat2 | 
                   1  |   -.423125   .2783135    -1.52   0.131    -.9735435    .1272936 
                   2  |  -.1540523   .3726572    -0.41   0.680    -.8910535     .582949 
                   4  |   .0719318   .4346279     0.17   0.869    -.7876286    .9314921 
              bmicat2 | 
                   2  |   .0576359   .2466911     0.23   0.816    -.4302431     .545515 
                   3  |  -.0489334   .2540454    -0.19   0.848     -.551357    .4534902 
              racethx | 
                   1  |  -.4531627   .3224679    -1.41   0.162    -1.090905    .1845795 
                   3  |   .0270999   .3087996     0.09   0.930    -.5836107    .6378104 
                   4  |  -.2905011   .2493947    -1.16   0.246    -.7837271    .2027249 
                   5  |  -.3448759   .6868663    -0.50   0.616    -1.703286    1.013534 
              regcat2 | 
                   1  |   .4420181   .3618344     1.22   0.224     -.273579    1.157615 
                   2  |   .5771603   .2449452     2.36   0.020      .092734    1.061587 
                   4  |   .4965339   .3367915     1.47   0.143    -.1695362    1.162604 
             1.binge2 |  -.4568187   .2639217    -1.73   0.086    -.9787745    .0651371 
               povcat | 
                   1  |  -.9555049   .4380112    -2.18   0.031    -1.821756   -.0892536 
                   2  |  -.2478917   .5249494    -0.47   0.638     -1.28608    .7902967 
                   3  |  -.9535605   .4322168    -2.21   0.029    -1.808352   -.0987687 
                   4  |  -.8089066   .2314143    -3.50   0.001    -1.266573   -.3512404 
               inscov | 
                   1  |   1.630839   .3263201     5.00   0.000     .9854779    2.276199 
                   2  |   1.500713   .4523487     3.32   0.001     .6061066     2.39532 
                pcs42 |   -.085994   .0150781    -5.70   0.000    -.1158139   -.0561741 
                mcs42 |  -.0098869   .0185662    -0.53   0.595    -.0466051    .0268313 
              k6sum42 |   .0647854   .0512515     1.26   0.208    -.0365743    .1661452 
               phq242 | 
                   1  |   .1059072   .3142879     0.34   0.737    -.5156576     .727472 
                   2  |   .2047224    .450697     0.45   0.650    -.6866175    1.096062 
                   3  |   1.212215   .8330678     1.46   0.148    -.4353362    2.859767 
                   4  |   .0925209    .712875     0.13   0.897    -1.317326    1.502368 
                   5  |          0  (empty) 
                   6  |  -.0389743   1.327388    -0.03   0.977     -2.66414    2.586191 





glm                   | 
              agelast |   .0125686   .0058949     2.13   0.035     .0009102    .0242269 
                tobs2 | 
                   1  |   .2671609   .1685367     1.59   0.115    -.0661528    .6004747 
                   2  |   .0285081   .1787777     0.16   0.874    -.3250591    .3820754 
                2.sex |  -.1815554   .2220142    -0.82   0.415    -.6206312    .2575204 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .2363892   .1719946     1.37   0.172    -.1037632    .5765417 
                  HS  |   .0569295    .189573     0.30   0.764    -.3179876    .4318466 
        SOME COLLEGE  |   .0817419   .2368567     0.35   0.731    -.3866878    .5501715 
              marcat2 | 
                   1  |   .1089897   .1717587     0.63   0.527    -.2306962    .4486756 
                   2  |   .0700352   .1980271     0.35   0.724    -.3216014    .4616719 
                   4  |   .0278552   .3016614     0.09   0.927    -.5687381    .6244486 
              bmicat2 | 
                   2  |  -.0686064   .1534513    -0.45   0.656    -.3720859    .2348732 
                   3  |     .06135   .1668256     0.37   0.714    -.2685798    .3912797 
              racethx | 
                   1  |  -.0907519   .2457461    -0.37   0.712    -.5767621    .3952583 
                   3  |   .1496835   .1946592     0.77   0.443    -.2352925    .5346595 
                   4  |   .0384385    .160984     0.24   0.812    -.2799384    .3568154 
                   5  |  -.4601158    .228316    -2.02   0.046    -.9116546    -.008577 
              regcat2 | 
                   1  |   .1782905   .2442561     0.73   0.467    -.3047729    .6613539 
                   2  |  -.0170598   .1654098    -0.10   0.918    -.3441895      .31007 
                   4  |    .137903   .2588982     0.53   0.595     -.374118     .649924 
             1.binge2 |  -.4771534   .1379921    -3.46   0.001    -.7500593   -.2042475 
               povcat | 
                   1  |  -.0072448   .2064153    -0.04   0.972    -.4154708    .4009811 
                   2  |  -.0920637   .3563864    -0.26   0.797    -.7968863    .6127589 
                   3  |  -.3963214   .1910549    -2.07   0.040    -.7741691   -.0184736 
                   4  |   .1602088   .1758436     0.91   0.364    -.1875557    .5079734 
               inscov | 
                   1  |   1.134259   .2838527     4.00   0.000     .5728853    1.695632 
                   2  |   1.304568   .3170781     4.11   0.000      .677485    1.931651 
                pcs42 |  -.0446406   .0067848    -6.58   0.000    -.0580588   -.0312225 
                mcs42 |  -.0310079    .011916    -2.60   0.010     -.054574   -.0074417 
              k6sum42 |  -.0217276   .0221661    -0.98   0.329    -.0655654    .0221102 
               phq242 | 
                   1  |    -.09249    .199679    -0.46   0.644    -.4873936    .3024136 
                   2  |  -.1284248   .2948409    -0.44   0.664    -.7115293    .4546797 
                   3  |  -.2207303   .3444264    -0.64   0.523    -.9018998    .4604391 
                   4  |  -.2283418   .3151703    -0.72   0.470    -.8516517     .394968 
                   5  |  -1.232874   .3842957    -3.21   0.002    -1.992893   -.4728554 
                   6  |  -.2327141   .4774268    -0.49   0.627    -1.176917    .7114891 
                _cons |   10.41554   .9596208    10.85   0.000     8.517709    12.31338 
--------------------------------------------------------------------------------------- 
Note: Strata with single sampling unit centered at overall mean. 
 
 * Margin plots for Age by Tobacco Status 
 margins, at (agelast=(30(10)80) tobs2 = (1,2,3)) 
 
Predictive margins 
Number of strata   =       162                 Number of obs     =       1,298 
Number of PSUs     =       297                 Population size   =  15,368,643 
Model VCE    : Linearized                      Design df         =         135 
 
Expression   : twopm combined expected values, predict() 
1._at        : agelast         =          30 




2._at        : agelast         =          30 
               tobs2           =           2 
3._at        : agelast         =          30 
               tobs2           =           3 
4._at        : agelast         =          40 
               tobs2           =           1 
5._at        : agelast         =          40 
               tobs2           =           2 
6._at        : agelast         =          40 
               tobs2           =           3 
7._at        : agelast         =          50 
               tobs2           =           1 
8._at        : agelast         =          50 
               tobs2           =           2 
9._at        : agelast         =          50 
               tobs2           =           3 
10._at       : agelast         =          60 
               tobs2           =           1 
11._at       : agelast         =          60 
               tobs2           =           2 
12._at       : agelast         =          60 
               tobs2           =           3 
13._at       : agelast         =          70 
               tobs2           =           1 
14._at       : agelast         =          70 
               tobs2           =           2 
15._at       : agelast         =          70 
               tobs2           =           3 
16._at       : agelast         =          80 
               tobs2           =           1 
17._at       : agelast         =          80 
               tobs2           =           2 
18._at       : agelast         =          80 
               tobs2           =           3 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         _at | 
          1  |   4034.126   896.6801     4.50   0.000     2260.768    5807.483 
          2  |   3222.614    789.643     4.08   0.000     1660.943    4784.285 
          3  |   3206.349   513.6461     6.24   0.000     2190.515    4222.183 
          4  |   4670.742   828.1915     5.64   0.000     3032.834     6308.65 
          5  |   3725.209   750.9914     4.96   0.000     2239.979    5210.439 
          6  |   3696.127   441.3434     8.37   0.000     2823.286    4568.969 
          7  |   5394.925   784.6905     6.88   0.000     3843.049    6946.802 
          8  |   4296.429   726.4633     5.91   0.000     2859.708     5733.15 
          9  |   4252.043   426.9187     9.96   0.000     3407.729    5096.357 
         10  |   6217.656   841.6065     7.39   0.000     4553.218    7882.095 
         11  |   4944.927   761.5421     6.49   0.000     3438.831    6451.023 
         12  |   4882.529   556.5951     8.77   0.000     3781.755    5983.303 
         13  |   7151.399   1079.167     6.63   0.000     5017.138     9285.66 
         14  |   5680.536   914.3955     6.21   0.000     3872.143    7488.929 
         15  |   5597.177    847.267     6.61   0.000     3921.544    7272.811 
         16  |    8210.32   1522.536     5.39   0.000     5199.213    11221.43 
         17  |   6514.439   1220.495     5.34   0.000     4100.676    8928.203 









svy:twopm totexpi c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , 
firstpart(logit) secondpart(glm, family(gamma) link(log)) 
(running twopm on estimation sample) 
 
Survey data analysis 
Number of strata   =       160                 Number of obs     =       1,088 
Number of PSUs     =       294                 Population size   =  13,025,624 
                                               Design df         =         134 
                                               F(  34,    101)   =        2.54 
                                               Prob > F          =      0.0002 
 
--------------------------------------------------------------------------------------- 
                      |             Linearized 
              totexpi |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
logit                 | 
              agelast |     .00393   .0112094     0.35   0.726    -.0182403    .0261003 
                tobs2 | 
                   1  |  -.2188141   .2379397    -0.92   0.359    -.6894175    .2517892 
                   2  |  -.2437136   .2640158    -0.92   0.358     -.765891    .2784637 
                2.sex |   1.108227   .5715452     1.94   0.055    -.0221896    2.238644 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.1043773   .3039787    -0.34   0.732    -.7055941    .4968396 
                  HS  |  -.3348051   .2666419    -1.26   0.211    -.8621762    .1925661 
        SOME COLLEGE  |  -.1129375   .3056098    -0.37   0.712    -.7173804    .4915055 
              marcat2 | 
                   1  |  -.0064504   .2725879    -0.02   0.981    -.5455818    .5326809 
                   2  |   .2499429   .3056257     0.82   0.415    -.3545314    .8544173 
                   4  |  -.3818723   .4019774    -0.95   0.344    -1.176914    .4131689 
              bmicat2 | 
                   2  |   .3070919    .211206     1.45   0.148    -.1106368    .7248206 
                   3  |   .2515883   .2377777     1.06   0.292    -.2186945    .7218712 
              racethx | 
                   1  |  -.4755246   .3508007    -1.36   0.178    -1.169347     .218298 
                   3  |  -.4836295   .2819257    -1.72   0.089    -1.041229    .0739704 
                   4  |   -.418038   .2574672    -1.62   0.107    -.9272632    .0911873 
                   5  |  -.3818102   .7598424    -0.50   0.616    -1.884646    1.121026 
              regcat2 | 
                   1  |   .5886035   .4053385     1.45   0.149    -.2130855    1.390293 
                   2  |   .1429476   .2810094     0.51   0.612      -.41284    .6987351 
                   4  |  -.1080479   .3419419    -0.32   0.753    -.7843494    .5682537 
             1.binge2 |  -.1723804   .2335171    -0.74   0.462    -.6342365    .2894757 
               povcat | 
                   1  |  -.8897641    .413883    -2.15   0.033    -1.708353   -.0711756 
                   2  |  -.4704084   .5089496    -0.92   0.357    -1.477022    .5362052 
                   3  |  -1.302972   .3734933    -3.49   0.001    -2.041676    -.564267 
                   4  |  -.9470192   .2285889    -4.14   0.000    -1.399128   -.4949102 
               inscov | 
                   1  |   1.575004   .3183678     4.95   0.000     .9453281     2.20468 
                   2  |   1.317395   .4266214     3.09   0.002     .4736121    2.161178 
                pcs42 |  -.0652491   .0161115    -4.05   0.000    -.0971148   -.0333834 
                mcs42 |   -.023464   .0173705    -1.35   0.179    -.0578199    .0108919 
              k6sum42 |   .0044122    .041712     0.11   0.916    -.0780868    .0869112 
               phq242 | 
                   1  |  -.2151516   .3291931    -0.65   0.515    -.8662382     .435935 
                   2  |   .2597069   .4146509     0.63   0.532    -.5604004    1.079814 
                   3  |          0  (empty) 
                   4  |   .8194732   .7345623     1.12   0.267    -.6333631    2.272309 




                   6  |   1.526835   1.179469     1.29   0.198    -.8059493     3.85962 
                _cons |   5.363542   1.609042     3.33   0.001     2.181137    8.545947 
----------------------+---------------------------------------------------------------- 
glm                   | 
              agelast |    .006204   .0059218     1.05   0.297    -.0055083    .0179163 
                tobs2 | 
                   1  |   .3239129   .1795632     1.80   0.073    -.0312318    .6790577 
                   2  |   .2700106   .1630855     1.66   0.100    -.0525441    .5925654 
                2.sex |   .3181315   .2716639     1.17   0.244    -.2191723    .8554354 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.2095454   .1664307    -1.26   0.210    -.5387163    .1196255 
                  HS  |   -.293531   .2397692    -1.22   0.223    -.7677528    .1806908 
        SOME COLLEGE  |   .1479551   .2379525     0.62   0.535    -.3226735    .6185837 
              marcat2 | 
                   1  |    .323562   .1623109     1.99   0.048     .0025393    .6445846 
                   2  |   .3208715   .2275727     1.41   0.161    -.1292277    .7709706 
                   4  |   .2056018    .312568     0.66   0.512    -.4126033    .8238069 
              bmicat2 | 
                   2  |   .0781474   .1644558     0.48   0.635    -.2471175    .4034122 
                   3  |   .1435625   .1523446     0.94   0.348    -.1577485    .4448735 
              racethx | 
                   1  |   .3866123   .3028786     1.28   0.204    -.2124287    .9856534 
                   3  |  -.2794542   .2139657    -1.31   0.194    -.7026411    .1437327 
                   4  |   .0192359   .1817564     0.11   0.916    -.3402466    .3787183 
                   5  |  -.7125657   .3024568    -2.36   0.020    -1.310773   -.1143588 
              regcat2 | 
                   1  |  -.0858684   .2473916    -0.35   0.729    -.5751659    .4034291 
                   2  |   .1635595    .167265     0.98   0.330    -.1672616    .4943806 
                   4  |   .0820755   .2584243     0.32   0.751    -.4290428    .5931938 
             1.binge2 |  -.2930343    .142511    -2.06   0.042    -.5748963   -.0111723 
               povcat | 
                   1  |  -.1323469   .2585875    -0.51   0.610    -.6437879    .3790941 
                   2  |  -.2809101   .3636527    -0.77   0.441    -1.000152    .4383317 
                   3  |    -.60652   .2109812    -2.87   0.005    -1.023804    -.189236 
                   4  |   -.020115   .1671071    -0.12   0.904    -.3506238    .3103937 
               inscov | 
                   1  |   1.401576   .2370262     5.91   0.000     .9327799    1.870373 
                   2  |   1.944569   .2663946     7.30   0.000     1.417687    2.471451 
                pcs42 |  -.0632391   .0078288    -8.08   0.000    -.0787231   -.0477551 
                mcs42 |  -.0410952   .0140024    -2.93   0.004    -.0687895   -.0134008 
              k6sum42 |  -.0210613   .0292644    -0.72   0.473    -.0789411    .0368185 
               phq242 | 
                   1  |  -.3784691   .2122905    -1.78   0.077    -.7983428    .0414045 
                   2  |  -.4123546   .2714674    -1.52   0.131    -.9492699    .1245607 
                   3  |  -.8206237   .2794668    -2.94   0.004     -1.37336    -.267887 
                   4  |  -1.255511   .4025839    -3.12   0.002    -2.051752   -.4592699 
                   5  |  -1.775673   .3801353    -4.67   0.000    -2.527515   -1.023832 
                   6  |  -1.099219   .4895141    -2.25   0.026    -2.067393   -.1310459 
                _cons |   11.79766   1.147556    10.28   0.000     9.527998    14.06733 
--------------------------------------------------------------------------------------- 
Note: Strata with single sampling unit centered at overall mean. 
*Overall conditional mean 
margins 
Predictive margins 
Number of strata   =       160                 Number of obs     =       1,085 
Number of PSUs     =       294                 Population size   =  13,025,624 
Model VCE    : Linearized                      Design df         =         134 
 
Expression   : twopm combined expected values, predict() 
------------------------------------------------------------------------------ 




             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       _cons |   3902.958   418.9036     9.32   0.000      3074.44    4731.476 
------------------------------------------------------------------------------ 
 
* Conditional mean by Tobacco Status 
margins tobs2 /* change in Tob_stat2*/ 
Predictive margins 
Number of strata   =       160                 Number of obs     =       1,085 
Number of PSUs     =       294                 Population size   =  13,025,624 
Model VCE    : Linearized                      Design df         =         134 
Expression   : twopm combined expected values, predict() 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       tobs2 | 
          1  |   4326.727   688.2648     6.29   0.000     2965.459    5687.995 
          2  |   4089.012   672.2159     6.08   0.000     2759.486    5418.538 




 * Marginal effects, averaged over the sample 
 margins, dydx(*) 
 
Average marginal effects 
Number of strata   =       160                 Number of obs     =       1,085 
Number of PSUs     =       294                 Population size   =  13,025,624 
Model VCE    : Linearized                      Design df         =         134 
Expression   : twopm combined expected values, predict() 
dy/dx w.r.t. : agelast 1.tobs2 2.tobs2 2.sex 1.educat3 2.educat3 4.educat3 1.marcat2 2.marcat2 
4.marcat2 2.bmicat2 3.bmicat2 1.racethx 3.racethx 4.racethx 5.racethx 1.regcat2 2.regcat2 
4.regcat2 1.binge2 1.povcat 2.povcat 3.povcat 4.povcat 1.inscov 2.inscov pcs42 mcs42 k6sum42 
1.phq242 2.phq242 3.phq242 4.phq242 5.phq242 6.phq242 
 
--------------------------------------------------------------------------------------- 
                      |            Delta-method 
                      |      dy/dx   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   25.73528    23.2201     1.11   0.270    -20.19003    71.66059 
                tobs2 | 
                   1  |   1130.531   716.8714     1.58   0.117    -287.3158    2548.378 
                   2  |    892.816   639.5516     1.40   0.165    -372.1056    2157.738 
                2.sex |   1846.117   1454.739     1.27   0.207    -1031.103    4723.338 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -861.4615   691.3877    -1.25   0.215    -2228.906    505.9829 
                  HS  |  -1222.768    918.612    -1.33   0.185    -3039.623    594.0861 
        SOME COLLEGE  |   642.6883   1128.927     0.57   0.570    -1590.133     2875.51 
              marcat2 | 
                   1  |   1183.402   631.4255     1.87   0.063    -65.44806    2432.251 
                   2  |   1275.903   895.8394     1.42   0.157    -495.9112    3047.717 
                   4  |   543.1766   1156.556     0.47   0.639     -1744.29    2830.643 
              bmicat2 | 
                   2  |   407.8242   605.6497     0.67   0.502    -790.0453    1605.694 
                   3  |    650.924   587.3619     1.11   0.270    -510.7754    1812.623 
              racethx | 
                   1  |   1599.391   1668.447     0.96   0.339    -1700.507    4899.289 
                   3  |  -1120.218   700.7717    -1.60   0.112    -2506.222    265.7866 
                   4  |  -91.75282   729.2547    -0.13   0.900    -1534.091    1350.586 




              regcat2 | 
                   1  |  -130.0111   877.2487    -0.15   0.882    -1865.056    1605.034 
                   2  |     719.16   693.6563     1.04   0.302    -652.7714    2091.091 
                   4  |   269.7005   1013.346     0.27   0.791    -1734.522    2273.923 
             1.binge2 |   -1173.71   575.1396    -2.04   0.043    -2311.235   -36.18368 
               povcat | 
                   1  |  -886.4802   1063.305    -0.83   0.406    -2989.513    1216.553 
                   2  |  -1256.043   1302.424    -0.96   0.337    -3832.011    1319.925 
                   3  |  -2427.784   628.1044    -3.87   0.000    -3670.065   -1185.502 
                   4  |  -472.2329   730.4016    -0.65   0.519     -1916.84    972.3743 
               inscov | 
                   1  |   3021.128    421.644     7.17   0.000      2187.19    3855.067 
                   2  |   5519.578   1124.153     4.91   0.000     3296.199    7742.958 
                pcs42 |  -272.0785   51.65142    -5.27   0.000     -374.236    -169.921 
                mcs42 |   -169.476   61.79692    -2.74   0.007    -291.6996   -47.25247 
              k6sum42 |  -80.49336   116.9578    -0.69   0.493    -311.8156    150.8288 
               phq242 | 
                   1  |  -1817.027   1006.609    -1.81   0.073    -3807.924    173.8703 
                   2  |  -1790.362   1281.457    -1.40   0.165     -4324.86    744.1352 
                   3  |          .  (not estimable) 
                   4  |  -3863.893   1307.663    -2.95   0.004    -6450.223   -1277.563 
                   5  |  -4543.219   1170.308    -3.88   0.000    -6857.884   -2228.553 
                   6  |   -3533.42   1583.011    -2.23   0.027    -6664.339   -402.5006 
--------------------------------------------------------------------------------------- 
Note: dy/dx for factor levels is the discrete change from the base level. 
 
* Margin plots for Age by Tobacco Status  
margins, at (agelast=(30(5)65) tobs2 = (1,2,3)) 
Predictive margins 
Number of strata   =       160                 Number of obs     =       1,085 
Number of PSUs     =       294                 Population size   =  13,025,624 
Model VCE    : Linearized                      Design df         =         134 
 
Expression   : twopm combined expected values, predict() 
1._at        : agelast         =          30 
               tobs2           =           1 
2._at        : agelast         =          30 
               tobs2           =           2 
3._at        : agelast         =          30 
               tobs2           =           3 
4._at        : agelast         =          35 
               tobs2           =           1 
5._at        : agelast         =          35 
               tobs2           =           2 
6._at        : agelast         =          35 
               tobs2           =           3 
7._at        : agelast         =          40 
               tobs2           =           1 
8._at        : agelast         =          40 
               tobs2           =           2 
9._at        : agelast         =          40 
               tobs2           =           3 
10._at       : agelast         =          45 
               tobs2           =           1 
11._at       : agelast         =          45 
               tobs2           =           2 
12._at       : agelast         =          45 
               tobs2           =           3 
13._at       : agelast         =          50 
               tobs2           =           1 




               tobs2           =           2 
15._at       : agelast         =          50 
               tobs2           =           3 
16._at       : agelast         =          55 
               tobs2           =           1 
17._at       : agelast         =          55 
               tobs2           =           2 
18._at       : agelast         =          55 
               tobs2           =           3 
19._at       : agelast         =          60 
               tobs2           =           1 
20._at       : agelast         =          60 
               tobs2           =           2 
21._at       : agelast         =          60 
               tobs2           =           3 
22._at       : agelast         =          65 
               tobs2           =           1 
23._at       : agelast         =          65 
               tobs2           =           2 
24._at       : agelast         =          65 
               tobs2           =           3 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         _at | 
          1  |   3855.589   756.6631     5.10   0.000     2359.041    5352.136 
          2  |   3643.078   777.9289     4.68   0.000     2104.471    5181.686 
          3  |   2852.506    436.862     6.53   0.000     1988.469    3716.543 
          4  |   3985.705   717.8111     5.55   0.000         2566    5405.411 
          5  |   3766.162   733.2432     5.14   0.000     2315.935     5216.39 
          6  |   2947.867   396.2475     7.44   0.000     2164.159    3731.575 
          7  |   4120.094   691.6778     5.96   0.000     2752.076    5488.112 
          8  |   3893.291   696.9289     5.59   0.000     2514.887    5271.695 
          9  |   3046.337   366.7051     8.31   0.000     2321.058    3771.616 
         10  |   4258.892   683.4774     6.23   0.000     2907.093    5610.691 
         11  |   4024.595   673.5335     5.98   0.000     2692.463    5356.727 
         12  |   3148.016    354.994     8.87   0.000       2445.9    3850.132 
         13  |   4402.241   698.0393     6.31   0.000     3021.641    5782.841 
         14  |   4160.207   668.1067     6.23   0.000     2838.809    5481.606 
         15  |   3253.006   367.2089     8.86   0.000     2526.731    3979.281 
         16  |   4550.287   738.5258     6.16   0.000     3089.612    6010.963 
         17  |   4300.267    685.183     6.28   0.000     2945.095     5655.44 
         18  |   3361.413   405.6644     8.29   0.000     2559.079    4163.747 
         19  |   4703.181   805.7177     5.84   0.000     3109.612    6296.751 
         20  |   4444.917   727.5737     6.11   0.000     3005.903    5883.931 
         21  |   3473.346   468.2953     7.42   0.000      2547.14    4399.553 
         22  |   4861.079   898.3889     5.41   0.000     3084.222    6637.936 
         23  |   4594.305   795.7926     5.77   0.000     3020.366    6168.244 
         24  |   3588.919   551.1012     6.51   0.000     2498.937    4678.901 
----------------------------------------------------------------------------- 
 
Age (≤ 65 years) and Male Expenditure Model 
 
* Two-part model, with logit first part and GLM second part all variables (i.e 
sociodemographic and comorbidities) 
svy: twopm totexpi c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 
,firstpart(logit) secondpart(glm, family(gamma) link(log)) 




Survey data analysis 
Number of strata   =       160                 Number of obs     =       1,023 
Number of PSUs     =       288                 Population size   =  12,527,088 
                                               Design df         =         128 
                                               F(  33,     96)   =        2.64 
                                               Prob > F          =      0.0001 
--------------------------------------------------------------------------------------- 
                      |             Linearized 
              totexpi |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
logit                 | 
              agelast |   .0006949   .0116623     0.06   0.953    -.0223809    .0237708 
                tobs2 | 
                   1  |  -.2209336   .2435647    -0.91   0.366     -.702868    .2610007 
                   2  |  -.2007821   .2677302    -0.75   0.455     -.730532    .3289678 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.0748593   .3100052    -0.24   0.810    -.6882576     .538539 
                  HS  |  -.3019874   .2739054    -1.10   0.272    -.8439561    .2399812 
        SOME COLLEGE  |  -.0521699   .3134091    -0.17   0.868    -.6723034    .5679636 
              marcat2 | 
                   1  |   .0548619   .2842743     0.19   0.847    -.5076234    .6173472 
                   2  |    .220344   .3143677     0.70   0.485    -.4016861    .8423742 
                   4  |  -.4382878   .3981575    -1.10   0.273    -1.226111    .3495349 
              bmicat2 | 
                   2  |   .3356067   .2205691     1.52   0.131    -.1008269    .7720403 
                   3  |   .2610218   .2464633     1.06   0.292     -.226648    .7486915 
              racethx | 
                   1  |   -.472339   .3650725    -1.29   0.198    -1.194697    .2500193 
                   3  |  -.5582216   .2880107    -1.94   0.055      -1.1281    .0116568 
                   4  |  -.4053915   .2597167    -1.56   0.121    -.9192854    .1085024 
                   5  |   .0554819   .7443055     0.07   0.941    -1.417254    1.528218 
              regcat2 | 
                   1  |   .6704057   .4051286     1.65   0.100    -.1312104    1.472022 
                   2  |   .1994403   .2843247     0.70   0.484    -.3631447    .7620253 
                   4  |   .0256272   .3390304     0.08   0.940    -.6452025    .6964568 
             1.binge2 |  -.2183974   .2382927    -0.92   0.361    -.6899002    .2531055 
               povcat | 
                   1  |  -.7697931   .4323271    -1.78   0.077    -1.625226    .0856399 
                   2  |  -.5472831    .513587    -1.07   0.289    -1.563503    .4689366 
                   3  |   -1.40861   .3968032    -3.55   0.001    -2.193752   -.6234666 
                   4  |  -.9827213    .229652    -4.28   0.000    -1.437127   -.5283157 
               inscov | 
                   1  |   1.581559   .3341463     4.73   0.000     .9203932    2.242724 
                   2  |   1.561297    .474469     3.29   0.001      .622479    2.500115 
                pcs42 |  -.0713578   .0175271    -4.07   0.000    -.1060381   -.0366775 
                mcs42 |  -.0225321   .0185876    -1.21   0.228    -.0593109    .0142468 
              k6sum42 |   .0225179     .04473     0.50   0.616    -.0659881     .111024 
               phq242 | 
                   1  |  -.2340909   .3410201    -0.69   0.494    -.9088575    .4406756 
                   2  |   .2063572   .4382907     0.47   0.639    -.6608758     1.07359 
                   4  |   1.578631   .8059011     1.96   0.052     -.015982    3.173244 
                   5  |   .4480438   1.081358     0.41   0.679    -1.691607    2.587695 
                   6  |   1.116415   1.198713     0.93   0.353    -1.255443    3.488273 
                _cons |   5.630388    1.71755     3.28   0.001     2.231922    9.028854 
----------------------+---------------------------------------------------------------- 
glm                   | 
              agelast |   .0053067   .0061233     0.87   0.388    -.0068093    .0174226 
                tobs2 | 
                   1  |   .3100775   .1866656     1.66   0.099    -.0592723    .6794272 
                   2  |   .2373006   .1685764     1.41   0.162    -.0962565    .5708578 




COLLEGE GRAD OR HIGH  |  -.1806012   .1767689    -1.02   0.309    -.5303687    .1691663 
                  HS  |  -.3110565   .2490626    -1.25   0.214    -.8038694    .1817565 
        SOME COLLEGE  |   .1994781   .2565327     0.78   0.438    -.3081157    .7070718 
              marcat2 | 
                   1  |   .3146846   .1698144     1.85   0.066    -.0213222    .6506915 
                   2  |    .323048    .243754     1.33   0.187    -.1592609     .805357 
                   4  |   .2171749   .3195987     0.68   0.498    -.4152059    .8495556 
              bmicat2 | 
                   2  |    .132129   .1709914     0.77   0.441    -.2062068    .4704648 
                   3  |   .1805135   .1663864     1.08   0.280    -.1487103    .5097374 
              racethx | 
                   1  |   .4533077   .3067169     1.48   0.142    -.1535841    1.060199 
                   3  |  -.3759723   .2182129    -1.72   0.087    -.8077439    .0557993 
                   4  |   .0437133   .1900559     0.23   0.818    -.3323448    .4197714 
                   5  |   -.697845   .3180671    -2.19   0.030    -1.327195    -.068495 
              regcat2 | 
                   1  |  -.0638655   .2506461    -0.25   0.799    -.5598116    .4320805 
                   2  |   .1640336   .1681374     0.98   0.331     -.168655    .4967222 
                   4  |   .0920951   .2605941     0.35   0.724    -.4235348     .607725 
             1.binge2 |  -.2987401   .1447225    -2.06   0.041    -.5850983    -.012382 
               povcat | 
                   1  |  -.1071281   .2678212    -0.40   0.690    -.6370582     .422802 
                   2  |  -.2480645   .3842643    -0.65   0.520    -1.008397     .512268 
                   3  |  -.6809079   .2163951    -3.15   0.002    -1.109083   -.2527332 
                   4  |  -.0329724   .1693833    -0.19   0.846    -.3681262    .3021813 
               inscov | 
                   1  |   1.269363   .2645949     4.80   0.000     .7458167    1.792909 
                   2  |   1.857952   .2867521     6.48   0.000     1.290564     2.42534 
                pcs42 |  -.0626617   .0077215    -8.12   0.000      -.07794   -.0473834 
                mcs42 |  -.0415874   .0143726    -2.89   0.004    -.0700261   -.0131487 
              k6sum42 |  -.0223108   .0295279    -0.76   0.451    -.0807367    .0361152 
               phq242 | 
                   1  |  -.3987987   .2239127    -1.78   0.077    -.8418482    .0442507 
                   2  |  -.3663879   .2732496    -1.34   0.182    -.9070589    .1742831 
                   3  |  -.8870842   .2948263    -3.01   0.003    -1.470448   -.3037201 
                   4  |  -1.258579   .4169911    -3.02   0.003    -2.083668   -.4334913 
                   5  |  -1.659381   .3904153    -4.25   0.000    -2.431885   -.8868779 
                   6  |  -1.199127   .4915472    -2.44   0.016    -2.171737   -.2265172 
                _cons |   11.92157   1.155468    10.32   0.000     9.635279    14.20786 
--------------------------------------------------------------------------------------- 
Note: Strata with single sampling unit centered at overall mean. 
*Overall conditional mean 
margins 
Predictive margins 
Number of strata   =       160                 Number of obs     =       1,020 
Number of PSUs     =       288                 Population size   =  12,527,088 
Model VCE    : Linearized                      Design df         =         128 
Expression   : twopm combined expected values, predict() 
------------------------------------------------------------------------------ 
             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       _cons |   3667.983   416.8423     8.80   0.000     2843.189    4492.777 
------------------------------------------------------------------------------ 
* Conditional mean by Tobacco Status 
margins tobs2 /* change in Tob_stat2*/ 
Predictive margins 
Number of strata   =       160                 Number of obs     =       1,020 
Number of PSUs     =       288                 Population size   =  12,527,088 
Model VCE    : Linearized                      Design df         =         128 





             |            Delta-method 
             |     Margin   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       tobs2 | 
          1  |   4073.945   684.6569     5.95   0.000     2719.235    5428.656 
          2  |   3796.062   656.8069     5.78   0.000     2496.457    5095.666 
          3  |    3053.73    363.281     8.41   0.000     2334.917    3772.544 
------------------------------------------------------------------------------ 
 Marginal effects, averaged over the sample 
 margins, dydx(*) 
Average marginal effects 
Number of strata   =       160                 Number of obs     =       1,020 
Number of PSUs     =       288                 Population size   =  12,527,088 
Model VCE    : Linearized                      Design df         =         128 
Expression   : twopm combined expected values, predict() 
dy/dx w.r.t. : agelast 1.tobs2 2.tobs2 1.sex 1.educat3 2.educat3 4.educat3 1.marcat2 2.marcat2 
4.marcat2 2.bmicat2 3.bmicat2 1.racethx 3.racethx 4.racethx 5.racethx 1.regcat2 2.regcat2 
4.regcat2 1.binge2 1.povcat 2.povcat 3.povcat 4.povcat 1.inscov 2.inscov pcs42 mcs42 k6sum42 
1.phq242 2.phq242 3.phq242 4.phq242 5.phq242 6.phq242 
--------------------------------------------------------------------------------------- 
                      |            Delta-method 
                      |      dy/dx   Std. Err.      t    P>|t|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   19.72142     22.643     0.87   0.385    -25.08163    64.52447 
                tobs2 | 
                   1  |   1055.764   721.9839     1.46   0.146    -372.8045    2484.333 
                   2  |   796.2622   654.6393     1.22   0.226    -499.0535    2091.578 
              educat3 | 
COLLEGE GRAD OR HIGH  |   -690.089   664.8362    -1.04   0.301    -2005.581     625.403 
                  HS  |  -1252.479   952.3155    -1.32   0.191    -3136.798    631.8397 
        SOME COLLEGE  |   712.4149   939.2606     0.76   0.450    -1146.073    2570.903 
              marcat2 | 
                   1  |   1174.519   677.0094     1.73   0.085    -165.0594    2514.098 
                   2  |   1266.312   908.5017     1.39   0.166    -531.3142    3063.937 
                   4  |   634.7261    1198.99     0.53   0.597     -1737.68    3007.132 
              bmicat2 | 
                   2  |   608.5925   610.7085     1.00   0.321    -599.7986    1816.984 
                   3  |   758.5206   610.2654     1.24   0.216    -448.9938    1966.035 
              racethx | 
                   1  |   1488.282   1143.814     1.30   0.196    -774.9492    3751.512 
                   3  |  -1585.221   888.1245    -1.78   0.077    -3342.528    172.0848 
                   4  |   10.62121   712.7059     0.01   0.988    -1399.589    1420.832 
                   5  |  -2539.193   1253.192    -2.03   0.045    -5018.848   -59.53782 
              regcat2 | 
                   1  |   13.33518    908.936     0.01   0.988     -1785.15     1811.82 
                   2  |   675.3293   618.5639     1.09   0.277    -548.6051    1899.264 
                   4  |   347.2678    964.155     0.36   0.719    -1560.478    2255.013 
             1.binge2 |  -1176.432   585.2533    -2.01   0.047    -2334.455   -18.40826 
               povcat | 
                   1  |  -677.2424   1019.389    -0.66   0.508    -2694.277    1339.792 
                   2  |  -1112.018   1429.205    -0.78   0.438    -3939.944    1715.909 
                   3  |  -3017.783   850.5411    -3.55   0.001    -4700.724   -1334.843 
                   4  |   -483.879   618.5462    -0.78   0.435    -1707.778    740.0203 
               inscov | 
                   1  |   5240.099   1219.284     4.30   0.000     2827.538    7652.661 
                   2  |   7391.552   1484.194     4.98   0.000     4454.821    10328.28 
                pcs42 |  -256.1957   49.86388    -5.14   0.000    -354.8599   -157.5315 
                mcs42 |  -160.8633    59.1569    -2.72   0.007    -277.9153   -43.81125 
              k6sum42 |  -73.51918   111.1418    -0.66   0.509    -293.4322    146.3938 




                   1  |  -1549.241   864.3641    -1.79   0.075    -3259.533    161.0512 
                   2  |  -1267.693    1044.68    -1.21   0.227     -3334.77    799.3844 
                   3  |   -3253.81   1316.707    -2.47   0.015    -5859.139   -648.4806 
                   4  |  -4033.431    1714.15    -2.35   0.020     -7425.17   -641.6919 
                   5  |  -5921.112   1800.511    -3.29   0.001     -9483.73   -2358.494 




















Healthcare Utilization Models 
  
Emergency room visits (ER) 
* Hurdle:Two-part model, with logit first part and Piosson second part for all variables (i.e 
sociodemographic and comorbidities)  
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , vce(robust)  
Iteration 0:   log pseudolikelihood = -527.65512   
Iteration 1:   log pseudolikelihood = -488.65173   
Iteration 2:   log pseudolikelihood = -483.40995   
Iteration 3:   log pseudolikelihood = -483.39281   
Iteration 4:   log pseudolikelihood = -483.39281   
 
Logistic regression                             Number of obs     =      1,308 
                                                Wald chi2(35)     =      85.57 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood = -483.39281               Pseudo R2         =     0.0839 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |  -.0135145   .0075628    -1.79   0.074    -.0283375    .0013084 
                tobs2 | 
                   1  |   .3668492   .2174766     1.69   0.092    -.0593971    .7930955 
                   2  |   .2505223   .2343581     1.07   0.285    -.2088113    .7098558 
                2.sex |   .3077268   .2726864     1.13   0.259    -.2267287    .8421824 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .0961242    .232606     0.41   0.679    -.3597753    .5520236 
                  HS  |  -.0442821    .243313    -0.18   0.856    -.5211667    .4326026 
        SOME COLLEGE  |   -.023248   .2707336    -0.09   0.932    -.5538762    .5073801 
              marcat2 | 
                   1  |  -.0888831   .2364731    -0.38   0.707    -.5523618    .3745957 
                   2  |   .1250408   .2643815     0.47   0.636    -.3931374    .6432189 
                   4  |   .3252572   .3054655     1.06   0.287    -.2734441    .9239585 




                   2  |  -.2453346   .2231541    -1.10   0.272    -.6827085    .1920394 
                   3  |  -.1099313   .2077931    -0.53   0.597    -.5171983    .2973357 
              racethx | 
                   1  |  -.1042317   .3197723    -0.33   0.744    -.7309739    .5225105 
                   3  |   .0647847   .2435401     0.27   0.790    -.4125452    .5421146 
                   4  |   .2619719   .2466642     1.06   0.288    -.2214811     .745425 
                   5  |    .179846   .4641951     0.39   0.698    -.7299596    1.089652 
              regcat2 | 
                   1  |   .4361185   .2933942     1.49   0.137    -.1389235     1.01116 
                   2  |   .4896813   .2219864     2.21   0.027      .054596    .9247667 
                   4  |  -.1794305   .2791778    -0.64   0.520     -.726609    .3677479 
             1.binge2 |  -.2080421   .2089706    -1.00   0.319     -.617617    .2015328 
               povcat | 
                   1  |   .1479691   .3038153     0.49   0.626    -.4474979    .7434361 
                   2  |   -.210096   .4468939    -0.47   0.638    -1.085992    .6657999 
                   3  |   -.215715   .3262807    -0.66   0.509    -.8552133    .4237834 
                   4  |   .2911892   .2250969     1.29   0.196    -.1499925     .732371 
               inscov | 
                   1  |   .5192446   .3501232     1.48   0.138    -.1669842    1.205473 
                   2  |    1.34212   .3886189     3.45   0.001     .5804411    2.103799 
                pcs42 |  -.0164959   .0090514    -1.82   0.068    -.0342362    .0012445 
                mcs42 |   .0007247   .0136023     0.05   0.958    -.0259352    .0273847 
              k6sum42 |    .067565   .0386872     1.75   0.081    -.0082606    .1433906 
               phq242 | 
                   1  |   .2873864   .2948171     0.97   0.330    -.2904445    .8652173 
                   2  |  -.2621818    .379441    -0.69   0.490    -1.005873     .481509 
                   3  |  -.0240553   .4827771    -0.05   0.960    -.9702809    .9221703 
                   4  |  -.0028663   .5691528    -0.01   0.996    -1.118385    1.112653 
                   5  |   -1.51684   1.091314    -1.39   0.165    -3.655777    .6220965 
                   6  |  -.2345369   .7225263    -0.32   0.745    -1.650662    1.181589 
                _cons |  -1.737642   1.196008    -1.45   0.146    -4.081774    .6064906 
--------------------------------------------------------------------------------------- 
*Hurdle Piosson Model estimates 
tpoisson ertot c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242  if ertot>0 , 
ll(0) vce(robust) 
Iteration 0:   log pseudolikelihood = -175.48536   
Iteration 1:   log pseudolikelihood = -139.49958   
Iteration 2:   log pseudolikelihood = -138.24711   
Iteration 3:   log pseudolikelihood = -138.20419   
Iteration 4:   log pseudolikelihood = -138.19524   
Iteration 5:   log pseudolikelihood = -138.19312   
Iteration 6:   log pseudolikelihood = -138.19264   
Iteration 7:   log pseudolikelihood = -138.19253   
Iteration 8:   log pseudolikelihood = -138.19251   
Iteration 9:   log pseudolikelihood = -138.19251   
Truncated Poisson regression                    Number of obs     =        182 
Limits:        lower =          0               Wald chi2(35)     =     268.59 
               upper =       +inf               Prob > chi2       =     0.0000 
Log pseudolikelihood = -138.19251               Pseudo R2         =     0.2779 
--------------------------------------------------------------------------------------- 
                      |               Robust 
                ertot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0065554   .0100686     0.65   0.515    -.0131788    .0262895 
                tobs2 | 
                   1  |   .4280123   .3860392     1.11   0.268    -.3286106    1.184635 
                   2  |   .2088302   .4732322     0.44   0.659    -.7186878    1.136348 
                2.sex |   .5784416   .3733406     1.55   0.121    -.1532926    1.310176 
              educat3 | 




                  HS  |   .2163224     .28767     0.75   0.452    -.3475004    .7801452 
        SOME COLLEGE  |  -.2538544   .3745386    -0.68   0.498    -.9879366    .4802279 
              marcat2 | 
                   1  |   .1018368   .3895788     0.26   0.794    -.6617237    .8653973 
                   2  |  -.7000288   .3914136    -1.79   0.074    -1.467185    .0671279 
                   4  |  -.3542364   .4662407    -0.76   0.447    -1.268051    .5595786 
              bmicat2 | 
                   2  |  -.8394927   .3280143    -2.56   0.010    -1.482389   -.1965964 
                   3  |  -.5318744   .2981098    -1.78   0.074    -1.116159    .0524101 
              racethx | 
                   1  |  -.1261414   .8017612    -0.16   0.875    -1.697564    1.445282 
                   3  |  -.1460761   .4100365    -0.36   0.722    -.9497329    .6575807 
                   4  |   -.389784   .4077349    -0.96   0.339     -1.18893    .4093617 
                   5  |  -.5380496   .5820267    -0.92   0.355    -1.678801    .6027017 
              regcat2 | 
                   1  |  -.2283217    .441643    -0.52   0.605    -1.093926    .6372828 
                   2  |   .3745224   .2873538     1.30   0.192    -.1886807    .9377256 
                   4  |  -.6689206   .7073545    -0.95   0.344     -2.05531    .7174688 
             1.binge2 |   -.973808   .4158016    -2.34   0.019    -1.788764   -.1588518 
               povcat | 
                   1  |   .4258721    .594184     0.72   0.474    -.7387072    1.590451 
                   2  |  -.4708315   1.139644    -0.41   0.680    -2.704492    1.762829 
                   3  |   .5473565   .4569473     1.20   0.231    -.3482438    1.442957 
                   4  |   .5097922    .425224     1.20   0.231    -.3236315    1.343216 
               inscov | 
                   1  |   .7365302   .5477095     1.34   0.179    -.3369607    1.810021 
                   2  |   1.141021   .4980706     2.29   0.022     .1648203    2.117221 
                pcs42 |   .0108142   .0155894     0.69   0.488    -.0197405    .0413688 
                mcs42 |   .0168534   .0198135     0.85   0.395    -.0219803    .0556871 
              k6sum42 |   .0807462   .0493186     1.64   0.102    -.0159165    .1774089 
               phq242 | 
                   1  |  -.7549338   .6702038    -1.13   0.260    -2.068509    .5586416 
                   2  |   -.159994   .5608412    -0.29   0.775    -1.259223    .9392346 
                   3  |  -.5396092   .6379838    -0.85   0.398    -1.790034     .710816 
                   4  |   -.309715   .5665842    -0.55   0.585      -1.4202    .8007696 
                   5  |  -13.81117   1.524454    -9.06   0.000    -16.79904   -10.82329 
                   6  |  -.7084642    .871547    -0.81   0.416    -2.416665    .9997365 
                _cons |  -2.906615   1.617434    -1.80   0.072    -6.076728    .2634979-------
------------------------------------------------------------------------------- 
Office-Based visits 
*Hurdle Piosson Model 1st part estimates 
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , vce(robust)  
Iteration 0:   log pseudolikelihood = -816.39687   
Iteration 1:   log pseudolikelihood = -681.31435   
Iteration 2:   log pseudolikelihood = -672.42965   
Iteration 3:   log pseudolikelihood = -672.26699   
Iteration 4:   log pseudolikelihood = -672.26674   
Iteration 5:   log pseudolikelihood = -672.26674   
Logistic regression                             Number of obs     =      1,298 
                                                Wald chi2(34)     =     192.25 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood = -672.26674               Pseudo R2         =     0.1765 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0168368   .0059994     2.81   0.005     .0050782    .0285954 
                tobs2 | 
                   1  |   -.295484   .1654275    -1.79   0.074    -.6197158    .0287479 




                2.sex |   1.047489   .3154674     3.32   0.001     .4291845    1.665794 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .2637928   .1845999     1.43   0.153    -.0980164     .625602 
                  HS  |   .0530896   .1926303     0.28   0.783    -.3244588     .430638 
        SOME COLLEGE  |   .1003371   .2189855     0.46   0.647    -.3288665    .5295407 
              marcat2 | 
                   1  |  -.2095862   .1791778    -1.17   0.242    -.5607683    .1415959 
                   2  |  -.1237406   .2253885    -0.55   0.583    -.5654939    .3180126 
                   4  |  -.0376856   .2862484    -0.13   0.895    -.5987222     .523351 
              bmicat2 | 
                   2  |   .3248639   .1732316     1.88   0.061    -.0146638    .6643915 
                   3  |   .1304622   .1779765     0.73   0.464    -.2183652    .4792897 
              racethx | 
                   1  |  -.3135539   .2230608    -1.41   0.160    -.7507451    .1236373 
                   3  |  -.1288438   .2128717    -0.61   0.545    -.5460647    .2883772 
                   4  |  -.3550016   .1951329    -1.82   0.069    -.7374551    .0274518 
                   5  |   .1237247   .4661889     0.27   0.791    -.7899886    1.037438 
              regcat2 | 
                   1  |   .3878437    .250147     1.55   0.121    -.1024354    .8781227 
                   2  |   .3965552   .1758603     2.25   0.024     .0518754    .7412349 
                   4  |   .0739696   .1944397     0.38   0.704    -.3071252    .4550644 
             1.binge2 |   -.196506   .1485125    -1.32   0.186     -.487585    .0945731 
               povcat | 
                   1  |  -.5897605   .2865432    -2.06   0.040    -1.151375   -.0281461 
                   2  |  -.0041755   .3701905    -0.01   0.991    -.7297356    .7213845 
                   3  |  -.2145813    .251385    -0.85   0.393    -.7072868    .2781242 
                   4  |  -.3213465   .1656436    -1.94   0.052     -.646002    .0033089 
               inscov | 
                   1  |   1.899153   .2474467     7.67   0.000     1.414166    2.384139 
                   2  |   1.775936   .3098596     5.73   0.000     1.168623     2.38325 
                pcs42 |  -.0704207   .0113077    -6.23   0.000    -.0925833    -.048258 
                mcs42 |  -.0292244   .0131746    -2.22   0.027     -.055046   -.0034027 
              k6sum42 |  -.0033955   .0358442    -0.09   0.925    -.0736489    .0668578 
               phq242 | 
                   1  |   .0671737   .2448048     0.27   0.784    -.4126348    .5469822 
                   2  |  -.1226567   .2973064    -0.41   0.680    -.7053665    .4600532 
                   3  |   .9335344   .6439804     1.45   0.147     -.328644    2.195713 
                   4  |   .2702809   .6161677     0.44   0.661    -.9373856    1.477947 
                   5  |          0  (empty) 
                   6  |   .1590792   .7941821     0.20   0.841    -1.397489    1.715648 





*Hurdle Piosson Model estimates 
tpoisson obtotv c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242  if obtotv>0 , 
ll(0) vce(robust) 
Iteration 0:   log pseudolikelihood = -4195.4307   
Iteration 1:   log pseudolikelihood = -4193.9898   
Iteration 2:   log pseudolikelihood = -4193.9872   
Iteration 3:   log pseudolikelihood = -4193.9872   
Truncated Poisson regression                    Number of obs     =        889 
Limits:        lower =          0               Wald chi2(35)     =     204.48 
               upper =       +inf               Prob > chi2       =     0.0000 
Log pseudolikelihood = -4193.9872               Pseudo R2         =     0.1566 
--------------------------------------------------------------------------------------- 
                      |               Robust 





              agelast |   .0113009   .0042423     2.66   0.008     .0029862    .0196156 
                tobs2 | 
                   1  |  -.1143025   .1328096    -0.86   0.389    -.3746045    .1459996 
                   2  |  -.1283631   .1264181    -1.02   0.310    -.3761379    .1194118 
                2.sex |  -.1380887   .1693459    -0.82   0.415    -.4700006    .1938231 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .1985675   .1277037     1.55   0.120    -.0517272    .4488621 
                  HS  |  -.0400095   .1431778    -0.28   0.780    -.3206328    .2406138 
        SOME COLLEGE  |   .1448467   .1522355     0.95   0.341    -.1535294    .4432228 
              marcat2 | 
                   1  |   .0563614    .117405     0.48   0.631    -.1737482     .286471 
                   2  |   .0689678   .1671322     0.41   0.680    -.2586053    .3965408 
                   4  |  -.2146906    .271524    -0.79   0.429     -.746868    .3174867 
              bmicat2 | 
                   2  |   .0372111   .1643063     0.23   0.821    -.2848233    .3592455 
                   3  |   .1977419   .1612058     1.23   0.220    -.1182157    .5136996 
              racethx | 
                   1  |  -.0818116   .1379132    -0.59   0.553    -.3521166    .1884934 
                   3  |   -.143568   .1661066    -0.86   0.387     -.469131     .181995 
                   4  |   .0012652   .1590829     0.01   0.994    -.3105315    .3130619 
                   5  |  -.2359867     .28442    -0.83   0.407    -.7934396    .3214662 
              regcat2 | 
                   1  |   .1165981   .1581629     0.74   0.461    -.1933955    .4265918 
                   2  |   .1519154   .1254316     1.21   0.226     -.093926    .3977568 
                   4  |   .0935053   .1297415     0.72   0.471    -.1607834    .3477939 
             1.binge2 |  -.2417031   .1137872    -2.12   0.034    -.4647218   -.0186843 
               povcat | 
                   1  |    .066964   .1618873     0.41   0.679    -.2503292    .3842572 
                   2  |  -.0214503   .1802957    -0.12   0.905    -.3748234    .3319228 
                   3  |  -.0558711   .1549167    -0.36   0.718    -.3595022      .24776 
                   4  |    .063079   .1229607     0.51   0.608    -.1779195    .3040774 
               inscov | 
                   1  |   .7448672   .2780018     2.68   0.007     .1999937    1.289741 
                   2  |   .8076762   .2894717     2.79   0.005     .2403221     1.37503 
                pcs42 |  -.0234392   .0054743    -4.28   0.000    -.0341687   -.0127098 
                mcs42 |  -.0153196   .0091351    -1.68   0.094    -.0332241    .0025849 
              k6sum42 |  -.0097936   .0225821    -0.43   0.665    -.0540537    .0344666 
               phq242 | 
                   1  |   .0676756    .162153     0.42   0.676    -.2501386    .3854897 
                   2  |  -.0320265   .1619046    -0.20   0.843    -.3493537    .2853007 
                   3  |   -.136403   .2045272    -0.67   0.505    -.5372689    .2644629 
                   4  |  -.1720725   .2104385    -0.82   0.414    -.5845245    .2403794 
                   5  |      .1653   .3558211     0.46   0.642    -.5320965    .8626964 
                   6  |  -.1144187   .2974172    -0.38   0.700    -.6973457    .4685084 







Hospital Outpatient visits 
*Hurdle Piosson Model 1st part estimates 
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , vce(robust)  
Iteration 0:   log pseudolikelihood = -485.96161   
Iteration 1:   log pseudolikelihood = -427.48217   
Iteration 2:   log pseudolikelihood = -415.46802   
Iteration 3:   log pseudolikelihood = -415.32979   
Iteration 4:   log pseudolikelihood =  -415.3296   




Logistic regression                             Number of obs     =      1,308 
                                                Wald chi2(35)     =     141.26 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood =  -415.3296               Pseudo R2         =     0.1453 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0175505   .0082517     2.13   0.033     .0013774    .0337235 
                tobs2 | 
                   1  |  -.0481112   .2271333    -0.21   0.832    -.4932844    .3970619 
                   2  |  -.4257712   .2655933    -1.60   0.109    -.9463246    .0947821 
                2.sex |   .3947112   .3182892     1.24   0.215    -.2291242    1.018547 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .9842729   .2899006     3.40   0.001     .4160781    1.552468 
                  HS  |   .8902138    .295547     3.01   0.003     .3109523    1.469475 
        SOME COLLEGE  |   1.056447   .3189116     3.31   0.001     .4313922    1.681503 
              marcat2 | 
                   1  |   .2032592   .2661672     0.76   0.445    -.3184189    .7249374 
                   2  |   .3711417   .2980781     1.25   0.213    -.2130807     .955364 
                   4  |   .5618671   .3881295     1.45   0.148    -.1988527    1.322587 
              bmicat2 | 
                   2  |   .0725509   .2685909     0.27   0.787    -.4538775    .5989794 
                   3  |    .187736   .2452924     0.77   0.444    -.2930282    .6685003 
              racethx | 
                   1  |  -.0858986   .3445966    -0.25   0.803    -.7612956    .5894984 
                   3  |  -.4093614   .2977689    -1.37   0.169    -.9929777    .1742548 
                   4  |   .0677415   .2795668     0.24   0.809    -.4801994    .6156825 
                   5  |  -.1813286   .5985208    -0.30   0.762    -1.354408    .9917505 
              regcat2 | 
                   1  |   .6303421   .3208834     1.96   0.049     .0014222    1.259262 
                   2  |   .3829294   .2276408     1.68   0.093    -.0632383    .8290971 
                   4  |  -.5039126    .336653    -1.50   0.134     -1.16374    .1559152 
             1.binge2 |  -.3117728   .2341094    -1.33   0.183    -.7706188    .1470732 
               povcat | 
                   1  |  -.4949694   .3749276    -1.32   0.187    -1.229814    .2398751 
                   2  |   .1409888   .4513187     0.31   0.755    -.7435796    1.025557 
                   3  |  -.1462253   .3399149    -0.43   0.667    -.8124462    .5199956 
                   4  |  -.1660053    .239161    -0.69   0.488    -.6347522    .3027415 
               inscov | 
                   1  |   1.029891   .4385278     2.35   0.019     .1703924     1.88939 
                   2  |   .8534226   .4859753     1.76   0.079    -.0990716    1.805917 
                pcs42 |  -.0479879   .0098784    -4.86   0.000    -.0673493   -.0286266 
                mcs42 |  -.0023717   .0153972    -0.15   0.878    -.0325496    .0278063 
              k6sum42 |    .051732   .0411445     1.26   0.209    -.0289097    .1323736 
               phq242 | 
                   1  |   .3251578   .3082234     1.05   0.291    -.2789488    .9292645 
                   2  |  -.0701067   .3800023    -0.18   0.854    -.8148974     .674684 
                   3  |  -.4311004    .521605    -0.83   0.409    -1.453427    .5912265 
                   4  |   -.650799    .541252    -1.20   0.229    -1.711633    .4100353 
                   5  |  -1.145806   1.279351    -0.90   0.370    -3.653289    1.361676 
                   6  |  -.4678984   .7865148    -0.59   0.552    -2.009439    1.073642 





*Hurdle Piosson Model estimates 
tpoisson optotv c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 





Iteration 0:   log pseudolikelihood = -321.96632   
Iteration 1:   log pseudolikelihood = -308.66006   
Iteration 2:   log pseudolikelihood = -308.51122   
Iteration 3:   log pseudolikelihood = -308.50979   
Iteration 4:   log pseudolikelihood = -308.50979   
Truncated Poisson regression                    Number of obs     =        160 
Limits:        lower =          0               Wald chi2(34)     =          . 
               upper =       +inf               Prob > chi2       =          . 
Log pseudolikelihood = -308.50979               Pseudo R2         =     0.2746 
--------------------------------------------------------------------------------------- 
                      |               Robust 
               optotv |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0206494   .0117688     1.75   0.079    -.0024171    .0437158 
                tobs2 | 
                   1  |   .0328895   .2166145     0.15   0.879     -.391667     .457446 
                   2  |  -.6288453   .4155325    -1.51   0.130    -1.443274    .1855836 
                2.sex |   .4347539   .3188746     1.36   0.173    -.1902287    1.059737 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .7025447   .3084982     2.28   0.023     .0978993     1.30719 
                  HS  |   .1157596   .3365218     0.34   0.731    -.5438111    .7753303 
        SOME COLLEGE  |  -.2871887   .3524441    -0.81   0.415    -.9779663     .403589 
              marcat2 | 
                   1  |   .4690977   .3683503     1.27   0.203    -.2528556    1.191051 
                   2  |   .0058586   .3399006     0.02   0.986    -.6603343    .6720516 
                   4  |     .78712   .4242371     1.86   0.064    -.0443694    1.618609 
              bmicat2 | 
                   2  |   .1907473   .4279312     0.45   0.656    -.6479825    1.029477 
                   3  |   .1014148   .3291321     0.31   0.758    -.5436723    .7465018 
              racethx | 
                   1  |  -.1778024   .4316192    -0.41   0.680     -1.02376    .6681556 
                   3  |   .0025738   .6401453     0.00   0.997    -1.252088    1.257236 
                   4  |   .3087647   .3854124     0.80   0.423    -.4466297    1.064159 
                   5  |  -1.019079   1.124085    -0.91   0.365    -3.222245    1.184086 
              regcat2 | 
                   1  |   .5299183   .4563484     1.16   0.246    -.3645081    1.424345 
                   2  |   .0730268   .2932798     0.25   0.803     -.501791    .6478446 
                   4  |   .8476742   .4201825     2.02   0.044     .0241316    1.671217 
             1.binge2 |   .1793379    .337259     0.53   0.595    -.4816775    .8403533 
               povcat | 
                   1  |  -1.329007     .66186    -2.01   0.045    -2.626229   -.0317857 
                   2  |   .0146332   .4177433     0.04   0.972    -.8041286    .8333951 
                   3  |   .3756531   .3005981     1.25   0.211    -.2135084    .9648145 
                   4  |  -.4807965   .2953234    -1.63   0.104     -1.05962    .0980268 
               inscov | 
                   1  |  -1.007375   .4729389    -2.13   0.033    -1.934319   -.0804322 
                   2  |   -.942767   .4475977    -2.11   0.035    -1.820042   -.0654915 
                pcs42 |  -.0166281   .0133852    -1.24   0.214    -.0428626    .0096063 
                mcs42 |   .0100274   .0205089     0.49   0.625    -.0301693    .0502241 
              k6sum42 |   .0443209   .0437465     1.01   0.311    -.0414207    .1300624 
               phq242 | 
                   1  |    .894428   .4070109     2.20   0.028     .0967013    1.692155 
                   2  |   .7900444   .4550466     1.74   0.083    -.1018307    1.681919 
                   3  |   .6776741   .5933243     1.14   0.253    -.4852202    1.840568 
                   4  |   .0999072   .5684551     0.18   0.860    -1.014244    1.214059 
                   5  |   .6075025   .8002736     0.76   0.448     -.961005     2.17601 
                   6  |  -.7170258   .9449706    -0.76   0.448    -2.569134    1.135083 









Hospital Inpatient visits 
*Hurdle Piosson Model 1st part estimates 
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , vce(robust)  
Iteration 0:   log pseudolikelihood = -298.30249   
Iteration 1:   log pseudolikelihood = -280.47312   
Iteration 2:   log pseudolikelihood = -248.85825   
Iteration 3:   log pseudolikelihood =  -248.1469   
Iteration 4:   log pseudolikelihood = -248.14543   
Iteration 5:   log pseudolikelihood = -248.14543   
 
Logistic regression                             Number of obs     =      1,308 
                                                Wald chi2(35)     =     114.70 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood = -248.14543               Pseudo R2         =     0.1681 
 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0161383   .0107411     1.50   0.133    -.0049138    .0371903 
                tobs2 | 
                   1  |   .3538343   .3075652     1.15   0.250    -.2489823     .956651 
                   2  |  -.3799129   .3696586    -1.03   0.304     -1.10443    .3446047 
                2.sex |  -.1249233   .4101811    -0.30   0.761    -.9288634    .6790168 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.5361302   .3672294    -1.46   0.144    -1.255887    .1836262 
                  HS  |  -.1226658   .3280373    -0.37   0.708     -.765607    .5202754 
        SOME COLLEGE  |   .1074975   .3634546     0.30   0.767    -.6048605    .8198555 
              marcat2 | 
                   1  |   .1766569   .3877062     0.46   0.649    -.5832332     .936547 
                   2  |   .2833022   .4267593     0.66   0.507    -.5531306    1.119735 
                   4  |   .3954837   .5543624     0.71   0.476    -.6910465    1.482014 
              bmicat2 | 
                   2  |   .5066758   .3941332     1.29   0.199    -.2658112    1.279163 
                   3  |   .3807568   .3645736     1.04   0.296    -.3337942    1.095308 
              racethx | 
                   1  |   .0483068   .5175404     0.09   0.926    -.9660537    1.062667 
                   3  |   .0356478   .3561874     0.10   0.920    -.6624667    .7337624 
                   4  |   .2072959   .3756397     0.55   0.581    -.5289443    .9435361 
                   5  |   .2674564   .5525373     0.48   0.628    -.8154967     1.35041 
              regcat2 | 
                   1  |  -.2600751   .4516127    -0.58   0.565     -1.14522    .6250696 
                   2  |  -.2209548   .3331348    -0.66   0.507    -.8738871    .4319774 
                   4  |  -.8819413   .4697311    -1.88   0.060    -1.802597    .0387146 
             1.binge2 |  -.1045359   .3243102    -0.32   0.747    -.7401721    .5311003 
               povcat | 
                   1  |  -.1867277   .4363721    -0.43   0.669    -1.042001    .6685459 
                   2  |  -.2653157    .608982    -0.44   0.663    -1.458898    .9282671 
                   3  |  -.4378296   .4693251    -0.93   0.351     -1.35769    .4820307 
                   4  |  -.4810704   .3849748    -1.25   0.211    -1.235607    .2734664 
               inscov | 
                   1  |   .6764091    .639147     1.06   0.290     -.576296    1.929114 
                   2  |   .7901079   .6451614     1.22   0.221    -.4743853    2.054601 
                pcs42 |   -.050687   .0115256    -4.40   0.000    -.0732767   -.0280972 
                mcs42 |  -.0053079   .0200527    -0.26   0.791    -.0446104    .0339947 
              k6sum42 |   .0547161    .053548     1.02   0.307    -.0502361    .1596684 
               phq242 | 




                   2  |  -.8440632   .6312365    -1.34   0.181    -2.081264    .3931376 
                   3  |  -.7373763   .7551436    -0.98   0.329    -2.217431     .742678 
                   4  |    .170513   .6584609     0.26   0.796    -1.120047    1.461073 
                   5  |  -.7686657   1.252487    -0.61   0.539    -3.223496    1.686164 
                   6  |  -.2333355   .9442539    -0.25   0.805    -2.084039    1.617368 
                _cons |  -1.803927   1.785307    -1.01   0.312    -5.303065    1.695211 
--------------------------------------------------------------------------------------- 
  
 *Hurdle Piosson Model estimates 
tpoisson ipngtd c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242  if ipngtd>0 , 
ll(0) vce(robust) 
 
Iteration 0:   log pseudolikelihood =  -895.2041   
Iteration 1:   log pseudolikelihood = -464.83757   
Iteration 2:   log pseudolikelihood = -309.17592   
Iteration 3:   log pseudolikelihood = -192.58375   
Iteration 4:   log pseudolikelihood = -191.13686   
Iteration 5:   log pseudolikelihood = -191.12919   
Iteration 6:   log pseudolikelihood = -191.12919   
 
--------------------------------------------------------------------------------------- 
                      |               Robust 
               ipngtd |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0180873   .0097017     1.86   0.062    -.0009277    .0371023 
                tobs2 | 
                   1  |   .6434621   .3795601     1.70   0.090     -.100462    1.387386 
                   2  |  -.0262953   .3153238    -0.08   0.934    -.6443186     .591728 
                2.sex |   .3836765   .2453334     1.56   0.118    -.0971681     .864521 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.1058688   .3788531    -0.28   0.780    -.8484072    .6366695 
                  HS  |   1.129212   .3476693     3.25   0.001     .4477925    1.810631 
        SOME COLLEGE  |   .0596198   .2674494     0.22   0.824    -.4645715     .583811 
              marcat2 | 
                   1  |   -.386643   .3382997    -1.14   0.253    -1.049698    .2764123 
                   2  |  -.5084107   .3744118    -1.36   0.174    -1.242244    .2254229 
                   4  |   .8624364   .5561576     1.55   0.121    -.2276124    1.952485 
              bmicat2 | 
                   2  |   .4016985    .307116     1.31   0.191    -.2002378    1.003635 
                   3  |   .5039153   .2945032     1.71   0.087    -.0733004    1.081131 
              racethx | 
                   1  |   1.177186   .4885521     2.41   0.016     .2196418    2.134731 
                   3  |   .7728373   .3053966     2.53   0.011     .1742709    1.371404 
                   4  |  -.7064896   .3628239    -1.95   0.052    -1.417612    .0046322 
                   5  |  -.7690285   .4226368    -1.82   0.069    -1.597381    .0593244 
              regcat2 | 
                   1  |    .299896    .465468     0.64   0.519    -.6124044    1.212197 
                   2  |  -.6155872   .3330922    -1.85   0.065    -1.268436    .0372615 
                   4  |   .0082274   .3759822     0.02   0.983    -.7286842    .7451389 
             1.binge2 |  -.3361988   .3757412    -0.89   0.371    -1.072638    .4002404 
               povcat | 
                   1  |   .6774472   .3353876     2.02   0.043     .0200995    1.334795 
                   2  |   -.008223   .4617167    -0.02   0.986    -.9131711    .8967251 
                   3  |   -.763004   .4973438    -1.53   0.125     -1.73778    .2117719 
                   4  |   .5714829   .2903333     1.97   0.049     .0024401    1.140526 
               inscov | 
                   1  |  -.5677419   .5772532    -0.98   0.325    -1.699137    .5636536 
                   2  |  -.3685124   .5060062    -0.73   0.466    -1.360266    .6232416 
                pcs42 |  -.0061151   .0133202    -0.46   0.646    -.0322221     .019992 




              k6sum42 |  -.0795008   .0359464    -2.21   0.027    -.1499545   -.0090471 
               phq242 | 
                   1  |   .0178828   .3683339     0.05   0.961    -.7040385     .739804 
                   2  |   .7663659   .3828313     2.00   0.045     .0160303    1.516702 
                   3  |  -.5101972   .5969091    -0.85   0.393    -1.680118    .6597232 
                   4  |   .0027136   .4633434     0.01   0.995    -.9054229      .91085 
                   5  |  -2.159661   .7731497    -2.79   0.005    -3.675007   -.6443157 
                   6  |   .6569241   .5886077     1.12   0.264    -.4967258    1.810574 
                      | 






*Hurdle Piosson Model 1st part estimates 
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242 , vce(robust)  
Iteration 0:   log pseudolikelihood = -793.51301   
Iteration 1:   log pseudolikelihood =  -719.7301   
Iteration 2:   log pseudolikelihood = -716.58987   
Iteration 3:   log pseudolikelihood = -716.56532   
Iteration 4:   log pseudolikelihood = -716.56532   
Logistic regression                             Number of obs     =      1,308 
                                                Wald chi2(35)     =     123.14 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood = -716.56532               Pseudo R2         =     0.0970 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |  -.0098785   .0058577    -1.69   0.092    -.0213594    .0016025 
                tobs2 | 
                   1  |  -.5306906   .1611925    -3.29   0.001     -.846622   -.2147592 
                   2  |  -.4992461   .1732044    -2.88   0.004    -.8387204   -.1597718 
                2.sex |  -.0402554   .2786983    -0.14   0.885     -.586494    .5059832 
              educat3 | 
COLLEGE GRAD OR HIGH  |   .4721171   .1754653     2.69   0.007     .1282114    .8160229 
                  HS  |   .1470452   .1940867     0.76   0.449    -.2333577    .5274481 
        SOME COLLEGE  |    .256672   .2138055     1.20   0.230    -.1623791     .675723 
              marcat2 | 
                   1  |    .376459   .1752615     2.15   0.032     .0329527    .7199653 
                   2  |   .2126135   .2144062     0.99   0.321     -.207615     .632842 
                   4  |  -.0699466   .2802357    -0.25   0.803    -.6191985    .4793053 
              bmicat2 | 
                   2  |   .0622733   .1700683     0.37   0.714    -.2710543     .395601 
                   3  |  -.0413113   .1746216    -0.24   0.813    -.3835634    .3009408 
              racethx | 
                   1  |  -.0970693   .2249226    -0.43   0.666    -.5379095    .3437709 
                   3  |  -.2286144   .2125018    -1.08   0.282    -.6451103    .1878816 
                   4  |  -.2393281   .1968749    -1.22   0.224    -.6251958    .1465397 
                   5  |  -.5851657   .4601301    -1.27   0.203    -1.487004    .3166728 
              regcat2 | 
                   1  |   .5026442   .2311992     2.17   0.030     .0495021    .9557863 
                   2  |    .432802   .1669266     2.59   0.010     .1056319    .7599722 
                   4  |   .6621034   .1895773     3.49   0.000     .2905386    1.033668 
             1.binge2 |  -.1109451   .1519592    -0.73   0.465    -.4087798    .1868895 
               povcat | 
                   1  |  -.9193867   .2653548    -3.46   0.001    -1.439473   -.3993009 




                   3  |  -1.076715   .2619222    -4.11   0.000    -1.590073   -.5633573 
                   4  |  -.6659233   .1563328    -4.26   0.000    -.9723299   -.3595166 
               inscov | 
                   1  |   1.086058   .3270659     3.32   0.001     .4450203    1.727095 
                   2  |   1.314026   .3544898     3.71   0.000     .6192389    2.008813 
                pcs42 |  -.0019713   .0078739    -0.25   0.802    -.0174038    .0134612 
                mcs42 |   .0050473   .0107243     0.47   0.638    -.0159719    .0260665 
              k6sum42 |   .0186635   .0307805     0.61   0.544    -.0416652    .0789922 
               phq242 | 
                   1  |   .1045737   .2450067     0.43   0.670    -.3756306    .5847779 
                   2  |    .284065   .2721872     1.04   0.297    -.2494121    .8175422 
                   3  |  -.4932559   .4949637    -1.00   0.319    -1.463367    .4768551 
                   4  |   .2911963   .4430826     0.66   0.511    -.5772296    1.159622 
                   5  |  -1.047299    1.28057    -0.82   0.413    -3.557171    1.462572 
                   6  |  -.8675374   .6528331    -1.33   0.184    -2.147067    .4119919 






*Hurdle Piosson Model estimates 
tpoisson dvtot c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov c.pcs42 c.mcs42 c.k6sum42 i.phq242  if dvtot>0 , 
ll(0) vce(robust) 
Iteration 0:   log pseudolikelihood = -548.38111   
Iteration 1:   log pseudolikelihood = -529.50306   
Iteration 2:   log pseudolikelihood = -529.15182   
Iteration 3:   log pseudolikelihood = -529.10636   
Iteration 4:   log pseudolikelihood = -529.09648   
Iteration 5:   log pseudolikelihood = -529.09438   
Iteration 6:   log pseudolikelihood = -529.09391   
Iteration 7:   log pseudolikelihood = -529.09379   
Iteration 8:   log pseudolikelihood = -529.09377   
Truncated Poisson regression                    Number of obs     =        386 
Limits:        lower =          0               Wald chi2(35)     =     204.85 
               upper =       +inf               Prob > chi2       =     0.0000 
Log pseudolikelihood = -529.09377               Pseudo R2         =     0.0772 
--------------------------------------------------------------------------------------- 
                      |               Robust 
                dvtot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0034422   .0054142     0.64   0.525    -.0071695     .014054 
                tobs2 | 
                   1  |  -.0104245     .13819    -0.08   0.940     -.281272     .260423 
                   2  |  -.2172335   .1557458    -1.39   0.163    -.5224896    .0880226 
                2.sex |  -.4912071   .2754773    -1.78   0.075    -1.031133    .0487184 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.0771707   .1721864    -0.45   0.654    -.4146499    .2603084 
                  HS  |  -.0856638   .1688669    -0.51   0.612    -.4166369    .2453092 
        SOME COLLEGE  |  -.2629496   .1986369    -1.32   0.186    -.6522707    .1263715 
              marcat2 | 
                   1  |  -.1054379   .1761199    -0.60   0.549    -.4506265    .2397507 
                   2  |   .0051965   .1697501     0.03   0.976    -.3275077    .3379007 
                   4  |  -.2023416   .2555857    -0.79   0.429    -.7032804    .2985972 
              bmicat2 | 
                   2  |   .5047509   .1653514     3.05   0.002     .1806682    .8288336 
                   3  |   .3242999   .1563735     2.07   0.038     .0178135    .6307863 
              racethx | 
                   1  |  -.0137411   .2094031    -0.07   0.948    -.4241637    .3966815 




                   4  |   .2656673   .1877859     1.41   0.157    -.1023862    .6337209 
                   5  |  -.4896896   .5300754    -0.92   0.356    -1.528618     .549239 
              regcat2 | 
                   1  |   .0502691    .215536     0.23   0.816    -.3721738     .472712 
                   2  |   .0409246   .1720089     0.24   0.812    -.2962066    .3780558 
                   4  |   .2434774   .1748587     1.39   0.164    -.0992393    .5861942 
             1.binge2 |  -.0272248   .1245548    -0.22   0.827    -.2713478    .2168982 
               povcat | 
                   1  |  -.2760822   .2814241    -0.98   0.327    -.8276633     .275499 
                   2  |    .296516   .2745461     1.08   0.280    -.2415846    .8346165 
                   3  |  -.0811298   .2855806    -0.28   0.776    -.6408574    .4785978 
                   4  |    .026816   .1449073     0.19   0.853    -.2571972    .3108292 
               inscov | 
                   1  |   .3951923   .4969009     0.80   0.426    -.5787155      1.3691 
                   2  |   .8502336   .5226723     1.63   0.104    -.1741852    1.874652 
                pcs42 |   -.009872   .0082064    -1.20   0.229    -.0259563    .0062123 
                mcs42 |  -.0089227   .0139343    -0.64   0.522    -.0362335    .0183881 
              k6sum42 |  -.0100694   .0402612    -0.25   0.803    -.0889798     .068841 
               phq242 | 
                   1  |  -.0492447   .1996165    -0.25   0.805    -.4404857    .3419964 
                   2  |  -.0840059   .2205595    -0.38   0.703    -.5162944    .3482827 
                   3  |  -.7843748   .5939681    -1.32   0.187    -1.948531    .3797813 
                   4  |  -.4332627   .3859984    -1.12   0.262    -1.189806    .3232802 
                   5  |  -11.79689   1.099792   -10.73   0.000    -13.95244   -9.641335 
                   6  |  -.5644977   .9787853    -0.58   0.564    -2.482882    1.353886 





Home Health Care visits 
*Hurdle Piosson Model 1st part estimates 
 generate any_off = hhtotdy>0 
logit any_off c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov, vce(robust) 
Iteration 0:   log pseudolikelihood =   -241.085   
Iteration 1:   log pseudolikelihood = -199.90625   
Iteration 2:   log pseudolikelihood = -186.08095   
Iteration 3:   log pseudolikelihood = -185.54356   
Iteration 4:   log pseudolikelihood = -185.53592   
Iteration 5:   log pseudolikelihood = -185.53591   
Logistic regression                             Number of obs     =      1,753 
                                                Wald chi2(26)     =     125.19 
                                                Prob > chi2       =     0.0000 
Log pseudolikelihood = -185.53591               Pseudo R2         =     0.2304 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              any_off |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |   .0392873   .0125304     3.14   0.002     .0147281    .0638465 
                tobs2 | 
                   1  |  -.4117874   .3856154    -1.07   0.286     -1.16758     .344005 
                   2  |  -.0330975   .3393711    -0.10   0.922    -.6982526    .6320576 
                2.sex |  -.1838346   .3724577    -0.49   0.622    -.9138384    .5461691 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -.4973059   .3988767    -1.25   0.212     -1.27909     .284478 
                  HS  |   .0824611   .3779785     0.22   0.827    -.6583631    .8232853 
        SOME COLLEGE  |  -.1680935    .468466    -0.36   0.720     -1.08627     .750083 
              marcat2 | 




                   2  |  -.2219835   .4489408    -0.49   0.621    -1.101891    .6579244 
                   4  |    -1.6054   1.028722    -1.56   0.119    -3.621658    .4108585 
              bmicat2 | 
                   2  |   .3896975   .3861904     1.01   0.313    -.3672219    1.146617 
                   3  |   .1373177    .379374     0.36   0.717    -.6062417    .8808772 
              racethx | 
                   1  |  -.3100632    .640145    -0.48   0.628    -1.564724    .9445979 
                   3  |   .0591062   .3913985     0.15   0.880    -.7080207    .8262331 
                   4  |   .1404872   .5476556     0.26   0.798     -.932898    1.213872 
                   5  |   .4830411   .5934985     0.81   0.416    -.6801946    1.646277 
              regcat2 | 
                   1  |   .2164733   .4793731     0.45   0.652    -.7230808    1.156027 
                   2  |  -.0148554    .402865    -0.04   0.971    -.8044564    .7747455 
                   4  |  -1.933773   1.062189    -1.82   0.069    -4.015626    .1480788 
             1.binge2 |  -.4355634   .4302853    -1.01   0.311    -1.278907    .4077803 
               povcat | 
                   1  |   1.201492   .5592529     2.15   0.032     .1053766    2.297608 
                   2  |   1.261699   .7011311     1.80   0.072    -.1124925    2.635891 
                   3  |   .1430912   .6722072     0.21   0.831    -1.174411    1.460593 
                   4  |   1.065295   .4997887     2.13   0.033     .0857276    2.044863 
               inscov | 
                   1  |   1.089894   1.072962     1.02   0.310    -1.013073     3.19286 
                   2  |   2.189757   1.038439     2.11   0.035      .154455     4.22506 









*Hurdle Piosson Model estimates 
tpoisson hhtotdy c.agelast ib3.tobs2 i.sex ib3.educat3 ib3.marcat2 i.bmicat2 ib2.racethx 
ib3.regcat2 i.binge2 ib5.povcat ib3.inscov  if hhtotdy>0 , ll(0) vce(robust) 
Iteration 0:   log pseudolikelihood = -740.93191   
Iteration 1:   log pseudolikelihood = -732.23292   
Iteration 2:   log pseudolikelihood = -732.13868   
Iteration 3:   log pseudolikelihood = -732.13846   
Iteration 4:   log pseudolikelihood = -732.13846   
Truncated Poisson regression                    Number of obs     =         47 
Limits:        lower =          0               Wald chi2(23)     =          . 
               upper =       +inf               Prob > chi2       =          . 
Log pseudolikelihood = -732.13846               Pseudo R2         =     0.6867 
--------------------------------------------------------------------------------------- 
                      |               Robust 
              hhtotdy |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
----------------------+---------------------------------------------------------------- 
              agelast |  -.0161357   .0178378    -0.90   0.366     -.051097    .0188257 
                tobs2 | 
                   1  |  -.9307224   .6100287    -1.53   0.127    -2.126357    .2649119 
                   2  |  -.2067102   .3422505    -0.60   0.546    -.8775088    .4640884 
                2.sex |   1.169077   .3930684     2.97   0.003     .3986772    1.939477 
              educat3 | 
COLLEGE GRAD OR HIGH  |  -1.235567    .782363    -1.58   0.114     -2.76897    .2978368 
                  HS  |  -1.210934    .260059    -4.66   0.000     -1.72064   -.7012275 
        SOME COLLEGE  |  -1.233186   .4045504    -3.05   0.002     -2.02609   -.4402817 
              marcat2 | 
                   1  |  -.1393737   .4907958    -0.28   0.776    -1.101316    .8225684 
                   2  |   .3095278   .6581212     0.47   0.638    -.9803661    1.599422 




              bmicat2 | 
                   2  |   .5265402   .4215924     1.25   0.212    -.2997657    1.352846 
                   3  |  -.1182179   .5414623    -0.22   0.827    -1.179464    .9430287 
              racethx | 
                   1  |   .5674279   .4973629     1.14   0.254    -.4073855    1.542241 
                   3  |  -.2495987   .3079433    -0.81   0.418    -.8531565    .3539592 
                   4  |  -1.395812   .7107053    -1.96   0.050    -2.788769   -.0028549 
                   5  |  -1.322271   1.193616    -1.11   0.268    -3.661716    1.017175 
              regcat2 | 
                   1  |  -.3187938   .8531722    -0.37   0.709    -1.990981    1.353393 
                   2  |   .8849095   .5080861     1.74   0.082    -.1109209     1.88074 
                   4  |   2.082465   .7657232     2.72   0.007     .5816756    3.583255 
             1.binge2 |  -.4362296   .6474849    -0.67   0.500    -1.705277    .8328175 
               povcat | 
                   1  |   .6568208   1.074768     0.61   0.541    -1.449687    2.763328 
                   2  |  -.1562196   1.070479    -0.15   0.884     -2.25432     1.94188 
                   3  |   .1061492   1.014628     0.10   0.917    -1.882485    2.094783 
                   4  |  -.3489774   .9604565    -0.36   0.716    -2.231438    1.533483 
               inscov | 
                   1  |   .8689721   .5387951     1.61   0.107    -.1870469    1.924991 
                   2  |    .889071   .5077466     1.75   0.080     -.106094    1.884236 
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SUMMARY 
Experienced research professional with proven abilities in statistical planning, analysis and 
reporting for scientific research including clinical, product, and consumer research studies. 
Substantial experience in population modeling and epidemiological, reduced harm, risk 
assessment and product support studies.  Results oriented with the ability to work individually 




❖ 16 years’ experience as a biostatistician working on multiple types of studies and analysis. 
❖ Experienced in Population Modeling and Decision analysis 
❖ Possess a broad knowledge of statistical modeling and analysis with emphasis on statistical 
applications and methodologies in both the Clinical/Public health research and industrial 
settings.  
❖ Demonstrated strong analytical, qualitative and quantitative abilities. 
❖ Possess a strong knowledge of public health issues and demonstrated experience in 
Epidemiology.   
❖ Experienced in report writing, manuscript writing and poster presentations. Published 
work includes 18 manuscripts and 21 scientific abstracts. 
❖ Proven record of team and individual performance, project/vendor management, 
communication and presenting to diverse audiences. 
 
EDUCATION      
 
School of Pharmacy, Virginia Commonwealth University, Richmond, VA                
Doctor of Philosophy (PhD), Pharmacoeconomics and Health Outcomes  
Expected May 2021 
 
Rollins School of Public Health, Emory University, Atlanta, GA                
Master of Science in Public Health, Biostatistics    May 2004 
Thesis: A Comparison of Missing Data Methods for Evaluating a Drug Treatment for 
Depression (Longitudinal data analysis). Charles C. Shepard Award finalist for the best Thesis 
in the Rollins School of Public Health. 
 
Saint Mary’s University, Halifax, Canada 




 Dean’s List throughout my undergraduate program     
 
PROFESSIONAL EXPERIENCE   
 
Principal Scientist II, Altria Client Services, Richmond, VA 2020-present 
Population Science, Lead the Population Assessment and Statistics Team 
 
Lead the development and execution of population assessment strategies, monitoring of 
surveillance systems and provide advance statistical  expertise  to determine the population 
impact related to product standards and reduced risk products.  
 
Principal Scientist I, Altria Client Services, Richmond, VA 2017-present 
Population Science, Lead the Population Health Impact Team 
 
Provide population modeling and statistical expertise to determine the population health 
impact related to product standards and reduced risk products.  
 
Some specific Accomplishments: 
 
• Lead the development and validation of two population health models; a Cohort based 
and Agent-based model to assess the overall health impact of reduce risk products on the 
U.S. population.  
• Designed experiments and conducted various statistical analyses using an array of 
statistical methodologies to support regulatory science.  
 
 
Senior Research Scientist (Senior Biostatistician), Altria Client Services, Richmond, 
VA 2010-2017 
Modeling & Simulation and Health Sciences    
 
Provide statistical expertise to accelerate product development, facilitate cost savings and 
assess tobacco use behavior, exposure, and population health effects.  
 
Some specific Accomplishments: 
• Lead the efforts in the development of dynamic population health effect models.  
• Performed various statistical analyses, designed experiments for various projects 
and model development.  
• Investigate and analyze data from publicly available surveys.  
• Applied innovative Missing Data techniques to evaluate the effect of menthol and 
nicotine under different sensations (Psychophysical data analysis). 
• Analyze data to answer questions posed by Federal Regulatory Agencies. 
• Evaluate the reliability and reproducibility of analytical lab data.  
  
Research Scientist (Biostatistician), Altria Client Services, Richmond, VA   2005- 2010 




Provided statistical expertise, lead and /or collaborate with Contract Research Organizations to 
facilitate the statistical analysis of clinical studies, including the review, revision and editing of 
study protocols, case report forms, data management plans, statistical analysis plans, statistical 
reports, clinical study reports and other study related documents. 
                                                                             
Some specific Accomplishments: 
• Performed multiple in-house analyses including linear and non-linear mixed models, 
general linear models, analysis of variance and covariance, regression analysis, logistic 
regression, etc. in lieu of hiring outside statistical firm, resulting in cost-savings to 
company. 
• A lead statistician for a 5000 participant clinical study with over 700 variables, including 
demographics, Biomarkers of exposure, Biomarkers of Potential Harm, behavior 
questions, etc.  
• Chosen as subject matter expert for extensive Survey Data Analysis (182 item 
Questionnaire) - including demographics, behavior questions, factor analysis and trend 
analysis, enabling the completion of the project and publication of results ahead of 
schedule. 
• Designated statistical expert on numerous clinical research studies which evaluated 
potential reduced risk products and biomarkers of potential harm. 
• Managed Contract Research Organizations, supervising seven (7) projects through 
inception to final report, writing statements of work, budgeting, and presenting results 
ahead of schedule and at a cost-savings to company.                           
• Statistical report writing, manuscript writing, poster presentations and PowerPoint 
presentations to various groups within the company and external audiences. 
• Introduced statistical techniques (Bland-Altman method) which enabled clinical 
evaluation to determine that spot-urine collection was comparable to 24hr urine 
collection which would, when implemented, result in cost-savings to the company.   
• Aided in the development of standard operating procedures (SOPs) for the 
Biostatistics and Data Management group and the Clinical Evaluation department. 
 
 
Biostatistician – Kelly Scientific Services, 2004 – 2005,  
Contractor, Clinical Evaluation  
 
Took initiative on assignments and was offered full-time permanent position within 3 
months of working in Clinical Evaluation group.                                                                     
• Performed a wide range of statistical analyses on data from clinical studies-e.g. 
descriptive statistics, general linear models, linear and non-linear mixed models, 
regression analysis, analysis of variance and covariance, etc.  
• Wrote statistical reports, tabulated results and produced graphs of findings with MS 
Excel and SAS graph. 
 
Research Assistant –Rollins School of Public Health, Biostatistics Consulting Center, 





Provided statistical and data management support for various studies, including a Suicide 
Prevention study, Birth control survey, Depression study, and a Parkinson Disease  study.  
 
• Performed statistical analyses e.g. Paired analysis, logistic regressions, summary 
statistics, Friedman’s test, Chi-square test, Fisher test etc. 
• Performed statistical analyses for a Birth Control Survey involving 502 individuals; 
looking at 27 variables, including demographic and behavioral knowledge of 
women ranging from ages 25 to 45.  
• Created tables and figures to facilitate communications among professional peers 
and to give a comprehensive summary of the findings of the studies.     
• SAS programming created SAS datasets and MS Excel spreadsheets. Collected, 
entered and cleaned data.  
 
COMPUTER SKILLS      
Proficient with SAS software, JMP, SPLUS, SPSS, R, Minitab, nQuery Advisor, Epi Info, 
experience with MATLAB and MARS software.            
 
SELECTED CONTINUING EDUCATION  
 
❖ Meta-Analysis: Combining Results of Multiple Studies, August 2015 
❖ Advanced Decision Modeling for Health Economic Evaluations, May 2015 
❖ Applications in using Large Databases, May 2015 
❖ Cost-Effectiveness Analysis alongside Clinical Trials, May 2015 
❖ Introduction to Modeling methods, May 2014 
❖ Agent-Based Modeling for Economic Evaluations, June 2014 
❖ SAS® Procedures for Analyzing Survey Data, August 2013 
❖ Patient-Reported Outcomes- Item Response Theory, May 2013 
❖ Bayesian Analysis- Overview and Applications, May 2013 
❖ Applying Mixed methods to Establish content validity of Patient-Reported, 
Clinician-Reported and Observer-Reported Outcome Assessment Instruments, May 
2013 
❖ Successful Data Mining in Practice, May 2013 
❖ Kepner-Tregoe Training: Problem solving and Decision making, November, 2012 
❖ Data Mining, Knowledge Modeling and Causal Analysis with Bayesian Belief 
Networks, October, 2011     
❖ Introduction to Mars: Predictive Modeling with Nonlinear Automated 
Regression Tools, August, 2007   
❖ Advances in Data mining: Jerome Friedmans’s TreeNet/MART and Leo 
Breiman’s Random Forests, August, 2007    
 
ADDITIONAL INFORMATION        
 
❖ Member of the American Statistical Association - Member since 2003   
❖ Member of International Society For Pharmacoeconomics and Outcomes Research - 
Member since 2013   




❖ Marquis Who's Who in America 2012 (Sixty-sixth Edition) 
❖ Finalist for the Charles C. Shepard’s Award for Best Thesis 2004, Emory University, 
Rollins School of Public Health 






Wei, L., Muhammad-Kah, R.S., Hannel, T. et al. (2020). The impact of cigarette and e-
cigarette use history on transition patterns: a longitudinal analysis of the population assessment 
of tobacco and health (PATH) study, 2013–2015. Harm Reduct J 17, 45  
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